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Text 1. Snakebite Antivenom Development 
Doctors Without Borders now describes snakebites as “one of the world’s most 
neglected public health emergencies” 
                                                               Pre-reading 
 
■ Work in pairs. Discuss the 
following questions and try to 
answer them. Then quickly scan the 
text to check your answers. 
1. What is venom? 
2. What do you know about 
snakebites? 
3. Do you know, in what countries 
people most often meet snakes? 
 
■ Read the given text and make your essential assignments: 
Modern medicine can grow kidneys from scratch, halt the spread of 
infectious diseases such as Ebola and diagnose the cause of a cough with a 
smartphone, yet snakebites still thwart us. Every year venom from snakes kills 
nearly 200,000 people and leaves hundreds of thousands disfigured or disabled, 
making these legless squamates the second deadliest animal. Only mosquitoes may 
kill more people every year (by spreading the protozoa that cause malaria). 
Venomous snakes recently slithered their way back into the news when it 
came to light that leaders in the pharmaceutical world had ceased developing 
antidotes. French drug company Sanofi Pasteur, for example, made headlines in 
September, when Doctors Without Borders pointed out that the final batch of 
FAV-Afrique—the only antivenom proved to effectively treat snakebite victims in 
sub-Saharan Africa—expires in June 2016. Sanofi, its sole manufacturer, had 
ended production in 2014 because the drug was not making enough money. Others 
in the industry had already made similar moves, including Behringwerke and 
Wyeth Pharmaceuticals (now part of Pfizer). 
The treatment situation has become so dire that Doctors Without Borders 
now describes snakebites as “one of the world's most neglected public health 
emergencies.” And in October dozens of experts at the 18th World Congress of the 
International Society on Toxinology in Oxford, England, called for the World 
Health Organization to relist snakebite as a neglected tropical disease. Most bites 
occur in Africa and Southeast Asia. 
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Antivenom development is stuck in the 19th century because the field is 
underfunded, says David Williams, a clinical toxinologist and herpetologist who 
heads the Australian Venom Research Unit at the University of Melbourne and is 
also CEO of the Australian nonprofit Global Snakebite Initiative. To isolate 
compounds for treatment, researchers typically inject subtoxic levels of venom into 
animals, collect the antibodies formed by the immune response and purify the 
result. Antivenom must be tailored to an array of toxins across different regional 
snake species. No universal antidote exists. 
Despite constraints, small research groups around the world are quietly 
working away at new, exciting solutions—waiting for a windfall of money and 
momentum. The most innovative of them is a targeted antivenom designed for sub-
Saharan Africa that could serve as a blueprint for making cheaper compounds to 
counter bites from snakes found in other regions. Researchers from the U.K., Costa 
Rica and Spain started with proven “base antivenom” for three snakes and have 
begun screening it against toxins from additional snakes. Venom proteins that fail 
to bind to the base antivenom are screened for toxicity; only proteins identified as 
dangerous toxins become part of the immunizing mixture used to make the next 
antivenom batch more effective. 
Such selective screening and iterative testing of specific proteins make for a 
stronger, targeted antidote compared with conventional antivenoms, which 
indiscriminately neutralize both toxic and nontoxic venom proteins. The group also 
plans to cut costs with a method pioneered in Costa Rica that requires fewer 
manufacturing steps. “Our goal is to make a product for sub-Saharan Africa that is 
cheaper or as cheap as $35 a vial,” says Robert Harrison, head of the Alistair Reid 
Venom Research Unit at the Liverpool School of Tropical Medicine in England. 
Sanofi's product costs $150 per vial. 
Other animals—and bacteria—may provide alternative antivenom. An 
opossum protein first identified in the 1990s has since been shown to protect mice 
from snake toxins that can cause widespread internal bleeding. Moreover, the 
protein neutralized hemorrhagic toxins from venomous snakes in both the U.S. and 
Pakistan. The finding suggests that the protein might possibly defend against all 
hemorrhagic snake toxins, says Claire Komives, a chemical engineer at San José 
State University. Komives has already demonstrated that she can 
engineer Escherichia coli bacteria to make the protein—which could reduce the 
cost of treatment to around $10 a dose. “I'm trying to make it in bacteria because 
we can scale [up production] cheaply,” she says.  
 Groups elsewhere have turned away from traditional antidote development 
altogether. Matthew Lewin, director of the Center for Exploration and Travel 
Health at the California Academy of Sciences, has begun screening existing fda-
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approved drugs for chemical ingredients that could form the basis of an injection or 
pill that stabilizes people bitten in the field or at least gives them time to reach a 
hospital. “If you had a pharmaceutical antidote, you could have it on your person,” 
Lewin says. Many snakebite deaths happen when victims cannot reach hospitals or 
clinics to receive an intravenous antivenom treatment. 
Similarly, Sakthivel Vaiyapuri, a pharmacology researcher at the University 
of Reading in England, is screening for molecules that block the effects of snake 
venom. He also hopes to eventually develop a cocktail of chemical inhibitors that 
could lead to a universal antidote. 
Modernized antivenom treatments would represent a solid first step toward 
reducing deaths from snakebites. Yet in the end, the best treatments in the world 
will fail without funding and distribution. “If the ministries of health responsible 
for health and well-being don't prioritize snakebite treatment,” says Williams of the 
Global Snakebite Initiative, “you're banging your head against a brick wall.” 
Scientific American December 1, 2015 
http://www.scientificamerican.com/article/snakebite-antivenom-
development-is-stuck-in-the-19th-century-what-s-next/ 
■ Glossary of essential terms  
№ English term Russian equivalent 
1. snakebite укус змеи 
2. venom яд 
3. squamates чешуйчатые 
4. protozoa  простейшие 
5. Doctors Without 
Borders 
«Врачи без границ» (международная независимая 
гуманитарная медицинская организация) 
6. batch партия 
7. kidney почки 
8. scratch ноль  
9. thwart сорвать 
10. cough кашель 
11. slither уползать 
12. dire остро 
13. underfunded недофинансированный 
14. tailor подогнать, приспособлять, адаптировать 
15. despite несмотря 
16. widespread широко распространенный 
17. hemorrhagic геморрагический 
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18. scale масштаб 
19. pill таблетка 
20. approved утвержден 
21. bang стучать 
22. halt остановить 
23. victim жертва 
24. expire терять силу, истекать, заканчиваться 
25. treatment лечение  
26. neglect пренебречь, забросить 
27. toxinologist токсиколог 
28. herpetologist герпетолог 
29. nonprofit некоммерческий 
30. antibodies антитела 
31. target цель, намечать 
32. blueprint модель, шаблон 
33. mixture смесь 
34. iterative повторяющийся 
35. vial флакон, пузырёк, ампула 
36. hemorrhagic геморрагический 
37. FDA-approved 
Food and Drug 
Administration 
Одобренный управлением по санитарному 
надзору за качеством пищевых продуктов и 
медикаментов  
38. brick кирпичный 
39. rattlesnake гремучая змея 
40. cords связки 
41. recurved hooks загнутые назад крючки 
■ Your Essential Assignments 
I. Quick check  
1. Why did many pharmaceutical companies stop production of antidotes? 
2. Briefly describe new tendencies in antidotes researches. 
3. How are researchers going to reduce the price of the antidote? 
II. Fill in the missing words: 
Term (verb) Noun Adjective 
exist ....... ....... 
develop ....... ....... 
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demonstrate ....... ....... 
neglected ....... ....... 
select ....... ....... 
produce ....... ....... 
isolate ….. …… 
III. Use monolingual English dictionary and write down what could the 
words given below mean: 
nonprofit; antibodies; subtoxic; reduce; widespread. 
IV. Find English equivalents to the following word combinations: 
№ Russian term English equivalent 
1. змеиные укусы всё ещё беспокоят нас  
2. безногие чешуйчатые  
3. прекратили разработку противоядий  
4. единственный производитель  
5. выделить (изолировать) соединение для 
лечения 
 
6. иммунный ответ  
7. несмотря на ограничения  
8. без разбора нейтрализуют как токсичные, так 
и нетоксичные белки 
 
9. животные и бактерии могут вырабатывать 
альтернативное противоядие 
 
10. защищает от всех токсинов  
11. внутривенное введение противоядия  
12. сходным образом (так же)  
13. коктейль из химических ингибиторов  
V. Give Russian equivalents to the following English phrases: 
№ English phrase Russian equivalent 
1. leaves hundreds of thousands disfigured or 
disabled 
 
2. Malaria, which is transmitted by mosquitoes, 
kills the most people each year. 
 
3. Venomous snakes recently slithered their way 
back into the news. 
 
4. This is one of the world's neglected emergencies.  
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5. to counter bites  
6. Antivenom must be tailored to an array of toxins 
across different regional snake species. 
 
7. The researchers have already demonstrated that 
bacteria with altered genome can produce an 
antidote. 
 
8. waiting for a windfall of money and momentum  
9. that requires fewer manufacturing steps  
10. is screening for molecules that block the effects 
of snake venom 
 
11. The best treatments in the world will fail without 
funding and distribution. 
 
VI. Find synonyms among the pool of words: 
Pool of words Synonyms 
1) 1.slither/2. explore/3.research/4. slip/5.glide  
2)1.innovative/2.introduce/3.advanced/4.progressive/5.inject/ 
6.input 
 
3)1.characteristically /2.effective/3. acting/4. typically  
4)1.manufactur/2.identifiy/3.produce/4.fabricate/ 
5.recognize 
 
VII. Answer the following questions. Use all information given before: 
1. Can scientists introduce a universal antidote? 
2. What animal kills the most people every year? 
3. What is screening? 
4. What do you think, why the sale of antidotes are not profitable for the 
pharmaceutical companies? 
5. Do enough African countries receive vials of antidote against snake venom? 
6. Why researchers want to use the modified bacterial gene for production of 
antivenoms? 
7. Is it true that most people die, because of a lack of a vaccine in the 
hospitals? 
8. In what countries do small groups of scientists work on development of 
innovative antidote? 
9. Doctors without Borders tried to draw attention to the problem of snake 
bites. Why do they do it? 
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VIII. Match the sentence halves. Make complete sentences: 
1. Every year venom from 
snakes kills 
A. “one of the world's most neglected public 
health emergencies.” 
2. Sanofi, its sole manufacturer B. nearly 200,000 people and leaves 
hundreds of thousands disfigured or 
disabled 
3. Doctors Without Borders 
now describes snakebites as 
C. collect the antibodies formed by the 
immune response and purify the result. 
4. 
 
Researchers typically inject 
subtoxic levels of venom into 
animals 
D. had ended production in 2014 because the 
drug was not making enough money. 
5. The most innovative of them 
is a targeted antivenom 
E. the protein might possibly defend against 
all hemorrhagic snake toxins 
6. The group also plans to cut 
costs with a method 
pioneered in Costa Rica 
F. that requires fewer manufacturing steps. 
7. The finding suggests that  G. you could have it on your person. 
8. If you had a pharmaceutical 
antidote 
H. designed for sub-Saharan Africa. 
 
Text 2. “Improving" Humans with Customized Genes 
Sparks Debate among Scientists” 
Pre-reading 
 
 
 
 
■ Work in pairs. Discuss the 
following questions and try to 
answer them. Then quickly scan the 
text to check your answers. 
1. What do you know about gene 
edition? What do you think about 
that?  
2. What is CRISPR? Do you know 
what is it? 
3. What genetic diseases do you 
know? 
11 
 
Exercise A. Match the words with their definitions: 
1. gene A is the genetic material of an organism, it consists of 
DNA (or RNA in RNA viruses), includes both the 
genes and the non-coding sequences of the DNA/RNA. 
2. heredity B is the passing of phenotypic traits from parents to their 
offspring, either through asexual reproduction or sexual 
reproduction. 
3. mutation C is the product of reproduction of a new organism 
produced by one or, in the case of sexual reproduction, 
two parents. 
4. genome D are macromolecular biological catalysts. 
5. genomic 
mutation 
E is a molecule that carries most of the genetic 
instructions used in the development, functioning and 
reproduction of all known living organisms and many 
viruses. 
6. offspring F is a particular abnormal condition, a disorder of a 
structure or function, that affects part or all of an 
organism. 
7. enzyme G is a nucleic acid sequence on double-stranded DNA or 
RNA wherein reading 5' (five-prime) to 3' (three prime) 
forward on one strand matches the sequence reading 
backward 5' to 3' on the complementary strand with 
which it forms a double helix. 
8. DNA H is a packaged and organized structure containing most 
of the DNA of a living organism. 
9. RNA I changes in the number of chromosomes. 
10. chromosome K is a polymeric molecule implicated in various 
biological roles in coding, decoding, regulation, and 
expression of genes. 
11. disease L is a permanent alteration of the nucleotide sequence of 
the genome of an organism, virus, or extrachromosomal 
DNA or other genetic elements. 
12. palindromic 
sequence 
M is a locus (or region) of DNA that encodes a functional 
RNA or protein product, and is the molecular unit of 
heredity. 
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■ Discuss these questions with your partner and your class. 
1. Do you know what eugenics is? 
2. Do you know anything about the Convention on Biomedicine and Human 
Rights? 
3. There is a positive and negative eugenics. What do you think about each 
of them? 
■ Read the given text and make your essential assignments: 
“Today we sense we are close to be being able to alter human heredity,” 
Nobel Laureate and California Institute of Technology virologist David Baltimore 
said December 1 at the opening of a much-anticipated human gene editing summit 
taking place in Washington, D.C. this week. Gene editing, or tweaking the human 
genome with additions, subtractions or alterations, is becoming increasingly 
realistic with modern technologies. “When will we be prepared to say we are 
justified to use gene editing for human enhancement purposes?” he asked. 
Part of the problem for researchers, doctors and ethicists alike is defining 
“enhancement” and deciding if it would be a move in the right direction, as the 
word would suggest. Is enhancement merely referring to boosting muscle tone and 
other desirable traits like achieving perfect pitch or does the term also encompass 
steps to guarantee better health by preventing disease? Some scientists disagreed 
over whether certain types of gene-editing would be important for helping patients, 
with one prominent researcher contending the technology would not often be 
needed, while another described dire current clinical needs for it. The international 
summit on gene editing, sponsored by Britain’s Royal Society, the Chinese 
Academy of Sciences, and the US National Academies, has grappled with such 
thorny questions during three days of sometimes-heated discussion on editing the 
human genome that comes to a close today. 
Baltimore, who is chairing the summit, believes that when it comes to 
drawing the line for enhancement, the determining factor is whether the change 
would be optional versus therapeutic. “To my mind enhancement is really 
optional,” he says. “You are not solving a life-threatening issue.” Making a change 
to the PCSK9 gene, for example, would lower the risk of cardiovascular disease 
and for someone with high LDL—the bad kind of cholesterol – it could be the 
difference between life and death, he says. In that case the intervention would be 
therapeutic. Whether or not to engage in future “improvements” that are 
considered more optional, however, remains murky. 
Take the DEC2 gene. Tweaking it could make a person function like the 
rare individuals who are born with a variant that allows them to function well with 
just a few hours of sleep. That trait is not necessary for most people, but it could be 
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useful for a solider in the battlefield, for example. Ultimately, enhancements of 
many kinds will “definitely” happen in the future, says Fyodor Urnov of Sangamo 
BioSciences, a company that is working in the gene editing space. The bigger 
question, he says, is when it will happen. 
Cheaper, and more efficient, gene editing technology that allows scientists 
to manipulate the human genome with greater ease and precision than ever before 
is forcing researchers to consider these questions quickly. Most notably, 
researchers are eyeing CRISPR—short for the cumbersomely-named clustered 
regularly interspaced short palindromic repeats. CRISPR is a powerful technology 
that allows editing—by way of replacing or repairing—of multiple genes at once in 
animal, plant and human cells. This biological dynamo could help unlock 
understanding of basic human biology and also help patients in need of medical 
care. The method has also sparked new ethical controversy. Last spring researchers 
in China announced they used CRISPR to alter the genomes of nonviable human 
embryos which could not develop into babies. They discovered the method is not 
yet accurate enough to be utilized in human embryos and also that it appeared to 
introduce unexpected mutations to other parts of the genome. Ultimately, this 
week’s discourse will lead to a consensus statement providing some guidance on 
how to approach using this and older gene editing technologies such as zinc finger 
nucleases and enzymes called transcription activator-like effector nucleases, or 
TALENs. Meanwhile, the National Academies are working on separate studies 
related to how to address these questions for work in other species. 
At issue this week is when and how to apply gene editing for research and clinical 
applications in humans. Gene editing could include altering genes in one person—
say to treat leukemia in one patient or make a cosmetic change—but, more 
controversially, it could also include making changes to the germ line that would 
then alter the genome for an individual’s children, grandchildren and the following 
generations, with potentially unknown repercussions. 
Although most scientists at the meeting appear enthusiastic about 
conducting gene editing work to cure diseases in individual patients they remain 
more wary of making changes to eggs, sperm or embryos that would have lasting 
repercussions in future generations. The former target, say, using gene editing 
techniques to inactivate HIV receptors and achieve resistance of blood cells to the 
virus (which Sangamo BioSciences is working on in clinical trials) is different than 
helping parents who both carry genes for Huntington’s Disease to have a child that 
is free of the disease (a change to the genome that would be passed on to future 
generations and would likely not be very commonly needed). 
For his part, Eric Lander from the Broad Institute said in a December 1 
presentation at the summit that the need to employ germ line editing would remain 
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very, very rare thanks to other already available reproductive technologies like in-
vitro fertilization that could help most people. What’s more important for avoiding 
genetic diseases is boosting access to gene testing so people can be more aware 
they are carriers for disease, he said. “What we should be thinking about is the vast 
majority of people with a recessive disease were not aware that they were carriers,” 
he said. Armed with that genetic data, people could then employ existing aides like 
IVF or pre-implantation genetic diagnosis to conceive healthy offspring. 
Yet at the clinical level the need for such germ line editing seems more real 
and arguably commonplace. George Daley of Harvard Medical School said on 
December 1 that he and his team have seen multiple patients affected by NEMO 
deficiency syndrome, a disorder where an inherited faulty gene results in a weak 
immune system and leaves patients prone to serious infections. To care for such 
patients, his team has seen families that try to have a second child– sometimes 
nicknamed a “savior sibling”—in the hopes that the second child’s bone marrow 
can be employed to help the older sibling. Yet by the time families try to conceive 
their second child the parents are older and that likely contributes to why they have 
trouble getting pregnant quickly via IVF, he says. In such instances families could 
save time and perhaps achieve greater success if CRISPR was on the table to help 
ensure a single embryo with good results, he says. The question boils down to if 
one should consider purely the statistics or the human, says Baltimore. But either 
way, even if such circumstances are rare, they still exist and cannot be ignored. 
Perhaps the fact that CRISPR could be performed is reason enough to leave it on 
the table. 
The need for guidance on how to attack these issues is undeniable 
considering the range of opinions at the conference. But guidance is not law. That 
may actually be a good thing. Guidance can remain more nimble than law and it is 
easier to get consensus among scientists working in the area than among 
individuals who do not work in the field, Baltimore says. In the absence of any 
international body that would be an obvious fit to enforce international regulations 
on gene editing there are historical precedents—like stem cell research—for 
providing guidance and then leaving the specifics up to regional authorities. Once 
the consensus statement is issued, either today or in the coming weeks and months, 
patients, lab scientists, ethicists and medical workers will be carefully watching 
what comes next. 
           Scientific American December 3, 2015 
http://www.scientificamerican.com/article/improving-humans-with-
customized-genes-sparks-debate-among-scientists1/ 
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■ Glossary of essential terms 
№ English term Russian equivalent 
1 heredity наследственность 
2 virologist вирусолог 
3 much-anticipated долгожданный 
4 gene editing генное редактирование 
5 tweaking тонкая настройка 
6 alteration внесение изменений 
7 subtraction вычитание 
8 prepared подготовленный 
9 justified оправдано 
10 enhancement усиление, улучшение 
11 purpose цель 
12 direction направление 
13 merely просто 
14 referring ссылаться 
15 boosting повышение 
16 desirable желательный 
17 pitch подача 
18 prominent известный 
19 dire ужасный, кошмарный 
20 current текущий, современный 
21 summit саммит 
22 grapple сцепиться 
23 thorny тернистый, острый 
24 chairing возглавляющий 
25 versus против 
26 solving решение 
27 cardiovascular disease сердечно-сосудистое заболевание 
28 intervention вмешательство 
29 murky темный, туманный 
30 trait черта 
31 battlefield поле боя 
32 efficient эффективный 
33 precision точность 
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34 notably особенно 
35 sparked загорелся 
36 nonviable нежизнеспособные 
37 guidance руководство 
38 meanwhile между тем 
39 germ line зародышевая линия 
40 repercussions последствия 
41 former бывший 
42 resistance устойчивость 
43 very очень 
44 area область 
45 aware известно 
46 conceive забеременеть 
47 arguably возможно 
48 commonplace банальный 
49 disorder расстройство 
50 savior спаситель 
51 bone marrow костный мозг 
52 pregnant беременная 
53 ensure убедиться 
54 undeniable бесспорно 
55 consensus консенсус 
56 absence отсутствие 
■ Your Essential Assignments: 
I. Quick check: 
1. What is CRISPR? 
2. How can we know whether we have a genetic mutation? 
3. How will CRISPR be able to help families, who want to have a healthy 
baby? 
II. Fill in the missing words: 
         Verb Noun 
define  
absent  
pregnant (become pregnant)  
intervene  
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enhance  
tune  
chair  
III. Use a monolingual English dictionary and give the definitions of the 
words below: 
guidance; intervention; enhancement; nonviable; heredity. 
IV. Find English equivalents to the following word combinations: 
№ Russian term English equivalent 
1 настройка генома человека с помощью 
дополнений, вычитаний и изменений 
 
2 относится к повышению мышечного тонуса  
3 меры, гарантирующие улучшение здоровья  
4 выдающийся исследователь  
5 бурные дискуссии  
6 разграничение, необходимое для улучшений  
7 разница между жизнью и смертью  
8 этические противоречия  
9 внесение изменений в зародышевую линию  
10 спаситель родного брата  
11 стволовые клетки  
12 руководство может оставаться более гибким  
V. Suggest Russian equivalents for the following word combinations: 
№ English term Russian equivalent 
1 tweaking the human genome  
2 who is chairing the summit  
3 to drawing the line  
4 solving a life-threatening issue  
5 lower the risk of cardiovascular disease  
6 more efficient  
7 unexpected mutations to other parts of the genome  
8 transcription activator-like effector nucleases  
9 the former target  
10 inactivate HIV receptors  
11 to conceive healthy offspring  
12 more nimble  
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VI. Find synonyms among the pool of words: 
Pool of words Synonyms 
1) heredity\long-awaited\inheritance\much-anticipated  
2) prominent\thorny\known\acute\famous\sharp  
3) merely\current\simply\feature\actual\trait  
4) savior\stability\redeemer\former\resistance\ex  
 
VII. Answer the following questions. Use all information given before. 
1. Why don’t scientists want to introduce gene editing to the masses? 
2. What "enhancements" of the human can you offer? 
3. How can genes be edited? 
4. What did researchers from China work with, applying CRISPR-system? 
5. Is there an accumulation of mutations at generations because of big 
survival of the population of Earth nowadays? 
6. What ethical problems can scientists face with? 
7. Why do people, who have a child with the NEMO syndrome, want to 
have a second baby? What for? 
8. What is better for scientists: guidance or law? 
VIII. Match the sentence halves. Make complete sentences: 
1. Part of the problem for 
researchers, doctors and 
ethicists alike is defining 
A. with greater ease and precision than ever 
before is forcing researchers to consider 
these questions quickly. 
2. Baltimore, who is chairing 
the summit, believes that 
B. is different than helping parents who both 
carry genes for Huntington’s Disease to 
have a child that is free of the disease (a 
change to the genome that would be 
passed on to future generations and would 
likely not be very commonly needed). 
3. Tweaking it could make a 
person function like 
C. to attack these issues is undeniable 
considering the range of opinions at the 
conference. 
4. Cheaper, and more efficient, 
gene editing technology that 
allows scientists to 
manipulate the human 
genome 
D. that when it comes to drawing the line for 
enhancement, the determining factor is 
whether the change would be optional 
versus therapeutic. 
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5. The former target, say, using 
gene editing techniques to 
inactivate HIV receptors and 
achieve resistance of blood 
cells to the virus (which 
Sangamo BioSciences is 
working on in clinical trials) 
E. consider purely the statistics or the human, 
says Baltimore. 
6. The need for guidance on 
how 
F. – sometimes nicknamed a “savior 
sibling”—in the hopes that the second 
child’s bone marrow can be employed to 
help the older sibling. 
7. To care for such patients, his 
team has seen families that 
try to have a second child 
G. very rare thanks to other already available 
reproductive technologies like in-vitro 
fertilization that could help most people.   
8. The question boils down to if 
one should 
H. “enhancement” and deciding if it would be 
a move in the right direction, as the word 
would suggest. 
9. For his part, Eric Lander 
from the Broad Institute said 
in a December 1 presentation 
at the summit that the need to 
employ germ line editing 
would remain very, 
K. the rare individuals who are born with a 
variant that allows them to function well 
with just a few hours of sleep. 
IX. Read and translate the short text without any dictionary: 
The ability to precisely and accurately change almost any part of any 
genome, even in complex species such as humans, may soon become a reality 
through genome editing. But with great power comes great responsibility – and 
few subjects elicit such heated debates about moral rights and wrongs. 
Although genetic engineering techniques have been around for some time, genome 
editing can achieve this with lower error rates, more simply and cheaply than ever 
– although the technology is certainly not yet perfect. 
Genome editing offers a greater degree of control and precision in how 
specific DNA sequences are changed. It could be used in basic science, for human 
health, or improvements to crops. There are a variety of techniques but clustered 
regularly inter-spaced short palindromic repeats, or CRISPR, is perhaps the 
foremost. 
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X. Food for thought: 
Genome editing techniques have so far been used to change genomes in 
individual cells and in entire (non-human) organisms. Benefits have included 
better targeted gene therapy in animal models of some diseases, such as Duchenne 
Muscular Dystrophy. It’s also hoped that it will lead to a better understanding of 
the structure, function and regulation of genes. Genetic modification through 
genome editing of plants has already created herbicide- and infection-resistant 
crops. 
But more contentious is how genome editing might be used to change traits 
in humans. While this has been the basis for many works of fiction, in real life our 
capacity to provide the sort of genetic engineering seen in films and books such as 
Gattaca and Brave New World has been substantially limited. 
Genome editing potentially changes this, presenting us with the very real 
possibility that any aspect of the human genome could be manipulated as we 
desire. This could mean eliminating harmful genetic conditions, or enhancing traits 
deemed advantageous, such as resistance to diseases. But this ability may also 
open the door to eugenics, where those with access to the technology could select 
for future generations based on traits considered merely desirable: eye, skin or hair 
color, or height. 
 
Text 3. Where to Draw the Line on Gene-Editing 
Technology 
                      Pre-reading 
 
1. Have you ever heard about 
gene-editing technology? 
2. Do you know what does 
CRISPR mean?
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■  Read the given text and make your essential assignments: 
The biologists have done it again. Not so long ago it was cloning and 
embryonic stem cells that challenged moral imagination. These days all eyes are on 
a powerful new technique for engineering or “editing” DNA. Relatively easy to 
learn and to use, CRISPR has forced scientists, ethicists and policymakers to 
reconsider one of the few seeming red lines in experimental biology: the difference 
between genetically modifying an individual’s somatic cells and engineering the 
germ line that will be transmitted to future generations. Instead of genetic 
engineering for one person why not eliminate that disease trait from all of her or 
his descendants? 
This week, the U.S. National Academy of Sciences, the Chinese Academy of 
Sciences, and the U.K. Royal Society are trying to find ways to redraw that red 
line. And redraw it in a way that allows the technology to help and not to hurt 
humanity. Perhaps the hardest but most critical part of the ethical challenge: doing 
that in a way that doesn’t go down a dark path of “improvements” to the human 
race. 
Compared to previous strategies, the technique known as CRISPR (clustered 
interspaced short palindromic repeats) is faster, more reliable and cheaper than 
previous methods for modifying the base pairs of genes. CRISPR is made up of 
scissors in the form of an enzyme that cuts DNA strands and an RNA guide that 
knows where to make the cut, so the traits expressed by the gene are changed. 
Already, labs are applying gene editing in pluripotent stem cells. Older methods 
are being used to help the human immune system’s T cells resist HIV, which might 
be done better with CRISPR. Gene editing trials are also in the offing for diseases 
like leukemia. It looks very much like these genies are out of the bottle. 
Since the 1960s, technical limitations, the prospect of unintended 
consequences, and the “eugenic” implications of deliberate alterations of future 
generations weighed heavily against germline engineering. Many countries, 
including many in Europe, have laws that forbid human germline modification. 
The National Institutes of Health won’t pay for such research but there’s no law 
against using private funds. China also doesn’t prohibit it. 
But over the past 20 years, advances in laboratory techniques, genetic 
screening for disease traits, and the prospective fruits of the Human Genome 
Project have smudged the red line. Gradually, the public health benefits of 
changing the human germline have gained as much emphasis as the risks. Some 
observers have noted that, aside from the efficiencies that could be realized with 
germline engineering, the ethical distinction between germline and somatic cell 
modification may already be moot, since even somatic cell modifications can 
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“leak” into effects on gametes. The emergence of CRISPR has made it impossible 
to delay more definitive guidance. 
Even apart from risks and benefits, are we prepared to modify our genetic 
heritage with all the implications for humanity’s relationship to the rest of the 
natural world? Following a wave of publicity about CRISPR, last spring a number 
of scientists and researchers called for a voluntary moratorium on its use. Their 
proposal was reminiscent of the Asilomar moratorium on recombinant DNA 
research in 1975. Asilomar is commonly (but not universally) thought to have been 
an effective response on the part of the scientific community to public fears about 
biohazards. 
But the world of life sciences research is far different now than it was 40 
years ago, when the community was much smaller and more intimate. 
Sophisticated experimental biology is now a globalized affair. Funding pressures, 
the virtually instantaneous availability of experimental procedures and results, and 
the fact that researchers may have limited face-to-face contact make self-policing 
far more challenging than it once was. Indeed, within weeks of the calls for a 
moratorium, a Chinese team performed a modification of non-viable embryos, a 
proof-of-concept experiment that fell smack into the ethical grey zone and further 
shook confidence in the prospects for an effective moratorium. 
With events moving so quickly, the summit organized by the U.S. National 
Academies, along with its British and Chinese counterparts, will need to face a few 
key ethical issues. How can technical risks, like “off target” effects that change an 
important gene instead of the one intended, be avoided? Are there any diseases that 
could justify attempts to diffuse genetic changes in a human population? And who 
is to make such monumental decisions on behalf of unborn generations? 
Recommendations from the Academies aren’t law but they can establish guiding 
principles for legitimate scientific practices. 
Ten years ago a National Academy of Sciences committee that I co-chaired 
set rules for doing human embryonic stem cell research that were voluntarily 
adopted in many parts of the world. When it comes to the ethics of science, the 
scientific community needs to lead but also needs to listen to non-scientists. 
Especially in the case of the human germline, one principle worth defending is that 
between therapy and enhancement. Even if population-wide disease prevention is 
sometimes acceptable, attempts to otherwise “improve” the human race should be 
banned. 
Other principles will apply mainly to agricultural research. Genetically 
modified plants and animals are the focus of a parallel National Academies study 
on the ecological risks of gene drive experiments that might someday lead to 
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deliberate changes of non-human populations in the wild. New techniques like 
CRISPR will make the recently approved fast growing salmon look old fashioned. 
The experiments that are both the most promising and the most risky are that 
those that involve rapidly propagating species like insects, like eliminating the 
ability of mosquitoes to carry the malaria parasite. And accidents are always 
possible so best biosafety practices will have to be reviewed and strengthened, 
including perhaps inbred biological barriers like the “suicide genes” that will cause 
modified organisms to die if they escape the lab. 
One thing is clear: CRISPR and its descendants will have lives beyond the 
laboratory. 
Jonathan D. Moreno is the David and Lyn Silfen University Professor at 
the University of Pennsylvania where he teaches bioethics and the history 
of science. He is the author of "The Body Politic: The Battle Over Science in 
America." 
Scientific American November 30, 2015 
http://www.scientificamerican.com/article/where-to-draw-the-line-on-gene-
editing-technology 
 Glossary of essential terms 
№ English term Russian equivalent 
1 experimental biology эксперементальная биология 
2 genetically modifying генетически модифицированный 
3 germline зародышевая линия 
4 cloning клонироание 
5 embryonic stem cells эмбриональные стволовые клетки 
6 human race человеческая раса  
7 enzyme фермент 
8 private funds частные средства 
9 distinction различия 
10 moot спор 
11 pluripotent плюрипотентные 
12 alteration переделка 
13 deliberate преднамеренная 
14 reminiscent напоминает 
15 genetic heritage генетическое наследство 
16 intimate близкие, глубокие 
17 biohazards биологическая опасность 
18 community община 
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19 smudged размазанный, нечеткий 
20 funding финансирование 
21 affair дело 
22 self-policing самоконтроль 
23 non-viable нежизнеспособный 
24 enhancement повышение 
25 unborn неродившийся 
26 proof-of-concept доказательство правильной концепции 
27 legitimate законные, допустимые 
28 prevention профилактика 
29 agriculture сельское хозяйство 
30 promising перспективный 
31 propagating распространяющиеся 
32 accidents несчастные случаи 
33 biosafety биобезопасность 
34 suicide gene гены-самоубийцы 
35 descendants потомки 
36 imagination воображение 
37 powerful мощный 
38 forced вынуждены 
39 instead вместо 
40 redraw перерисовать 
41 improvements улучшение 
42 limitations ограничения 
43 consequences последствия 
44 benefit выгода 
 Your Essential Assignments 
I. Quick cheсk: 
1. What stands for CRISPR?   
2. Are there laws prohibiting the modification of the human germ-line?  
3. What diseases can be treated with gene editing trials? 
4. What does CRISPR technique do? 
 
II. Suggest Russian equivalents for the following word combinations:  
№ English term Russian equivalent 
1 embryonic stem cells  
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2 genetically modifying  
3 somatic cell modification  
4 humanity’s relationship  
5 scientific community  
6 pluripotent stem cells  
7 proof-of-concept  
8 key ethical issues  
9 unborn generations  
10 ecological risks  
11 suicide genes  
III. Fill in the gaps with the words and expressions from the text: 
1. Not so long ago it was_____ and _____that challenged moral imagination.   
2. Labs are already applying ____editing _____cells. 
3. Other principles will apply mainly to _____ research.   
4. The _____that are both the most promising and the most risky are that 
those that involve rapidly propagating species like_______, like eliminating the 
ability of mosquitoes to carry the ______parasite 
5. But the ______sciences research is far different now than it was 40 years 
ago, when the _____was much smaller and more intimate.  
6. Indeed, within weeks of the calls for a________, a Chinese team 
performed a modification of________, a proof-of-concept experiment that fell 
smack into the ethical grey zone and further shook confidence in the prospects for 
an effective moratorium. 
IV. Use monolingual English dictionary and write down what could the 
words given below mean: 
Germline, imitations, modifications, focus, experiments, descendants. 
V. Find English equivalents for the following word combinations:  
№ Russian term English equivalent 
1 "редактирование" ДНК  
2 генная инженерия  
3 базовая пара генов  
4 Т-клетки иммунной системы  
5 лейкемия  
6 лабораторные методы  
7 рекомбинанторные исследования  
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8 нежизнеспособные эмбрионы  
9 сельскохозяйственные исследования  
10 генетически модифицированные растения и 
животные 
 
11 паразит малярии  
12 жизнь за пределами лаборатории  
13 "гены-самоубийцы"  
VI. Fill in the missing words: 
Term (verb) Noun Adjective 
experiment   
modify   
improve   
inherit   
risk   
imagine   
 
VII. Match the sentence halves. Make complete sentences. 
1. Not so long ago it was cloning and 
embryonic stem cells 
A. is faster, more reliable and cheaper 
than previous methods for 
modifying the base pairs of genes. 
2. Perhaps the hardest but most critical 
part of the ethical challenge: 
B. are trying to find ways to redraw 
that red line. 
3. Following a wave of publicity about 
CRISPR 
C. will have lives beyond the 
laboratory. 
4. When it comes to the ethics of 
science, 
D. attempts to otherwise “improve” the 
human race should be banned. 
5. Even if population-wide disease 
prevention is sometimes acceptable, 
E. the scientific community needs to 
lead but also needs to listen to non-
scientists. 
6. One thing is clear: CRISPR and its 
descendants 
F. last spring a number of scientists 
and researchers called for a 
voluntary moratorium on its use. 
7. This week, the U.S. National 
Academy of Sciences, the Chinese 
Academy of Sciences, and the U.K. 
G. doing that in a way that doesn’t go 
down a dark path of 
“improvements” to the human race. 
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Royal Society 
8. Compared to previous strategies, the 
technique known as CRISPR 
(clustered interspaced short 
palindromic repeats) 
H. that challenged moral imagination. 
VIII. Read and translate the short text without any dictionary: 
Mankind has always dreamed of, to display a miracle cure, heal all diseases, 
or at least something similar. Cloning is one of the closest to this idea means. 
Cloning allows you to grow parts of the human body, using the DNA of the 
host. These body parts can be used to replace the existing, but not useful. It is also 
possible to clone certain organs and replaced them sick bodies. Many people die 
from organ failure or loose bodies in accidents or born with imperfections. These 
people could be cured with the help of cloning. 
IX. Match these words with their definitions: 
1 enzyme A a result or effect of an action or condition. 
2 agriculture B a series of germ cells each descended or developed from 
earlier cells in the series, regarded as continuing through 
successive generations of an organism. 
3 benefits C property that is or may be inherited; an inheritance 
4 diseases D human beings in general; humankind. 
5 improve E the ability to do something or act in a particular way, 
especially as a faculty or quality. 
6 clone F the faculty or action of forming new ideas, or images or 
concepts of external objects not present to the senses. 
7 somatic cell G the action of stopping something from happening or 
arising. 
8 prevention H any cell of a living organism other than the reproductive 
cells. 
9 imagination I an organism or cell, or group of organisms or cells, 
produced asexually from one ancestor or stock, to which 
they are genetically identical. 
10 power J make or become better. 
11 human race K a disorder of structure or function in a human, animal, or 
plant, especially one that produces specific signs or 
symptoms or that affects a specific location and is not 
simply a direct result of physical injury. 
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12 heritage L a public performance or other entertainment of which the 
proceeds go to a particular charitable cause. 
13 germ line M the science or practice of farming, including cultivation of 
the soil for the growing of crops and the rearing of 
animals to provide food, wool, and other products. 
14 consequences N a substance produced by a living organism that acts as a 
catalyst to bring about a specific biochemical reaction. 
X. Food for thought: 
          According to the supporters of eugenics, the society through the 
development of medical and social support for the disabled and other "artificial" 
measures to improve the quality of life has weakened the action of natural 
selection, whereby there was a danger of degeneration of nations. "Subnormal" 
individuals participating in reproduction, "clog up" the so-called "gene pool of the 
nation" substandard genes. Eugenic practices aimed at to stop the degeneration of 
the genetic population. 
        What do you think? Should people get involved in the genome or leave the 
matter to God? 
 
Text 4. Childhood Cancer Risk Hides in 
Families 
Genome study finds mutations passed on from parents are linked to at least one in 
12 cancers in kids 
 
                                                      Pre - reading. 
 
 
■ Work in pairs. Discuss the 
following questions and try to 
answer them.  
1. What are the causes of the 
cancer cells? 
2. What has always characterized 
cancer? 
3. What happens when a cancer 
cell is reborn? 
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■ Read the given text and make your essential assignments 
A substantial number of children with cancer carry cancer-predisposing 
mutations inherited from a parent, according to a new study published Wednesday 
in The New England Journal of Medicine. Researchers examined the genes of 
more than a thousand children with cancer and found that 8.5 percent of them—
most of whom had little family history of cancer—carry handed-down gene 
mutations that make them more susceptible to the disease. The figure might seem 
small, especially within a relatively rare diagnosis, but its implications are large—
for the young patients and for their family members who might also be at risk—
and could help doctors select more appropriate treatments. 
Pediatric cancer is a mysterious case. Most cancers in the general 
population are caused by genetic mutations accumulated over a lifetime. But kids 
have not been around long enough to experience large amounts of UV rays, 
chemicals or other exposures that can lead to or exacerbate errors in DNA and spur 
cancer growth. 
These findings "give us fundamental insights into the etiology of pediatric 
cancer—to help treat patients," says James Downing, chair of Childhood Cancer 
Treatment, president and CEO of St. Jude Children's Research Hospital and co-
author of the new study, which is part of the Saint Jude–Washington University 
Pediatric Cancer Genome Project. 
Predispositions 
The researchers analyzed the genes of 1,120 pediatric cancer patients 
(median age 6.9), honing in on 60 genes that are associated with cancer 
predisposition to look for DNA errors passed down from a parent, known as germ-
line mutations. These cancer-linked errors were present in 95 patients, most 
commonly in children with solid tumors outside of the central nervous system—
and least frequently in those with leukemia. "This kind of work helps in 
understanding where the tumors are coming from—and also what are some of the 
underlying driving mutations," says Lisa Diller, chief medical officer of Dana–
Farber/Boston Children's Cancer and Blood Disorders Center, who was not 
involved in the new work 
For comparison, the team also analyzed these same genes in 966 
(noncancerous patient) adults in the general population as represented by the 1,000 
Genomes Project and found these germ-line mutations in only about 1.1 percent of 
people. 
The researcher uncovered data from the pediatric cancer population that 
might alter long-standing traditions. "A big surprise is the family history," says 
Jinghui Zhang, chair of the Computational Biology department at Saint Jude's and 
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a co-author of the study. Or, more precisely, the lack thereof. Family histories have 
been a central tool for understanding the nature of a cancer and identifying persons 
who might be at risk. But Zhang and her colleagues found that of the patients with 
these germ-line mutations and with family cancer data, only 40 percent had a 
family history of cancer (which was a similar rate to the pediatric patients who did 
not have one of these flagged mutations). Furthermore, only 57 percent of the 
family cancers matched with the genetic predisposition. 
Test and screen? 
The heritable nature of these genetic mutations means that some in a 
patient's family—parents or siblings—might indeed harbor the same errors. But 
instituting testing and screening for all close relatives of a patient's is not an 
automatic next step. Although a family will likely want to know: "How likely is it 
that the germ-line mutation would progress to a harmful cancer?" Downing notes 
the answer will vary for different mutations. Heritable syndromes, including cancer 
predisposition, have a wide range of likelihoods of actually causing the disease, a 
concept known as penetrance. Many mutations—which exponentially raise risk for 
carriers against that of the general population—only go on to cause cancer in a 
relatively small fraction of carriers, Zhang explains. For most of these variants, 
however, "the penetrance is unknown," she says. 
Some of the risk might become known when a parent is diagnosed with 
cancer. Interestingly, a handful of children with cancer harbored germ-line 
mutations on the BRACA1 or BRACA2 genes, which are typically associated with 
adult-onset cancers. In her hospital, Diller says, they reassure mothers with 
BRACA-associated breast cancer that any risk they might have passed down to 
their offspring is only for cancer later in life. Now, Diller says, "we'll have to look 
at if we need to change that policy—whether we should consider children of 
BRACA carriers at a higher risk" for cancers much earlier in life. 
Treatment 
In the meantime knowing that a patient has one of these mutations can help 
their doctors select treatment. "When a child has a mutation in these genes, it really 
tells us to stop and pause," Downing says. "We really need to approach that 
individual patient differently." Some gene signatures, for instance, raise the 
individual's susceptibility to the effects of radiation, a treatment that might 
otherwise be standard. 
Additionally, Diller points out, having a germ-line mutation that is linked 
to a cancer in a paired organ, such as a kidney or retina, means that the other organ 
is also at higher risk. So instead of removing a kidney, as might be common in 
severe renal adenocarcinomas, doctors might prefer to do their best to save that 
organ, knowing that the other one might fall victim to cancer as well. 
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Bone marrow transplants, a common treatment for childhood cancers, might 
also need new considerations for these patients. Among the best marrow donors 
are matched siblings. But, as Diller notes, knowing these germ-line mutations' 50 
percent probability of being present in a sibling, "you would want to make sure 
that the matched sibling is not also a carrier of the gene syndrome," she says. 
Growing data, spreading syndromes 
The findings provide the basis for a new program at Saint Jude's known as 
Genomes for Kids, or G4K, which will test all new admitted pediatric cancer 
patients for germ-line mutations. This will not only allow clinicians to use the 
results when deciding on treatment and family screening but help researchers pin 
down more links between heritable mutations and childhood cancer. 
        As more data come in, the frequency of these germ-line predisposition gene 
mutations will likely rise, Downing notes. "That frequency [of 8.5 percent] will 
probably be a lower limit," he says. "There will be more and more genes 
identified." And as the roster of potentially pathogenic gene mutations grows—and 
as more people have their genomes tested—Diller says we also need to be ready 
with better information about individual risk, along with helpful screening and 
lifestyle recommendations. For carriers of these mutations, Downing says, we still 
do not know if or when surveillance is appropriate. And that is no small issue, as 
Diller points out. Finding, for example, that a sibling of a cancer patient also 
carries the mutation, "you immediately make them into a patient rather than a 
healthy child—just because they carry a gene that we don't know how to interpret," 
she says. 
        Scientific American November 18, 2015 
        http://www.scientificamerican.com/article/childhood-cancer-risk-hides-in-
families/ 
■ Glossary of essential terms for you to know 
 English term Russian equivalent 
1 implication значение, следствие 
2 exacerbate обострять, усиливать 
3 spur подгонять, толкать 
4 substantial существенный, значительный 
5 predisposing предрасположенный 
6 susceptible восприимчивый 
7 screen сортировать  
8 rare редкий 
9 harbor питать, затаить 
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10 surveillance наблюдение 
11 renal почечный 
12 mysterious мистический 
13 case случай 
14 to accumulate накапливать 
15 exposure воздействие 
16 to spur побуждать 
17 chair председатель 
18 predisposition предрасположение, склонность 
19 germ-line mutation мутация зародышевой линии 
20 tumor опухоль 
21 to alter изменять 
22 more precisely точнее 
23 sibling родной брат, родная сестра 
24 indeed действительно 
25 likelihood вероятность 
26 penetration проникновение 
27 breast молочная железа 
28 additionally кроме того 
29 kidney почка 
30 retina сетчатка 
31 severe тяжелый, выраженный 
32 marrow костный мозг 
33 roster список 
34 to alter изменить 
35 to approach подходить, подступаться 
I. Try to match the definition with the correct word. 
 
1.mutation A. medical care for an illness or injury 
2.disease B. the hereditary passing of biological attributes from 
ancestors to off-spring 
3.cancer C. disease of uncontrolled cellular proliferation 
4.treatment D. the state of being predisposed 
5.predisposition E. heritable change in genetic material 
6.inheritance F. the presiding officer of a meeting, organization, 
committee, or other deliberative body 
7.chair G. the proportion of individuals carrying a particular 
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variation of a gene that also express an associated trait 
8.penetrance H. an abnormal condition of the body causing discomfort or 
dysfunction 
II. Use monolingual English dictionary and write down what could the 
words given below mean: 
Childhood; growth; susceptible; exposure; chemical; penetrance. 
 
III. Find English equivalents to the following word combinations: 
Russian term English equivalent 
1. известен как  
2. может помочь врачам выбрать наиболее 
подходящие процедуры 
 
3. наследуемая природа генетических мутаций  
4. предрасполагающие к раку мутации   
5. таинственный случай  
6. пересадка костного мозга  
7. немедленно сделать  
8. унаследовал от родителей  
9. парный орган  
10. экспоненциально повышают риск для носителей  
11. главный инструмент для понимания природы 
рака 
 
12.информация об индивидуальном риске  
13. семейная история рака  
14. центральная нервная система   
15. восприимчивы к болезни  
 
IV. Give Russian equivalents to the following English terms: 
 
English term Russian equivalent 
1. family histories have been a central tool for 
understanding the nature of a cancer 
 
2. DNA errors passed down from a parent  
3. for comparison  
4. pediatric cancer is a mysterious case  
5. the researchers uncovered data from the pediatric 
cancer population 
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6. an automatic next step  
7. could help doctors select more appropriate treatments  
8. in a relatively small fraction of carriers  
9. researchers examined the genes  
10. to give us fundamental insights into the etiology of 
pediatric cancer 
 
11. children with solid tumors outside of the central 
nervous system 
 
12. cancer-predisposing mutations  
13. known as germ-line mutations  
14. a big surprise is the family history  
15. genetic mutations accumulated over a lifetime  
V. Match the sentence halves. Make complete sentences: 
 
1. This will not only allow 
clinicians to use the results when 
deciding on treatment and family 
screening but 
A. the individual's susceptibility to the effects 
of radiation, a treatment that might otherwise 
be standard. 
2. Some of the risk might 
become known 
B. a central tool for understanding the nature 
of a cancer and identifying persons who might 
be at risk. 
3. Among the best marrow 
donors 
C. a patient has one of these mutations can 
help their doctors select treatment. 
4. The heritable nature of these 
genetic mutations means 
D. when a parent is diagnosed with cancer. 
5. Some gene signatures, for 
instance, raise 
E. help researchers pin down more links 
between heritable mutations and childhood 
cancer. 
6.Family histories have been F. that some in a patient's family—parents or 
siblings—might indeed harbor the same errors.
7. Most cancers in the general 
population are caused 
G.are matched siblings. 
8. In the meantime knowing that H. by genetic mutations accumulated over a 
lifetime. 
 
VI. Translate into English using all the active possible: 
1. Семейные истории были главным инструментом для понимания 
природы рака и выявления лиц, которые могут оказаться под угрозой. 
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2. Это не только позволит врачам использовать результаты при 
принятии решения о лечении и семейном скрининге, но и поможет 
исследователям установить большую связь между наследственными 
мутациями и раком детей. 
3. Детский рак - это таинственное явление. 
4. Но назначение тестирования и скрининга всех близких 
родственников пациента не является автоматически следующим шагом. 
5. Лучшие доноры костного мозга – братья и сестры. 
6. Большинство случаев рака среди населения в целом вызвано 
генетическими мутациями, накопленными в течение жизни. 
7. Более того, только 57% случаев рака в семье обусловлено 
генетической предрасположенностью. 
 
VII. Fill in the missing words: 
Verb Noun 
to examine  
 selection 
to accumulate  
 association 
to know  
 presentation 
 involvement 
to represent  
to understand  
 identification 
 inclusion 
to explain  
 consideration 
to treat  
to remove  
 preference 
 spread 
 reassurance 
to provide  
 admission 
 allowance 
to appropriate  
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VIII. Write words for the definitions. 
1. Someone who receives treatment from a doctor or other medically 
educated person. 
p____________________ 
 
2. Observation of individuals or groups of individuals. 
s____________________ 
3. The measure of how often a periodic event occurs. 
f_____________________ 
 
4. Substance inside bones. 
m____________________ 
 
5. An organ in the body that produces urine. 
k_____________________ 
 
6. A group of organisms of one species, occupying a defined area. 
p_____________________ 
 
7. A value or condition that is not consistent with the true, specified, or 
expected value or condition. 
e_____________________ 
 
8. Originator or creator of a work. 
a_____________________ 
 
IX. Fill each gap with one word.  
1. Pediatric cancer is a __________ case. 
2. __________ histories have been a __________ tool for understanding the 
__________ of a cancer and identifying persons who might be at risk. 
3. Or, more precisely, the __________ thereof. 
4. The researches uncovered data from the __________ cancer population 
that might alter long-standing traditions. 
5. In the meantime knowing that a patient has one of these mutations can 
__________ their doctors __________ treatment. 
6. Most cancers in the general population by __________ mutations 
__________ over a lifetime. 
7. Some of the _________ might become known when a parent is diagnosed 
with cancer. 
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8. But instituting __________ and __________ for all close relatives of a 
patient's is not an automatic __________ step. 
 
X. Complete with the right preposition. 
1. Genome study finds mutations passed on from parents are linked to 
_____ least one _____ 12 cancers in kids. 
2. Most cancers _____ the general population are caused _____ genetic 
mutations accumulated over a lifetime. 
3. _____ carriers_____ these mutations, Downing says, we still do not 
know if or when surveillance is appropriate. 
4. This will not only allow clinicians to use the results when deciding 
_____ treatment and family screening but help researchers pin down more links 
between heritable mutations and childhood cancer. 
5. As more data come in, the frequency _____ these germ-line 
predisposition gene mutations will likely rise, Downing notes. 
6. Bone marrow transplants, a common treatment _____ childhood 
cancers, might also need new considerations _____ these patients. 
 
 
Text 5. General Anesthesia Causes No Cognitive 
Deficit in Infants 
Pre-reading 
 
■ Work in pairs. Discuss the 
following questions and try to 
answer them. 
 What is anesthesia? 
 Are there restrictions on the use 
of anesthesia? 
■ Read the given text and make your essential assignments: 
Early-life exposure to anesthesia does not appear to lead to long-term 
cognitive problems, researchers announced today. New evidence from the first, 
randomized anesthesia trial in kids provides the strongest indication yet that 
exposing young children to anesthesia—at least for a brief time—will not saddle 
them with developmental deficits. The news comes just a couple of weeks after a 
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medical advisory group reiterated its concerns about such exposures among 
children younger than four years. Previously, multiple animal and human 
studies have linked such exposure with cognitive impairment, but none of the 
information on humans came from a gold-standard, randomized study design that 
could help eliminate other reasons to explain such a connection. 
This is a “reassuring finding, but it is not the final answer,” says Dean 
Andropoulos, anesthesiologist in chief at Texas Children’s Hospital and an expert 
who was not involved in the work. The new study assesses only what happens to 
youngsters after a relatively brief bout with anesthetics, so it is possible that longer 
or repeated exposures to such chemicals may still cause neurodevelopmental 
issues. There may also be deficits in anesthesia-exposed children that are not 
measurable until later in life. 
The study followed more than 500 infants undergoing hernia repair across 
the U.S., Australia, the U.K., Canada, the Netherlands, New Zealand and Italy. The 
surgeries lasted an average of roughly an hour. About half of the children were 
randomly selected to be put under with general anesthesia, and the other half 
stayed awake during the surgery and received targeted anesthetic in a specific body 
region. The kids in the study were all younger than 60 weeks and were matched by 
where they had the surgery and whether they were born prematurely. 
At age two, the children in both groups completed a battery of neurocognitive tests 
that examined how they thought and reacted to the world around them. The 
researchers found that the kids in both groups performed similarly. “This is the 
strongest evidence we have to date that a brief anesthetic exposure likely isn’t a 
problem,” says Andrew Davidson, leader of the investigation and director of the 
Melbourne Children’s Trials Center at the Murdoch Children's Research Institute. 
The findings were published October 24 in the Lancet and will be presented 
Sunday at the American Society of Anesthesiologists annual meeting in San Diego. 
In recent weeks a medical group concerned about exposing young children to 
anesthesia, which includes the American Academy of Pediatrics and the U.S. Food 
and Drug Administration, cited the growing body of literature linking anesthesia 
exposure and neurodevelopmental issues to emphasize that although parents 
should not hold off on medically necessary surgery, they should always weigh the 
pros and cons of exposing a young child to anesthesia or sedatives. Numerous 
animal studies have indicated that anesthesia exposure early in life, when the brain 
is exceptionally sensitive, can lead to brain cell death and altered connections 
between neurons. The group also urged medical providers and parents to try to 
avoid using anesthetics during diagnostic procedures such as MRIs whenever 
possible. 
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Many of the surgeries performed on young children are short, similar to the 
ones in the experiment, but there are still unanswered questions about how these 
brief exposures to anesthesia may influence brain function later in life. To test if 
there may be harm from short exposures, those in the current study will also be 
reassessed at age five with a new spate of memory and cognitive tests that could 
pick up subtler differences that may not have been apparent at a young age, 
Davidson says. “There are some aspects of development—like high executive 
function, reasoning skills and memory—that you don’t actually acquire until you 
are older.” 
Although most kids are generally healthy and do not require early-life 
surgeries or diagnostic procedures, in total at least half a million children younger 
than three years are exposed to anesthetic agents annually. There are several 
ongoing studies examining the long-term neurocognitive effects of such 
experiences. Meanwhile researchers are also looking into possible alternative 
anesthetics and ways to mitigate any anesthesia-related neurological damage. 
Scientists are also trying to determine how to assess any real-world implications of 
a child’s potential anesthesia-linked neurological deficits. Testing a few points 
worse on IQ tests or other cognitive measurements may not substantially change a 
child’s daily life. But developmental experts have worried about how those deficits 
could stack up if they are common among many kids exposed to early anesthesia. 
        Until now, findings from observational studies of kids who had early-life 
surgeries have been mixed. They could not definitively answer if the anesthesia 
itself harms the brain or if some other underlying issues were at work—such as 
sicker kids need surgery and go on to have cognitive issues fueled by their illness. 
This new study, at least, helps to answer that question. 
        Scientific American October 24, 2015 
           http://www.scientificamerican.com/article/general-anesthesia-causes-no-
cognitive-deficit-in-infants/ 
■ Glossary of essential terms for you to know 
 English term             Russian equivalent 
1 anesthesia наркоз 
2 infant младенец 
3 hernia грыжа 
4 announce объявлять 
5 evidence подтверждение 
6 indication доказательство 
7 a brief time короткое время  
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8 a medical advisory group врачебно- консультативная группа 
9 concern обеспокоенность 
10 previously ранее 
11 impairment нарушение 
12 study design исследование 
13 reassure обнадеживает 
14 brief bout непродолжительная схватка 
15 exposures воздействие 
16 exposed children облученные дети 
17 undergoing  перенесших  
18 surgery операция 
19 targeted anesthetic местная анестезия 
20 react реагировать 
21 similarly аналогично 
22 society общество 
23 drug сильнодействующие лекарства 
24 necessary причины 
25 weigh взвешивать 
26 sedatives седативные средства 
27 altered connections измененные соединения 
28 avoid избежать 
29 diagnostic procedures диагностические процедуры 
30 brief exposures краткие воздействия 
31 harm вред 
32 spate всплеск 
33 subtler differences тонкие различия 
34 the current study текущее исследование 
35 annually ежегодно 
36 ongoing продолжающееся 
37 experience переживание 
38 meanwhile между тем 
39 mitigate смягчать 
40 assess оценить 
41 implication последствия 
42 measurement измерение 
43 not substantially не существенно 
44 until до сих пор 
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45 definitively окончательно 
46 harms the brain вредит мозгу 
 
■ Your Essential Assignments 
I. Quick check 
1. What is anesthesia? 
2. What is the effect of anesthesia on the infants’ health? 
3.  Does anesthesia influence on children's development? 
II. Suggest Russian equivalents for the following word combinations: 
English term Russian equivalent 
cognitive deficit  
reiterated its concerns  
help eliminate other reasons  
brief bout with anesthetics  
awake during  the surgery  
reacted to the world around them  
weigh the pros and cons  
exceptionally sensitive  
a new spate of memory  
ways to mitigate any anesthesia  
change a child’s daily life  
 III. Find synonyms among the pool of words: 
Pool of words Synonyms 
1 announce 2 assesses 3 evaluate 4 declare  
1 respond 2react 3 explore4 research  
1 impairment 2 necessary3 violations 4 reasons  
IV.  Pick antonyms to the words 
Words Antonyms (opposites) 
evidence  
harm  
healthy  
react  
mitigate  
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V. Use a monolingual English dictionary and write down what could the 
words given below mean: 
Infant, concern, impairment, surgery, harm, implication 
VI. Find English equivalents to the following word combinations: 
Russian term English equivalent 
Обеспечивается сильнейшим доказательством  
Продолжительное или многократное воздействие 
такими химическими веществами 
 
Подвергнуты общему наркозу  
Руководитель исследования  
Не стоит откладывать операцию по медицинским 
показаниям 
 
Оставшиеся без ответа вопросы  
Умение аргументировать свою точку зрения  
Подвергаются воздействию анестетиков ежегодно  
 Ученые изучают возможности альтернативных 
анестетиков 
 
VII  Fill in the gaps with the words and expressions from the text: 
1. This is a…… says Dean Andropoulos, anesthesiologist in chief at Texas 
Children’s Hospital and an expert who was not involved in the work. 
2.  The surgeries lasted an average…. 
3.  In recent weeks a medical group concerned about exposing young 
children to anesthesia, which includes…….., cited the growing body of literature 
linking anesthesia exposure and neurodevelopmental issues to emphasize that 
although parents should not hold off on medically necessary surgery, they should 
always weigh the pros and cons of exposing a young child to anesthesia or 
sedatives 
4. Although most kids are………. in total at least half a million children 
younger than three years are exposed to anesthetic agents annually 
5. Scientists are also trying to determine……… of a child’s potential 
anesthesia-linked neurological deficits. 
VIII. Match the sentence halves. Make complete sentences: 
1. Early-life exposure to anesthesia 
does 
A Sunday at the American Society of 
Anesthesiologists annual meeting in San 
43 
 
Diego 
2. The kids in the study were B on IQ tests or other cognitive 
measurements may not substantially 
change a child’s daily life. 
3. The findings were published 
October 24 in the Lancet and will be 
presented 
C to avoid using anesthetics during 
diagnostic procedures such as MRIs 
whenever possible. 
4. The group also urged medical 
providers and parents to try 
D not appear to lead to long-term cognitive 
problems, researchers announced today 
5. Although most kids are generally 
healthy and do not require early-life 
surgeries or diagnostic procedures, 
E have been mixed 
6. Meanwhile researchers are also 
looking into 
F possible alternative anesthetics and ways 
to mitigate any anesthesia-related 
neurological damage 
7. Testing a few points G helps to answer that question. 
8. Until now, findings from 
observational studies of kids who had 
early-life surgeries 
H in total at least half a million children 
younger than three years are exposed to 
anesthetic agents annually 
9. This new study, at least, I all younger than 60 weeks and were 
matched by where they had the 
surgery and whether they were born 
prematurely. 
 
IX. Translate into English using the text 
1. Эта новость появилась буквально через пару недель после того, как 
врачебно-консультативная группа вновь выразила свою обеспокоенность по 
поводу таких случаев среди детей моложе 4 лет. 
2. Изучению подверглись более 500 новорожденных, перенесших 
грыжесечение по всей территории США, Австралии, Великобритании, 
Канады, Нидерландов, Новой Зеландии и Италии. 
3. В возрасте 2 лет дети в обеих группах завершили комплекс 
нейрокогнитивных тестов, было проверено, как они думают и реагируют на 
окружающий их мир. 
4. Результаты были опубликованы 24 октября в Ланцет и будут 
представлены в воскресенье на ежегодном совещании американского 
общества анестезиологов в Сан-Диего. 
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5. Многочисленные исследования на животных показали, что 
воздействие наркоза на ранних этапах жизни, когда мозг исключительно 
чувствительный, может привести к смерти клеток мозга и изменению 
соединений между нейронами. 
X. Read and translate the short text without any dictionary: 
From the moment of birth in the human brain is, there are 14 billion cells, and the 
number is until death does not increase. On the contrary, after 25 years it decreases 
by 100 thousand a day. A minute spent on reading pages, dies about 70 cells. After 
40 years of degradation of the brain is sharply accelerated, and after 50 neurons 
(nerve cells) dry out and reduces the volume of the brain. 
XI.  Answer the following questions. Use all information given before. 
1.  What did scientists do according to the text? 
2. How were the children chosen for the study? 
3.  What does leader Andrew Davidson say about the study? 
4.  What are the challenges associated with anesthetics studied by scientists? 
 
 
Text 6. Bee Symbiosis Reveals Life's Deepest 
Partnerships: Q&A 
 
Pre-reading 
 
■ Work in pairs. Discuss the following 
questions and try to answer them. 
 What is bee symbiosis? 
 What other kinds of symbiosis can you 
name? 
■ Read the given text and make your essential assignments: 
The biologist Nancy Moran has spent a career investigating the surprising 
nature of symbiosis, a phenomenon in which two species can appear to merge into 
one. Two years ago, Nancy Moran moved from Yale University to the University 
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of Texas, Austin, along with 120,000 bees. Bees are famous for living in large 
social groups, but Moran was interested in more than just the hive: She’s delving 
into the diverse ecosystem of bacteria that evolved along with the bees, a group 
that contributes to the health of hives and their resilience to infection. 
Bees and their microbiota are just one example of symbiosis — a close 
relationship between two species that typically helps both. Symbiosis can take a 
variety of forms. Cleaner fish scour dead skin from other fish and gain a meal in 
the process. The myriad microbes that live within our guts help us digest certain 
foods. 
But much of Moran’s work has focused on a deeper kind of partnership, one 
involving microbes known as endosymbionts that are passed from their host to its 
offspring. With her collaborator Paul Baumann, a bacteriologist at the University 
of California, Davis, Moran uncovered the tightly interwoven nature of these host-
microbe relationships. Many pairs have become completely dependent on each 
other, some even swapping genes. Her research centered largely on aphids, sap-
feeding insects that infest plants. The aphids can’t survive without a microbe 
called Buchnera aphidicola, which lives within the insect and provides it with 
essential nutrients. 
Moran is now doing similar work with bees, and her research could 
eventually help scientists understand colony collapse disorder, the mysterious 
plague devastating honeybee populations. Moran hopes an evolutionary biologist’s 
perspective will also provide important insight into the workings of the human 
microbiome — the collection of microbes that live on and inside us — which has 
become a hot topic in human health. 
Quanta Magazine spoke with Moran in July at the Society for Molecular 
Biology and Evolution conference in Vienna, where she presented her latest 
research on bees. An edited and condensed version of the interview follows. 
QUANTA MAGAZINE: What was the field of symbiosis like when you 
started in the 1980s? 
NANCY MORAN: It was a fringe topic in biology at the time. Most 
symbionts can’t be studied outside their host, and everyone was ignoring them. 
There were very limited tools for studying them. Then in the 1980s, new molecular 
methods became available to amplify DNA and then sequence it. 
How did you use those tools to study symbiosis? 
One of the first things we did was create an evolutionary tree for aphids and 
their resident bacteria, Buchnera. We figured out they had coevolved for more than 
100 million years, since aphids first appeared. Aphids basically wouldn’t exist 
without symbionts. We found that pattern to be quite widespread. Major groups of 
insects evolved because they had symbionts. 
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How do symbionts help their insect hosts? 
They often provide nutrition. Aphids live on plant sap, which is unsuitable 
for animals because it doesn’t have all the essential amino acids Buchnera makes 
essential amino acids for them. The tsetse fly, which feeds on blood, has a 
symbiont that makes B vitamins. Using genomics, we have been able to find the 
exact genes that are required for making nutrients such as amino acids or vitamins. 
How do symbionts change in response to their hosts? 
When we started to sequence whole genomes of symbiotic bacteria, we 
realized they had unusual patterns of gene evolution. Endosymbionts often lose 
lots of genes. In fact, the extreme tininess of some of the endosymbiont genomes 
was a surprise when we started, so much so that we didn’t believe our initial 
results. For the aphid-Buchnera case, the genome size of the Buchnera symbiont 
had been predicted to be seven times the size of the E. coli genome, when in fact it 
was only one-seventh the size! 
When a symbiont becomes integrated with a host so closely, the result is 
something like a totally new creature, a fusion of the host and symbiont,  that now 
has capabilities not present in either one alone. 
You’ve discovered that sometimes symbiotic relationships are more 
complex than simply host and symbiont. Can you give us an example? 
Aphids have symbiotic bacteria called Hamiltonella defensa that protect 
them against wasps. But the bacteria are only protective if they’re infected by a 
certain virus. So the virus, within the symbiont, within the aphid, is protecting all 
of them. It’s a multilevel system; all three benefit if the aphid is resistant to the 
wasp. 
I think I am drawn to the complexity of these things that come about during 
evolution. They look so complicated and elaborate, but you can understand them if 
you think about how selection acted at different levels. 
The term symbiosis generally refers to a helpful relationship between two 
species. But you caution that it can have a downside. 
Symbionts aren’t always good. The evolutionary interests of bacteria can be 
in agreement with those of the host, or against them. Symbiotic bacteria might 
evolve to benefit the host so that the host will live longer (and continue providing a 
home for the bacteria). Or the bacteria might kill the host, so that the host corpse 
will disperse microbes. For example,Photorhabdus luminescens is a gut symbiont 
of nematode worms. The nematodes colonize an insect, and the P. 
luminescens exits the nematodes, infects the insect, and kills it. Then the 
nematodes take up the bacteria and travel to a new host. 
In the last few years, you’ve moved from studying aphids and 
endosymbionts to bees and their microbes. What inspired the change? 
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It’s very difficult to perform experiments on endosymbionts because the 
organisms need them to survive. You can’t remove the symbiont and see what 
happens. 
What drew you to bees? 
Bees are social insects, which gives microbes the opportunity to be 
transferred from animal to animal. In this way, the bee microbiome is a lot like the 
human microbiome. 
How can the bee microbiome help us understand the human version? 
Different bee colonies have different strains with different gene collections, 
just as people have their own unique collection of microbes. 
In human microbiome studies, the links between the microbiome and health 
are correlative. We rarely have causative data. In bees, we can do more direct 
experiments. We can do something to the colony and see if it thrives or fails. For 
example, we isolate pupae in the lab and inoculate the emerging adult bees with 
specific bacteria. It’s a simpler system but still complex. 
What do you hope to learn about bee health? 
Clean bees, those with no microbes, may be worse at dealing with 
environmental challenges, such as food shortages, stress and pathogens. There’s 
some evidence that certain bacterial strains can protect honeybees against an RNA 
virus that is the species’ most common and deadly pathogen. The virus is 
widespread in bees, and it kills some colonies but seems innocuous in others. 
Why? It probably has to do with the microbiome and how resilient the colony is. 
Will your work identify potential causes of colony collapse disorder? 
It’s only speculation at this point. But you can imagine that a naturally 
occurring bee colony has little exposure to other colonies. A microbe will survive 
only if its host colony survives. But commercial bees are raised closer together 
than in the wild, so there’s more opportunity for microbes to spread among 
colonies. If you take a lot of colonies and put them a few feet apart, you could 
create conditions where there’s greater advantage [from the microbe’s perspective] 
to invading other colonies rather than relying on a single host. That could select for 
bacteria that are harmful to the colony — for example those that cause the bees to 
develop diarrhea and spread the microbe. Modeling studies based on human 
pathogens suggest that lots of social contact could create more-harmful microbes. 
Over the last 30 years, symbiosis has transformed from an unpopular area 
of research to a trendy topic — the human microbiome is the subject of 
thousands of publications. What’s missing from the latest studies? 
Nowadays, we see a lot of headlines that assume a diverse microbiota is 
good. The general tone, even among biologists — except for evolutionary 
biologists — is that it’s all beneficial. But diversity can be good or bad. An 
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evolutionary perspective might provide some balance. We need to understand 
evolutionary processes at different levels, such as between a host and its microbes, 
and among different kinds of bacteria living inside the host. 
Scientific American October 5, 2015 
http://www.scientificamerican.com/article/bee-symbiosis-reveals-life-s-
deepest-partnerships-q-a/ 
■ Glossary of essential terms for you to know 
№ English term Russian equivalent 
1. bee пчела 
2. evolve развиваться, эволюционировать 
3. hive улей 
4. resilience устойчивость 
5. symbiosis симбиоз 
6. myriad мириады, бесчисленное количество 
7. host хозяин 
8. eventually в конечном счете 
9. gut кишка, внутренности 
10. fringe край, грань 
11. aphid тля 
12. wasp оса 
13. pattern узор, структура, модель 
14. plague чума 
15. amplify усилить 
16. widespread распространенный 
17. digest переваривать, усваивать 
18. endosymbiont эндосимбионт 
19. response ответ, реакция 
20. innocuous безобидный, безвредный 
21. tsetse fly муха цеце 
22. sap сок 
23. essential незаменимые 
24. genomics геномика 
25. tininess миниатюрность 
26. creature творение, создание 
27. fusion слияние 
28. infect заражать 
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29. multilevel многоуровневый 
30. elaborate сложный 
31. selection выбор, отбор 
32. act действовать 
33. downside обратная сторона 
34. strain штамм 
35. pathogen патогенный микроорганизм 
36. innocuous безобидный, безвредный 
37. pupae куколки 
38. thrive процветать 
40. delve вникать, копать 
■ Your Essential Assignments 
I. Quick check : 
1. What is symbiosis? 
2. What is the name of a microbe, which lives within aphids? 
II. Fill in the gaps with the words and expression from the text: 
1. Bees and their microbiota are just one example of symbiosis — a close 
…between two species that typically helps both. 
2. The myriad microbes that live within our …help us …certain foods. 
3. Many …have become completely dependent on each other, some even 
…genes. 
4. Aphids basically wouldn’t exist …symbionts. 
5. The …fly, which feeds on blood, has a symbiont that makes B vitamins. 
6. Endosymbionts often …lots of genes. 
7. The evolutionary interests of …can be in agreement with those of the 
host, or …them. 
8. Bees are …insects, which gives microbes the opportunity to be …from 
animal to animal. In this way, the bee microbiome is a lot like the human 
microbiome. 
III. Suggest Russian equivalents for the following word combinations: 
№ English term Russian equivalent 
1. large social groups  
2. resilience to infection  
3. the myriad microbes  
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4. deeper kind of partnership  
5. completely dependent on each other  
6. mysterious plague  
7. most symbionts  
8. limited tools  
9. evolutionary tree  
10. quite widespread  
11. multilevel system  
12. different strains  
 
IV. Answer the following questions. Use all information given before: 
1. What forms of symbiosis can you name? 
2. Why do microbes live in the humans’ guts? 
3. What is Moran’s research centered on? 
4. What lice cannot survive without a microbe called Bunchera aphidicola? 
5. What similar work is Moran doing at the moment? 
6. Whom her research could help to? 
7. What does Moran hope for in the future? 
8. Why do major groups of insects have evolved? 
V. Find English equivalents for the following word combinations: 
№ Russian term English equivalent 
1. Тесная взаимосвязь  
2. Определенные продукты  
3. Различные формы  
4. Аналогичная работа  
5. Таинственная чума  
6. Эволюционный биолог  
7. Горячая тема  
8. Коллекция микробов  
9. Основные группы  
10. Сок растения  
11. Необычные закономерности  
12. Незаменимые аминокислоты  
13. Первоначальные результаты  
14. Новое творение  
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15. Полезные отношения  
16. Симбиотические бактерии  
17. Прямые эксперименты  
 
VI. Translate into English using all the active possible: 
1. Пчелы и их микрофлора являются лишь одним из 
примеров симбиоза — тесной взаимосвязи между двумя видами, которая 
обычно помогает обоим. 
2. Мириады микробов, которые живут в наших кишках, помогают нам 
переваривать определенные продукты. 
3. Тля в принципе не может существовать без симбионтов. 
4. Основные  группы насекомых эволюционировали, потому что они 
были симбионтами. 
5. С помощью геномики, мы нашли  точные гены, необходимые для 
принятия питательных веществ, таких как аминокислоты или витамины. 
6. Тля имеет симбиотические бактерии, которые 
называются  Hamiltonella- защитник, они защищают их от осы. 
7. Термин симбиоз в целом относится к полезным отношениям между 
двумя видами. 
VII. Use a monolingual English dictionary and write down what could 
the words given below mean: 
Symbiosis, endosymbionts,  bee , tininess, creature, strain, research, 
evolution.  
VIII. Food for thought: 
Imagine that scientists have learned to instill any bacteria to man. How do 
you think can we improve health and human’s resistance to infections? 
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Text 7. Disguised Nanoparticles Slip Past Body's 
Immune Defense 
Drug-delivery systems coated in platelets repair damaged blood vessels 
 
 
Pre-reading 
■ Work in pairs. Discuss the 
following questions and try to 
answer them. 
1. What do you know about 
immune system?  
2. What is the role of the immune 
particles? 
 
 
■ Read the given text and make your essential assignments: 
Researchers say that they have found a way to smuggle drug-carrying 
nanoparticles past the body’s immune system: by camouflaging them to look like 
cell fragments found in human blood. 
Man-made nanoparticles — created from plastic or metal — can be designed 
to deliver a cargo of drugs to specific areas of the body. But they are often attacked 
and swallowed up by the body’s natural defence system, which sees them as 
foreign invaders. 
The disguised particles are not only able to evade detection, but also exploit 
the natural properties of platelets to treat bacterial infections and to repair damaged 
blood vessels more effectively than conventional ways of delivering drugs, report 
the team. The researchers were led by Liangfang Zhang at the University of 
California, San Diego, and published their work in Nature on September 16. 
Zhang’s team began with 100-nanometer-wide particles made of the 
biodegradable polymer PLGA, and coated them in membranes taken from human 
platelets — cell fragments found in the blood that accumulate at sites of tissue 
damage and begin the clotting process. This helps the particles to evade the 
immune system, the authors say. 
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Researchers have previously tried to attach key parts of platelet membranes 
onto nanoparticles to avoid immune attack; in particular, the platelet’s CD47 
protein. That protein sends out a 'don’t eat me' signal to the body's immune system, 
says Dennis Discher, a nanoengineer at the University of Pennsylvania in 
Philadelphia. But Zhang's nanoparticles boast the most complete set of membrane 
proteins yet, says OmidFarokhzad, a physician and nanotechnologist at the 
Brigham and Women’s Hospital in Boston, Massachusetts, who wrote a News & 
Views article that accompanied the paper. 
Cloaked assassins 
The platelet-coated nanoparticles have other advantages. Bacteria such as 
methicillin-resistantStaphylococcus aureus (MRSA), for instance, can stick to 
platelets — a feature they exploit to protect themselves from the immune system. 
This makes them naturally more likely to interact with coated nanoparticles. 
Platelets are also attracted to specific areas of the body where tissue damage is 
occurring. 
The particles harness platelets' unique natural abilities, says Samir 
Mitragotri, a chemical engineer at the University of California, Santa Barbara, who 
was not involved in the work. “This a highly innovative approach,” he adds. 
Zhang’s team injected cloaked nanoparticles — with antibiotics inside — 
into mice infected with MRSA. This reduced MRSA bacteria populations in the 
liver and spleen by 1,000 times compared to when mice were given conventional 
antibiotics, and required just one-sixth of the conventional drug dose. (In other 
organs nanoparticles were also more effective than conventional drug delivery, but 
the difference was less pronounced). 
The team also exploited the fact that platelets tend to migrate to damaged 
blood vessels. They loaded camouflaged nanoparticles with a drug called 
docetaxel, to see if it could prevent the excess thickening of damaged artery walls 
(an effect that can cause problems after surgery). When these nanoparticles were 
injected into rats that had damaged blood vessels, the particles clustered in larger 
concentrations at the damaged sites than in the rats' healthy tissue. And the 
docetaxel treatment was more effective when delivered this way than when it was 
delivered into the blood stream without using nanoparticles, the team showed. 
The ability to deliver high drug doses to these sites while avoiding immune-
system cells called macrophages, which usually destroy most nanoparticles even at 
disease sites, is impressive, says Discher. 
Question marks 
But not everyone is convinced about the particles' cloaking ability. Although 
a small fraction of the particles clustered at sites of disease, the vast majority of 
them quickly ended up in the animals’ liver and spleen — suggesting that the 
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majority of particles were still being caught by immune defenses in those 
locations, says MoeinMoghimi, a specialist in nanotechnology pharmaceuticals at 
the University of Copenhagen. Moghimi thinks that a much more stringent 
examination of the body’s immune response to the particles is needed. 
Zhang says that his team next plans to make larger amounts of the cloaked 
nanoparticles, and to test their use in larger animals before therapies could begin 
trials in humans. Because platelets tend to cluster around cancer cells in the blood, 
as well as around bacteria, the team will next see whether cloaked nanoparticles 
could be used to target cancer, he adds. 
Developing therapies from hybrid nanoparticles that combine synthetic and 
biological components will be a long and bumpy road, says Farokhzad. “But is this 
a technology I would bet on? Absolutely. I think the promise is huge." 
Scientific American September 16, 2015 
http://www.scientificamerican.com/article/disguised-nanoparticles-slip-
past-body-s-immune-defense/ 
 
■ Glossary of essential terms  
№ English term  Russian equivalent 
1 nanoparticles наночастицы 
2 smuggle переправить 
3 to camouflage маскировать, скрывать 
4 natural properties натуральные свойства 
5 body’s natural defense system естественная система защиты организма
6 unique natural abilities уникальные природные способности 
7 swallow проглотить 
8 invader захватчик 
9 blood vessels кровеносные сосуды 
10 exploit использовать 
11 the biodegradable polymer биоразлагаемый полимер 
12 hybrid nanoparticles гибридные наночастицы 
13  tissue ткань, 
14 can stick to platelets может присоединяться к  тромбоцитам 
15 conventional drug delivery обычная доставка лекарств 
16 to coat покрывать 
17 platelets тромбоциты  
18 boast хвалиться 
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19 resistant стойкий, сопротивляющийся 
20 occur происходят 
22 harness жгут 
23 conventional обычный 
24 spleen селезенка 
25 liver печень 
26 thickening утолщение, уплотнение 
27 cluster кластер 
28 vast обширные 
29 tend как правило 
30 bumpy ухабистая 
■ Your Essential Assignments 
I.  Use a monolingual English dictionary and give the definitions of the 
words below:  
Antibiotic, engineer, harness, abilities, chemical, nanoparticles 
II. Fill in the gaps with the words and expressions from the text:  
1. The platelet-coated nanoparticles …… 
2. Platelets are ……..of the body where tissue damage is occurring.  
3. The team also exploited the fact ……to damaged blood vessels  
4. Moghimi thinks ……to the particles is needed. 
III. Suggest Russian equivalents for the following word combinations: 
1 created  from plastic or metal  
2 unique natural abilities  
3 damaged blood vessels  
4 to treat bacterial infections  
5 specialist in nanotechnology pharmaceuticals  
6 to test their use in larger animals  
7 combine synthetic and biological  components  
8 destroy most nanoparticles  
IV. Make a sentence with the words:  
Paper, membrane, proteins, nanotechnologist, antibiotics. 
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V. Find English equivalents for the following word combinations: 
 Russian terms English equivalents 
1 замаскированные частицы  
2 поврежденные кровеносные сосуды  
3 избежать частиц иммунной системы   
4 взятых из человеческих тромбоцитов  
5 процесс свертывания   
6 инновационный подход  
7 утолщение стенок артерий  
8 наночастицы замаскированные лекарством  
9 техногенные наночастицы  
VI.Find synonyms among the pool of words 
Pool of words   Synonyms 
1Natural/2alone / 3only/ 4native  
1Supply, /2 process/ 3operation /4deliver  
1Effective/ 2vessels /3 efficient  / 4water-craft  
1Large/2 big/3 commonly/4 usually  
VII. Match the sentence halves. Make complete sentences: 
1 Researchers have previously 
tried to attach key parts of platelet 
membranes onto nanoparticles 
A which usually destroy most 
nanoparticles even at disease sites 
2 The ability to deliver high drug 
doses to these sites while avoiding 
immune-system cells called 
macrophages 
B to evade the immune system, the 
authors say. 
 
3 The disguised particles are not 
only able to evade detection, but 
also exploit the natural properties 
of  
C to avoid immune attack; in particular, 
the platelet’s CD47 protein 
4 This helps the particles  D in larger concentrations at the 
damaged sites than in the rats' healthy 
tissue. 
5 The team also exploited the fact 
that platelets  
E that his team next plans to make larger 
amounts of the cloaked nanoparticles, 
57 
 
and to test their use in larger animals 
before therapies could begin trials in 
humans 
6 When these nanoparticles were 
injected into rats that had 
damaged blood vessels, the 
particles clustered  
F tend to migrate to damaged blood 
vessels. 
7 Zhang says G to treat bacterial infections and to 
repair damaged blood vessels more 
effectively than conventional ways of 
delivering drugs, report the team. 
VIII. Answer  the following questions. 
1) What are the advantages of nanoparticles coated platelets? 
2) How did Zhang’s team use the ability of platelets migrate to the damaged 
blood vessels? 
3) What man-made nanoparticle materials are made? 
4) Why did the researchers tryto attach a key part of the platelet membrane 
to nanoparticles? 
5) What are the plans of the Zhang’s team? 
IX.Fill in the missing words: 
Term(verb) Noun 
attack  
swallow  
evade  
exploit  
repair  
attach  
deliver  
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Text 8. Where Could the First CRISPR Baby Be 
Born? 
A look at the legal landscape suggests where human genome editing might be used 
in research or reproduction 
 
            Pre – reading 
■ Work in pairs. Discuss the following 
questions and try to answer them. Then 
quickly scan the text to check your 
answers. 
1. What is genetic engineering? 
2. What is an embryo? 
3. Which country is already doing 
experiments with editing the genome of                          
human embryos? 
 
■ Read the given text and make your essential assignments: 
CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats / 
CRISPR associated protein 9), which has brought unprecedented ease and 
precision to genetic engineering, could be used to manipulate the DNA of embryos 
in a dish to learn about the earliest stages of human development. 
They are meeting in China; they are meeting in the United Kingdom; and 
they met in the United States last week. Around the world, scientists are gathering 
to discuss the promise and perils of editing the genome of a human embryo. 
Should it be allowed—and if so, under what circumstances? 
The meetings have been prompted by an explosion of interest in the 
powerful technology known as CRISPR/Cas9, which has brought unprecedented 
ease and precision to genetic engineering. This tool, and others like it, could be 
used to manipulate the DNA of embryos in a dish to learn about the earliest stages 
of human development. In theory, genome editing could also be used to 'fix' the 
mutations responsible for heritable human diseases. If done in embryos, this could 
prevent such diseases from being passed on. 
The prospects have prompted widespread concern and discussion among 
scientists, ethicists and patients. Fears loom that if genome editing becomes 
acceptable in the clinic to stave off disease, it will inevitably come to be used to 
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introduce, enhance or eliminate traits for non-medical reasons. Ethicists are 
concerned that unequal access to such technologies could lead to genetic classism. 
And targeted changes to a person's genome would be passed on for generations, 
through the germ line (sperm and eggs), fuelling fears that embryo editing could 
have lasting, unintended consequences. 
Adding to these concerns, the regulations in many countries have not kept 
pace with the science. 
Nature has tried to capture a snapshot of the legal landscape by querying 
experts and government agencies in 12 countries with histories of well-funded 
biological research. The responses reveal a wide range of approaches. In some 
countries, experimenting with human embryos at all would be a criminal offence, 
whereas in others, almost anything would be permissible. 
Concerns over the manipulation of human embryos are nothing new. Rosario 
Isasi, a legal scholar at McGill University in Montreal, Canada, points to two key 
waves of legislation over the years: one sparked by concerns about the derivation 
of embryonic stem cells, which was largely deemed acceptable; the other about 
reproductive cloning, which was largely prohibited for safety reasons. 
The current regulatory mosaic is their legacy. Tetsuya Ishii, a bioethicist at 
Hokkaido University in Sapporo, Japan, spent nearly a year analysing relevant 
legislation and guidelines in 39 countries, and found that 29 have rules that could 
be interpreted as restricting genome editing for clinical use (M. Araki and T. Ishii 
Reprod. Biol. Endocrinol. 12, 108; 2014). But the 'bans' in several of these 
countries — including Japan, China and India—are not legally binding. “The truth 
is, we have guidelines but some people never follow them,” said Qi Zhou, a 
developmental biologist at the Chinese Academy of Sciences Institute of Zoology 
in Beijing, at a meeting hosted by the US National Academy of Sciences in 
Washington DC last week. Ishii considers the rules in nine other countries—among 
them Russia and Argentina—to be “ambiguous”. The United States, he notes, 
prohibits federal funding for research involving human embryos, and would 
probably require regulatory approval for human gene editing, but does not 
officially ban the use of the technique in the clinic. In countries where clinical use 
is banned, such as France and Australia, research is usually allowed as long as it 
meets certain restrictions and does not attempt to generate a live birth (see 
'CRISPR embryos and the law'). 
Many researchers long for international guidelines that, even if not 
enforceable, could guide national lawmakers. Developing such a framework is one 
of the aims of ongoing discussions; the US National Academy, for example, plans 
to hold an international summit in December and then produce recommendations 
for responsible use of the technique in 2016. 
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But the research has already begun, and more is coming. Scientists in China 
announced in April that they had used CRISPR to alter the genomes of human 
embryos, albeit ones incapable of producing a live baby (P. Liang et al. Protein 
Cell 6, 363–372; 2015). Xiao-Jiang Li, a neuroscientist at Emory University in 
Atlanta, Georgia, who has used the technique in monkeys, says he has heard 
rumours that several other Chinese laboratories are already doing such 
experiments. And in September, developmental biologist Kathy Niakan of the 
Francis Crick Institute in London applied to the UK Human Fertilisation and 
Embryology Authority for permission to use the technique to study errors in 
embryo development that can contribute to infertility and miscarriage. No one so 
far has declared an interest in producing live babies with edited genomes, and 
initial experiments would suggest that it is not yet safe. But some suspect that it is 
only a matter of time. 
Ishii predicts that countries with high rates of in vitro fertilization will be the 
first to attempt clinical applications. Japan, he says, has one of the highest numbers 
of fertility clinics in the world, and has no enforceable rules on germline 
modification. The same is true for India. 
Guoping Feng, a neuroscientist at the Massachusetts Institute of Technology 
in Cambridge, hopes that with improvement, the technique could eventually be 
used to prevent genetic disease. But he argues that it is much too soon to be trying 
it in the clinic. “Now is not the time to do human-embryo manipulation,” he says. 
“If we do the wrong thing, we can send the wrong message to the public—and then 
the public will not support scientific research anymore.” 
Scientific American October 14, 2015 
http://www.scientificamerican.com/article/where-could-the-first-crispr-
baby-be-born/? 
 
■ Glossary of essential terms  
№ English term Russian equivalent 
1 ease легкость, простота 
2 precision точность 
3 guidelines принципы 
4 promise перспектива 
5 ambiguous неоднозначно 
6 to prohibit запрещать 
7 dish пробирка 
8 reveal раскрывать 
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9 manipulate управлять 
10 circumstances обстоятельства  
11 unintented непреднамеренный, непредусмотренный 
12 prompt побуждать, подсказывать, толкать 
13 concern беспокойство 
14 stave off предотвратить 
15 ethicist специалист по этике 
16 targeted целенаправленный 
17 neuroscientist нейробиолог 
18 cloning клонирование  
19 inevitably неизбежно 
20 pass on передавать, проходить 
21 fertilization оплодотворение  
22 infertility бесплодие 
23 miscarriage выкидыш 
24 improvement улучшение 
25 permissible допустимый 
26 offence правонарушение 
27 legislation законодательство 
28 point указывать, направлять 
29 legacy наследие 
30 binding связующий, обязательный 
31 ambiguous неоднозначно 
32 attempt попытка 
33 framework структура, рамки 
34 albeit хотя и 
35 incapable недееспособный 
36 developmental  эволюционный 
37 suspect подозрение 
38 permission разрешение 
39 matter дело, вопрос 
40 germline зародышевая 
 
■ Your Essential Assignments 
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I. Fill in the missing words: 
Term (verb) Noun Adjective 
   edit ....... ....... 
   gather ....... ....... 
   allow ....... ....... 
   prevent ....... ....... 
            predict ....... ....... 
   publish ....... ....... 
reproduce ….. …… 
 
II. Match these words with their definitions: 
1. embryo A. change 
2. mutation B. action outside the law 
3. editing C. a method which allows to solve the required task 
4. genome D. the initial stage of development of the animal 
5. offence E. guardian of hereditary information 
6. generation F. a place where research is carried out 
7. DNA G. a sudden change in the DNA 
8. technology H. a place where health services have 
9. recommendation I. all children 
10. institute J. the set of all genes 
11. clinic K. the pathological process in the organism 
12. disease L. helpful information 
 
III. Find English equivalents to the following word combinations: 
№ Russian term English equivalent 
1. редактирование генома  
2. генная инженерия  
3. управление ДНК  
4. человеческий эмбрион  
5. мощная технология  
6. наследственные заболевания человека  
7. взрыв интереса  
8. уголовное преступление  
9. китайская лаборатория  
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10 научные исследования  
 
IV. Give Russian equivalents to the following English terms: 
№ English term Russian equivalent 
1 around the world  
2 stages of development  
3 passed on for generations  
4 study errors  
5 initial experiments  
6 funding for research  
7 enforceable rules  
8 genetic disease  
9 international summit  
10 criminal offence  
V. Find synonyms among the pool of words: 
Pool of words Synonyms 
1) 1. editing /2. precision /3. redaction/ 4. accuracy  
2) 1. powerful /2. stage/3. lap /4. strong  
3) 1. target /2. introduce / 3. goal /4. enter  
4) 1. reliable/2. largely /3. responsible/4. mostly  
VI.  Answer the following questions. Use all information given before: 
1. What is the editing of the genome? 
2. What are the experts concerned about? 
3. What will you need to edit the genome? 
4. Are there countries, where clinical trials are forbidden? 
5. When will CRISPR / Cas9 be available to use? 
6. What is the human genome editing technology? 
7. What is the purpose of using CRISPR/Cas9 technology? 
8. What biological object are scientists experimenting on? 
VII. Use monolingual English dictionary and write down what could the 
words given below mean: 
Reproduction, offence, mutation, embryo, engineering. 
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VIII. Read and translate the short text without any dictionary 
The functions of CRISPR (Clustered Regularly Interspaced Short 
Palindromic Repeats) and CRISPR-associated (Cas) genes are essential in adaptive 
immunity in select bacteria and archaea, enabling the organisms to respond to and 
eliminate invading genetic material. These repeats were initially discovered in the 
1980s in E. coli but their function wasn’t confirmed until 2007 by Barrangou and 
colleagues, who demonstrated that S. thermophilus can acquire resistance against a 
bacteriophage by integrating a genome fragment of an infectious virus into its 
CRISPR locus. 
 
IX. Read and translate the short text without any dictionary: 
Американским ученым удалось модифицировать систему 
редактирования генома CRISPR/Cas9, снизив количество ошибок 
практически до нуля. Низкая точность была основной преградой к 
использованию системы на человеке, сообщает сайт N+1 со ссылкой на 
журнал Science. 
Система CRISPR/Cas9 состоит из эндонуклеазы Cas9, которая способна 
разрезать двухцепочечную молекулу ДНК, и связанной с ней молекулы РНК, 
которая по принципу комплементарности (форма взаимодействия в 
генотипе, приводящая к новому признаку) позволяет белку найти нужный 
участок в геноме. Такая система позволяет редактировать определенные 
участки ДНК, нацеливаясь на них последовательностью направляющей РНК. 
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Text 9. The Woman Who Stared at Wasps 
The biologist Joan Strassmann discusses the evolution of cooperation, how amoebas 
can teach us about competition, and why the definition of “organism” needs an 
overhaul 
  
Pre-reading 
■ Work in pairs. Discuss the 
following questions and try to 
answer them. 
1. Should people be afraid of wasps? 
2. What ways do wasps help to improve 
human’s life? 
■ Read the given text and make your essential assignments: 
As an undergraduate in the 1970s, Joan Strassmann split her time between 
writing short stories and laying siege to the office of her mentor, the sociobiologist 
Dick Alexander. For two years, she insisted on meeting with him every Friday to 
discuss research, a schedule that she now thinks was probably quite an imposition. 
“He would give me so much reading,” she recalled, “it would take me forever. I 
would work night and day to finish it, and maybe this was his strategy—maybe he 
was hoping I’d cancel or something.” But that intense focus became one of the 
hallmarks of her pioneering research on social insects. 
In graduate school at the University of Texas, Austin, Strassmann began to 
study wasps that live in hierarchical colonies, starting with a nest that was thriving 
in a tractor shed near the main campus. “I was really planning to work on 
something else, some other social organism, like ground squirrels,” said 
Strassmann, now at Washington University in St. Louis. “Everyone knew that I 
was actually terrified of wasps.” But on a dare, she and a friend ventured into the 
shed and painted each wasp with a different identifying dot of paint, the standard 
preparation for studying the social dynamics of an insect colony. Then she just 
started watching them. And watching them. 
She was in good company. Insects that live in cooperative colonies—ants, 
termites, and some wasps and bees—have fascinated scientists for more than a 
century because they pose an evolutionary conundrum. Darwin himself saw their 
way of life as a challenge to his ideas. The theory of evolution seems to predict that 
each individual will fight to pass on its traits, but in a colony, only a very small 
number of insects actually get to reproduce: the queens and their mates. The rest 
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give up their chance to contribute to the gene pool, caring for the offspring of 
others instead. How could this lifestyle, known as eusociality, have evolved? How 
could it make sense for the ancestors of modern worker bees or wasps to give up 
their autonomy? It seems biologically implausible. 
Right around the time Strassmann was in college, however, biologists began 
to understand how social insects could fit into the framework of evolutionary 
theory. In a seminal paper, W.D. Hamilton proposed that cooperation might make 
sense in closely related individuals that share enough genes. If a bee with a 
maiden-aunt helper produces twice as many offspring as it might have otherwise, 
that arrangement makes evolutionary sense for the non-reproducing assistant, 
which is indirectly passing on its genes. But that benefit is reduced as relatedness 
declines, so eusociality would only arise among close relatives. 
Strassmann found clear evidence of Hamilton’s idea in her tractor-shed 
wasps. When a nest is destroyed, its members will disperse to sister nests in a 
pattern that reflects their level of relationship to the queens. Each wasp serves only 
the leaders it is most closely related to. Strassmann continued to study wasps over 
the next 20 years with her husband and collaborator, David Queller, and the two 
have uncovered many other details of how relatedness shapes the behavior of 
social insects, including how colonies keep relatedness high when multiple queens 
reign, and what it takes to turn a worker into a queen. 
About 17 years ago, however, the pair began to shift to a new model 
organism, the amoeba Dictyostelium discoideum. They suspected that this unusual 
creature could offer new insights into the dynamics of cooperation. In moments of 
starvation, these soil-dwelling amoebas crowd together and build a tower rising 
above the ground from which they disperse their spores to other, more hospitable 
places. Some 20 percent of the group will sacrifice themselves to build the tower 
with their bodies, while the rest take advantage of it to spread their genes. 
Quanta Magazine spoke with Strassmann about the evolution of social 
insects, the secret lives of queen wasps, and what she’s learned about cooperation 
from a single-celled creature. An edited and condensed version of the interview 
follows. 
QUANTA MAGAZINE: You began to study social wasps just as 
scientists were debating the origins of eusociality. What was that like? 
JOAN STRASSMANN: It was a really exciting time. W.D. Hamilton’s 
paper came out in 1964, but it wasn’t really appreciated until the early ’70s, when I 
was in college. He outlined the framework of something called inclusive fitness, 
which is the sum of the effects of an individual’s actions on its own and others’ 
reproduction. Ultimately, it is the measure of an individual’s actions on the 
representation of its genes in the next generation. 
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You gave up wasps for a single-celled creature. That’s a huge jump. 
Most people don’t change model organisms midcareer. 
It was kind of an insane thing to do. Especially since we had been studying 
wasps in Tuscany. We know Italian, we’ve lectured in Italian, we have a lot of 
really good friends there … yeah. It’s insane! 
The amoebas must have been doing something really amazing for you to 
change. 
All social-insect people know about Dictyostelium because it has a solitary 
stage and a social stage. The single cells eat bacteria by engulfment, they live in 
soil, and so on. But when they starve, they aggregate and form a multicellular body 
that crawls toward light and ultimately coalesces into a structure called a fruiting 
body. About 20 percent of the cells form a stalk. The others flow up to the top and 
form spores, which are then dispersed. Conceptually, this can be viewed as similar 
to a social-insect colony. The stalk is the workers—they don’t get to reproduce, but 
we think they enhance dispersal of the spores. 
But if the Dictyostelium cells in that multicellular body aren’t all genetically 
identical, are some sacrificing themselves for others with whom they have nothing 
in common? You know how I told you the only way groups evolve eusociality is 
by daughters’ staying with their mothers? The idea that you would get eusociality 
from aggregation seems really wrong. There should be too many conflicts there. 
Who’s going to die, who’s going to become the spores, and so on. There were 
some obvious questions to ask. 
In 1998, scientists had sequenced the Dictyostelium genome but hadn’t 
published it yet. We knew we’d be able to plunder it for relatedness analysis. Dave 
and I just reached the point where we felt, “Wow, we’ve thought of this—we are 
going to feel like damn fools if somebody does this instead of us.” 
So what did you do? 
I got on the Internet and discovered there was a Dictyostelium email list. I 
just started posting questions. I wanted to know whether two different strains 
would still form a fruiting body together. 
The first study we did, we found that different strains do mix, and they do 
cheat. Two different strains will not contribute equally to spore and stalks. One of 
them is taking advantage of the other. So this is a good way to look at social 
organisms. 
Why does that make them a good model? 
Because there’s conflict—social competition. 
How conflicts are controlled in social organisms is a major topic of 
evolution research. In eusocial organisms, controlling conflict—through castes, for 
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instance, which make it very clear who gives way to whom—allows them to live 
together. 
In Dicty, where some take advantage of others, we can ask questions about 
how they manage the conflict so as to allow this form of sociality to persist. 
What made Dicty really attractive was that we could ask “why?” on a 
mechanistic level, because we could knock out genes and do all those things that 
cell biologists do. That was super-exciting to us. It’s just been fabulous. We’ve 
found that there are over 100 genes that, if inactivated, will cause a Dicty strain to 
begin to cheat, for instance. That suggests that the genetics of sociality in Dicty is 
complex. 
And we’re moving into bacteria now. We found some insane relationships 
between bacteria and Dicty: For instance, Dictyostelium actually appear to farm 
bacteria for their own consumption! So we’re not working on wasps at all. It’s sad 
but true. 
Now you’re trying to define what it means to be an organism? 
We feel that defining the actual key characteristics that make an organism 
has never been properly done. People have proposed requirements “genetic 
uniformity,” “all connected together” and “single-cell bottlenecks”—that means 
that there’s a phase where the organism is just a single cell. 
None of them really hold up—plants don’t have single-cell bottlenecks, for 
instance. Working on Dicty, you realize how narrow-minded most biologists are. 
They are so blinded by a very few organisms. If you want to think about what an 
organism is, you can’t start with a mouse. You can’t! You have to start with, well, 
is a biofilm an organism? If it is, why? If not, why not? 
What Dave and I came up with—and this is mostly Dave—is that what 
makes an organism is the level at which there is the highest level of cooperation 
and the lowest level of conflict. If the parts, whatever they are, are largely 
cooperative and whatever conflict there was has been controlled, that’s an 
organism. Our plan is to write a book on this. 
My favorite example is the Portuguese man-of-war. They say it’s not an 
organism, that it’s a colony of lots of little organisms. No—it’s an organism! I’m 
sorry! 
Reprinted with permission from Quanta Magazine, an editorially 
independent publication of the Simons Foundation whose mission is to enhance 
public understanding of science by covering research developments and trends in 
mathematics and the physical and life sciences. 
Scientific American December 1, 2015 
http://www.scientificamerican.com/article/the-woman-who-stared-at-wasps/ 
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■   Glossary of essential terms 
№ English term Russian equivalent 
1. laying siege осаждать, отправлять 
2. mentor наставник 
3. overhaul капитальный ремонт 
4. hallmark фирменная марка, проба, отличительный признак 
5. consumption потребление 
6. nest гнездо 
7. squirrel белка 
8. a dare спор, вызов 
9. fascinate очаровывать 
10. implausible неправдоподобный 
11. framework рамки, структура 
12. benefit выгода 
13. destroy разрушать 
14. disperse рассеиваться 
15. uncovered раскрывать, снимать 
16. relatedness связанность 
17. starvation голодание 
18. sacrifice  жертвовать 
19. engulfment поглощение 
20. colundrum загадка, головоломка 
21. advantage преимущество 
22. fabulous невероятный, сказочный 
23. trait черта, особенность 
24. appear появиться 
25. venture предприятие 
26. Portuguese man-
of-war  
Португальский кораблик 
27. wasp оса 
28. arrangement договоренность 
29. venture предок 
30. maiden-aunt девичья бабка 
31. shed сарай 
32. decline снижение 
33. collaborator сотрудник, соратник 
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34. reign царствовать 
35. soil-dwelling почвенные 
36. appreciate ценить 
37. midcareer в середине карьеры 
38. insane ненормальный 
39. solitary одинокий 
40. coalesces срастается 
41. crawl ползать 
42. fruiting body плодовые тела 
43. plunder грабеж 
44. strain напряжение 
45. persist сохраняться 
 
■ Your Essential Assignments 
I. Fill in the missing words: 
Term (verb) Noun 
employ ....... 
exist ....... 
prevent ....... 
evolve ....... 
support ....... 
separate ....... 
 
II. Use monolingual English dictionary and write down what could the 
words given below mean: 
Benefit; bacteria; evolved; termites, wasp, advantage. 
III. Read and translate the short text without any dictionary. 
It is unlikely there will be a being more simply than an amoeba, after all it 
only the thin external cover filled with watery liquid, and in it — the kernel 
containing genetic material. Amoebas have no constant form, but is before and the 
back, and they move, contracting and pushing out itself in the direction of food. 
They eat, enveloping smaller parts of seaweed and bacteria and absorbing them, 
and breed divison. 
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IV. Match the sentence halves. Make complete sentences: 
1. I was really planning to work 
on something else, some 
other social organism, 
A. have fascinated scientists for more than 
a century because they pose an 
evolutionary conundrum. 
2.  Insects that live 
in cooperative colonies—
ants, termites, and some 
wasps and bees 
B. offer new insights into the dynamics of 
cooperation. 
3. Strassmann found clear 
evidence 
C.  but it wasn’t really appreciated until the 
early ’70s, when I was in college. 
4. 
 
Each wasp serves only the 
leaders  
D. like ground squirrels 
5. They suspected that this 
unusual creature could  
E. that it’s a colony of lots of little 
organisms. 
6. W.D. Hamilton’s paper came 
out in 1964, 
F. it is most closely related to. 
7. The first study we did, we 
found that different strains 
do mix, 
G. and they do cheat. 
8. They say it’s not an 
organism, 
H. of Hamilton’s idea in her tractor-shed 
wasps. 
 
V. Find Russian equivalents for the following word combinations 
№ English term Russian equivalent 
1.  evolutionary conundrum  
2.  biologically implausible  
3.   multiple queens  
4.  a single-celled creature  
5.  multicellular body  
6.  in addition  
7.   just a single cell  
8.   fruiting body  
9.  social competition  
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VI. Answer the following questions. Use all information given before: 
1. What insects live in cooperative colonies? 
2. Why do some social amoebas sacrifice themselves? 
3. What is the inclusive fitness? 
4. What stages does Oictyostelium have? 
5. What is the fruiting body? 
VII. Match words with their definitions. 
1. Schedule A. To continue to do smth. although it is annoying other 
people. 
2.  Venture  B. When smth. becomes less in amount, importance, quality  
3. Offspring C.  A system of rules, ideas, that used to plan or decide smth. 
4. Framework D. The child of a person or animal. 
5. Decline  E. A flying insect with thin, black and yellow body. 
6. Wasp 
 
F. To leave a safe place and go somewhere, that may evolve 
risks. 
7. Persist G. A list of planned activities or thought to be done. 
 
VIII. Read and translate the short text without any dictionary. 
В аспирантуре в Университете Техаса, Остин, Штрассман начала 
изучать ос, которые живут в иерархических колониях, начиная с гнезд, 
которые процветали в сарае, недалеко от главного университетского городка. 
"Я на самом деле планировала работать над чем-то еще, каким-то другим 
социальным организмом, как белки," сказала Штрассман, теперь уже в 
Университете Вашингтона в Сент-Луисе. "Все знали, что я была в ужасе от 
ос." Но на спор, она и ее друг рискнули пойти в сарай и окрасить каждую осу 
различной выделяющейся краской. Так и началась эта история…  
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Text 10. Dinosaurs Evolved in a Startlingly Short 
Time 
New fossil dates show beasts arose from their ancestors in half the time 
researchers previously thought 
 
 
Pre-reading 
■ Work in pairs. Discuss the 
following questions and try to 
answer them. 
1. What do you know about 
dinosaurs? 
2. What ages have dinosaurs existed? 
■ Read the given text and make your essential assignments: 
Animals escaping from an erupting volcano 235 million years ago in 
northwestern Argentina. These species, found as fossils in the Chanares Formation, 
include early mammal relatives (the dicynodont Dinodontosaurus in the left 
background, and the cynodont Massetognathus in the left foreground) and early 
dinosaur precursors (Lewisuchus in the right background, and Lagerpeton in the 
right foreground). By measuring radioactive isotopes in zircons crystals from the 
volcanic ash, scientists were able to determine the precise age of this fossil 
assemblage. 
Victor Leshyk 
Dinosaurs took less than 5 million years to evolve from their reptile 
predecessors, the early dinosauromorphs, a new study finds. 
The finding revamps the time line between the dinosaurs and early 
dinosauromorphs. Until now, researchers thought that it took at least 10 million to 
15 million years for the early dinosauromorphs to evolve into dinosaurs. 
"It really narrows the amount of time between the appearance of these early 
dinosauromorphs and the first dinosaurs," said study co-researcher Randall Irmis, a 
paleontologist at the University of Utah and a curator of paleontology at the 
Natural History Museum of Utah. "Rather than there being 10 [million] or 15 
million years between when the first dinosauromorphs show up and the first 
dinosaurs, now it's just 5 million years." 
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Early dinosauromorphs were just like dinosaurs, except for a few key 
features. For instance, dinosaurs had a ball-and-socket hip that could rotate easily, 
and additional sacral vertebrae (a vertebra at the end of the spine), which helped 
strengthened the hips. This allowed dinosaurs to develop stronger leg muscles, 
which, along with their forward-hinging feet, helped them run faster than their 
competitors. They also developed an extra hole in their skulls, which let them cool 
off after vigorous activity. 
Even though paleontologists had studied these predecessors previously, they 
still haven't been certain about the age of the rocks containing early 
dinosauromorph fossils, Irmis said. He and his colleagues gave the matter a closer 
look, investigating the Chanares Formation in northwestern Argentina, a site 
known for containing the fossils of early dinosauromorphs and early dinosaurs. 
The researchers relied on a handy mineral called zircon to help them date the 
early dinosauromorph-containing rock layer. When zircon crystals form, they 
trap the radioactive element uranium within them. Over time, uranium decays into 
lead. 
"We know the exact rate at which uranium decays into lead," Irmis told Live 
Science. By measuring the ratio of uranium to lead, researchers can determine how 
long ago the zircon crystal formed. 
However, zircon isn't present in all rocks. So the researchers looked for 
volcanic ash, where the mineral is more commonly found. Luckily, they found 
zircon crystals in a rock layer that contained early dinosauromorphs. The scientists 
took a sample from that layer, as well as from the younger layer above it, so they 
could bookend the finding. 
Dating the rock 
The researchers crushed the rock samples so they could isolate the zircon 
crystals, which are as small as grains of sand, Irmis said. Then, the scientists 
analyzed about 20 zircon crystals from each sample, using a mass spectrometer, an 
instrument that separates elements and isotopes (a variation of an element) by mass 
and concentration, the researchers said. 
What's more, the zircon crystals contained a helpful cross-check: They have 
different uranium isotopes that decay at different rates, and "we're fairly confident 
we've got the right age if they all agree with each other," Irmis said. 
The results show that the rock layer is between 234 million and 236 million 
years old, from the Late Triassic period, he said, meaning the early 
dinosauromorphs within the layer are the same age. This new date is 5 million to 
10 million years younger than previously thought, Irmis said. 
Dinosaurs may have evolved rapidly (geologically speaking), but it appears 
they came to dominate paleo-Earth in a smooth and gradual manner, Irmis said. 
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That is, they didn't suddenly wrest power from their early dinosauromorph 
relatives.  
"When we look at the ecosystems of [the] first dinosauromorphs and the 
ecosystems with the first dinosaurs, it's interesting that we don't see much 
difference in how the ecosystems are put together," Irmis said. "You don't seem to 
see dinosaurs showing up and immediately taking over." 
He added, "it really emphasizes that there wasn't much special about the first 
dinosaurs. They were pretty similar to their early dinosauromorph relatives and 
probably doing very similar things." 
Dinosaurs move forward 
Some dinosauromorphs persisted for another 20 million years after dinosaurs 
emerged, Irmis said. But the dinosaurs' adaptations appear to have been 
advantageous in the long run, Irmis said. These changes helped dinosaurs prosper 
until the 6-mile-long (10 kilometers) asteroid wiped them out 66 million years ago, 
Irmis said. 
But dinosaurs took a while to spread throughout the world, the researchers 
note. The dinosaurs didn't dominate the mid to high latitudes—such as present-day 
Argentina, Brazil and South Africa—until the late Triassic, about 215 million 
years ago. It took dinosaurseven longer to dominate the lower latitudes, such as 
present-day western and eastern North America, areas that were closer to the 
equator at that time, Irmis said. 
The new research is a "solid study," said Kenneth Lacovara, a professor of 
paleontology and geology and the dean of the School of Earth & Environment at 
Rowan University in New Jersey, who wasn't involved with the study. 
"The story is that there was a very rapid evolution and a very rapid 
achievement of dominance in the fauna as they go from [early] dinosauromorphs 
to dinosaurs," Lacovara said. It shows that "being a dinosaur is a really good idea. 
It really works. It allows them to outcompete things that aren't like dinosaurs. And 
if you include birds, being a dinosaur is still a pretty good thing." 
The findings were published online today (Dec. 7) in the journal 
Proceedings of the National Academy of Sciences. 
Scientific American December 8, 2015 
http://www.scientificamerican.com/article/dinosaurs-evolved-in-a-
startlingly-short-time/ 
■ Glossary of essential terms for you to know 
 English term             Russian equivalent 
1. escape побег 
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2.  erupt прорезываться 
3.  startlingly поразительно 
4.  fossil ископаемое 
5.  precursor предвестник 
6.  ash пепел 
7.  precise точный 
8.  assemblage сборище 
9.  revamp реконструкция 
10. ball-and-socket hip шаровидное бедро 
11. rotate поворачиваться 
12. sacral крестцовый 
13. forward-hinging feet вперед – закрученные ноги 
14. skull череп 
15. vigorous бодрый 
16. site место 
17. layer слой 
18. amass копить 
19. persist упорствовать 
20. emerge появляться 
21. prosper преуспевать 
22. latitude широта 
23. dean декан 
24. outcompete вытеснять 
 
■ Your Essential Assignments 
I. Fill in the missing words: 
Term Noun 
Adapt  
Inherit  
Form  
Differ  
Discover  
Describe  
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II. Use monolingual English dictionary and write down what could the 
words given below mean:  
Sample, evolve, similar, research, vigotous. 
III. Find synonyms among the pool of words: 
Pool of words Synonyms 
1) evolve, develop, narrow, progress, reduce.  
2) finding, competitors, rival, discovery  
3) after, smooth, post, sleek  
4) movement, accept, motion, agree  
IV. Find English equivalents to the following word combinations: 
English term Russian equivalent 
To develop into dinosaurs  
The finding revamps the time line  
A handy mineral  
Radioactive isotopes  
Researchers can determine  
The zircon crystal  
Adaptation appears  
Dominate the mid to high latitudes  
V. Find opposites to the given words 
Word  Opposite  
Evolution  
Future  
Accept  
To survive  
To fail  
Gradually  
To escape  
VI. Give Russian equivalents to the following English terms: 
English term Russian equivalent 
Удобный минерал  
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Обнаружение обновляет временную линию  
Чтобы превратиться в динозавров  
Доминируют в средних и высоких широтах  
Исследователи могут определить  
Адаптация появляется  
Кристалл циркона  
Радиоактивные изотопы  
VII. Match these words with their definitions 
Word Definition 
1. Identical A. The act or process of producing young animals or plants 
2. Evolution B. To find something that was hidden or that people did not 
know about before 
3. Feature C. Exactly the same 
4. Reproduction D. Someone’s child or children, animal’s baby or babies. 
5. Existence E. Something important or typical of  a place or thing 
6. To discover F. A substance in general that everything in the world consist of 
7. Matter G. The gradual change and development 
8. Offspring H. The state of existing 
9. Evidence I. Fact that makes you believe that smth. exists or is true. 
VIII. Translate into English using all active possible. 
1. Динозаврам требовалось время, чтобы распространиться по всему 
миру, отмечают исследователи. 
2. Это действительно сужает количество времени между появлением 
ранних динозавроморфов и первых динозавров. 
3. Это позволило динозаврам развивать сильные мышцы ног. 
4. Даже если палеонтологи ранее изучали этих предшественников, они 
до сих пор не были уверены о возрасте пород, содержащих окаменелости 
ранних динозавроморфов. 
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Text 11. Beyond Resveratrol: The Anti-Aging NAD 
Fad 
 Pre-reading 
■ Work in pairs. Discuss the following questions and try to answer 
them. 
1. What is NAD? 
2. What do you know about mitochondria? 
3. What causes heart failure?  
4. What leads to mitochondrial dysfunction?  
 
■Read the given text and make your essential assignments: 
Mitochondria are our cells' energy dynamos. Descended from bacteria that 
colonized other cells about 2 billion years, they get flaky as we age. A prominent 
theory of aging holds that decaying of mitochondria is a key driver of aging. While 
it's not clear why our mitochondria fade as we age, evidence suggests that it leads 
to everything from heart failure to neurodegeneration, as well as the complete 
absence of zipping around the supper table. 
Recent research suggests it may be possible to reverse mitochondrial decay 
with dietary supplements that increase cellular levels of a molecule called NAD 
(nicotinamide adenine dinucleotide). But caution is due: While there's promising 
test-tube data and animal research regarding NAD boosters, no human clinical 
results on them have been published. 
 
STRUCTURE OF NICOTINAMIDE 
ADENINE DINUCLEOTIDE, OXIDIZED 
(NAD+). 
NAD is a linchpin of energy metabolism, 
among other roles, and its diminishing level with 
age has been implicated in mitochondrial 
deterioration. Supplements containing 
nicotinamide riboside, or NR, a precursor to NAD 
that's found in trace amounts in milk, might be 
able to boost NAD levels. In support of that idea, 
half a dozen Nobel laureates and other prominent 
scientists are working with two small companies 
offering NR supplements. 
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The NAD story took off toward the end of 2013 with a high-profile paperby 
Harvard's David Sinclair and colleagues. Sinclair, recall, achieved fame in the mid-
2000s for research on yeast and mice that suggested the red wine ingredient 
resveratrol mimics anti-aging effects of calorie restriction. This time his lab 
made headlines by reporting that the mitochondria in muscles of elderly mice were 
restored to a youthful state after just a week of injections with NMN (nicotinamide 
mononucleotide), a molecule that naturally occurs in cells. 
It should be noted, however, that c strength was not improved in the NMN-
treated mice the researchers speculated that one week of treatment wasn't enough 
to do that despite signs that their age-related mitochondrial deterioration was 
reversed. 
NMN isn't available as a consumer product. But Sinclair's report sparked 
excitement about NR, which was already on the market as a supplement called 
Niagen. Niagen's maker, ChromaDex, a publicly traded Irvine, Calif., company, 
sells it to various retailers, which market it under their own brand names. In the 
wake of Sinclair's paper, Niagen was hailed in the media as a potential blockbuster. 
In early February, Elysium Health, a startup cofounded by Sinclair's former 
mentor, MIT biologist Lenny Guarente, jumped into the NAD game by unveiling 
another supplement with NR. Dubbed Basis, it's only offered online by the 
company. Elysium is taking no chances when it comes to scientific credibility. Its 
website lists a dream team of advising scientists, including five Nobel laureates 
and other big names such as the Mayo Clinic's Jim Kirkland, a leader in 
geroscience, and biotech pioneer Lee Hood. I can't remember a startup with more 
stars in its firmament. 
A few days later, ChromaDex reasserted its first-comer status in the NAD 
game by announcing that it had conducted a clinical trial demonstrating that a 
single dose of NR resulted in statistically significant increases in NAD in humans 
the first evidence that supplements could really boost NAD levels in people. 
Details of the study won't be out until it's reported in a peer-reviewed journal, the 
company said. (ChromaDex also brandishes Nobel credentials: Roger Kornberg, a 
Stanford professor who won the Chemistry prize in 2006, chairs its scientific 
advisory board. He’s the son of Nobel laureate Arthur Kornberg, who, ChromaDex 
proudly notes, was among the first scientists to study NR some 60 years ago.) 
SIRT1 PROTEIN, RED, CIRCLES THE CELL'S CHROMOSOMES, 
BLUE. 
The NAD findings tie into the ongoing story about enzymes called sirtuins, 
which Guarente, Sinclair and other researchers have implicated as key players in 
conferring the longevity and health benefits of calorie restriction. Resveratrol, the 
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wine ingredient, is thought to rev up one of the sirtuins, SIRT1, which appears to 
help protect mice on high doses of resveratrol from the ill effects of high-fat diets.  
A slew of other health benefits have been attributed to SIRT1 activation in 
hundreds of studies, including several small human trials. 
Here's the NAD connection: In 2000, Guarente's lab reported that NAD fuels 
the activity of sirtuins, including SIRT1the more NAD there is in cells, the more 
SIRT1 does beneficial things. One of those things is to induce formation of new 
mitochondria. NAD can also activate another sirtuin, SIRT3, which is thought to 
keep mitochondria running smoothly. 
The Sinclair group's NAD paper drew attention partly because it showed a 
novel way that NAD and sirtuins work together. The researchers discovered that 
cells' nuclei send signals to mitochondria that are needed to maintain their normal 
operation. SIRT1 helps insure the signals get through. When NAD levels drop, as 
they do with aging, SIRT1 activity falls off, which in turn makes the crucial signals 
fade, leading to mitochondrial dysfunction and all the ill effects that go with it. 
NAD boosters might work synergistically with supplements like resveratrol 
to help reinvigorate mitochondria and ward off diseases of aging. Elysium is 
banking on this potential synergyits NR-containing supplement includes a 
resveratrol-like substance called pterostilbene (pronounced tero-STILL-bean), 
which is found in blueberries and grapes. 
Why pterostilbene instead of resveratrol? 
While resveratrol has hogged the anti-aging spotlight over the past decade, 
unsung researchers in places like Oxford, Miss., have quietly shown that 
pterostilbene is a kind of extra-potent version of resveratrol. The pterostilbene 
molecule is nearly identical to resveratrol's except for a couple of differences that 
make it more "bioavailable" (animal studies indicate that about four times as much 
ingested pterostilbene gets into the bloodstream as resveratrol). Test-tube and 
rodent studies also suggest that pterostilbene is more potent than resveratrol when 
it comes to improving brain function, warding off various kinds of cancer and 
preventing heart disease. 
Scientific American March 11, 2015 
http://blogs.scientificamerican.com/guest-blog/beyond-resveratrol-the-anti-
aging-nad-fad/ 
■ Glossary of essential terms  
 English term Russian term 
1 flake расслаиваться, шелушиться 
2 dietary supplements пищевые добавки 
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3 boosters ускорители 
4 diminishing уменьшающийся 
5 deterioration ухудшение 
6 precursor предшественник 
7 yeast дрожжи 
8 decay распад 
9 fade увядать 
10 to  zip сжимать 
11 to induce побудить 
12 to rev up для увеличения скорости 
13 synergistically синергично, автономно 
14 reinvigorate активизировать 
15 ward off отвратить 
16 speculate предполагать 
17 extra-potent version очень мощная версия 
18 ingested поглощенный 
19 test-tube пробирка 
20 nickels and dimes червонцы и пятаки 
21 drag off утащить 
22 astonishing удивительный 
23 to be hailed быть расценена 
24 credibility правдоподобие 
25 oxidized окисленный 
26 prominent видный 
27 biotech биотехнологии 
28 blueberries черника 
29 grapes виноград 
30 to protect защищать 
31 longevity долговечность 
32 peer-reviewed рецензируемые 
33 brain головной мозг 
34 buzz about шуметь  по поводу 
35 sidewalk тротуар 
36 mentor наставник 
37 preventing предотвращение 
38 evidence доказательства 
■ Your Essential Assignments 
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I. Quick check 
1. What is the difference between a NAD and a NR? 
2. What is the core energy of metabolism? 
II. Find synonyms among the pool of words 
 
Pool of words Synonyms 
1.protect/2.mentor/3.defend/4. tutor/5. coacher  
1.formation/2.deterioration/3.degradation/4.organization  
1. announce2 opportunity /3. .report /4.chance  
1. publicly/2 openly/3.researcher/4.explorer  
 
III. Fill in the gaps with the words and expressions from the text 
 
1.  The researchers discovered that __ __ send signals to mitochondria that 
are needed to maintain their normal operation. 
2.  A slew of other __ __ have been attributed to SIRT1 activation in 
hundreds of studies, including several small human trials. 
3.  A prominent theory of aging holds that __ __ __ is a key driver of aging. 
4.  Elysium isn't the only __ vendor. 
5. The scientists reportedly characterized NR's __ __ __ as "nothing short 
of astonishing." 
6.  Details of the study won't be out until it's reported in __ __ __, the 
company said. 
7.  Test-tube and __ __ also suggest that pterostilbene is more potent than 
resveratrol when it comes to improving __ __, warding off various kinds __ __ and 
preventing heart disease. 
8.  Even before Sinclair's paper, researchers had shown in 2012 that when 
given doses of NR, __ on high-fat diets gained 60 percent __ __ than they did on 
the same diets without NR. 
9.  When NAD levels drop, as they do with aging, SIRT1 __ __ off, which 
in turn makes the __ __ fade, leading to __ __ and all the ill effects that go with it. 
10.  Besides, it probably won’t be __ __ more data come out given the 
growing buzz __ __. 
 
IV. Fill in the missing words: 
 
Term Noun Adjective 
connect   
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find   
colonize   
report   
V. Use monolingual English dictionary and write down what could 
words given bellow mean: 
diet, supplement, booster, ward, to hail, injection. 
 
VI. Suggest Russian equivalents for the following word combinations 
 
VII. Read and translate the short text without any dictionary:  
Elysium isn't the only pterostilbene vendor. In fact, ChromaDex also offers 
pterostilbene for supplements separately from Niagen. 
How excited should we be about all this? If I were a middle-aged mouse, I'd 
be ready to spend some of the nickels and dimes I'd dragged off the sidewalk to try 
NR supplements. Even before Sinclair's paper, researchers had shown in 2012 that 
when given doses of NR, mice on high-fat diets gained 60 percent less weight than 
they did on the same diets without NR. Further, none of the mice on NR showed 
signs of diabetes, and their energy levels improved. The scientists reportedly 
characterized NR's effects on metabolism as "nothing short of astonishing." 
But the paucity of human data gives me pause. Nobel laureates 
notwithstanding, I plan to wait until more is known before jumping up from the 
supper table to run out for some NR. Besides, it probably won’t be long before 
more data come out given the growing buzz about NAD. 
 
№ English  term Russian equivalent 
1 Mitochondria are our cells' energy dynamos  
2 Human clinical results on them have been published  
3 NAD can also activate another sirtuin  
4 SIRT1 activity falls off  
5 SIRT1 helps insure the signals get through  
6 Resveratrol, the wine ingredient, is thought to rev 
up one of the sirtuins 
 
7 Further, none of the mice on NR showed signs of 
diabetes 
 
8 Ward off diseases of aging  
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Text 12. CRISPR tweak may help gene-edited crops 
by pass biosafety regulation 
  
            Pre-reading 
■ Work in pairs. Discuss the 
following questions and try to 
answer them. 
1. What do you know about biosafety 
regulation? 
2. Do you think that CRISPR can 
help gene-editing crops? 
Read the given text and make your essential assignments: 
A twist on a revolutionary gene-editing technique may make it possible to 
modify plant genomes while sidestepping national biosafety regulations, South 
Korean researchers say.Plant scientists have been quick to experiment with the 
popular CRISPR/Cas9 technique, which uses an enzyme called Cas9, guided by 
two RNA strands, to precisely cut segments of DNA in a genome. By disabling 
specific genes in wheat and rice, for example, researchers hope to make disease-
resistant strains of the crops. But the process can introduce bits of foreign DNA 
into plant genomes. And some jurisdictions, such as the European Union, could 
decide to classify such plants as genetically modified organisms (GMOs)1 — 
making their acceptance by regulatory bodies contentious, says geneticist Jin-Soo 
Kim of Seoul National University. 
Kim and his team tweaked the technique so that it can delete specific plant 
genes without introducing foreign DNA, creating plants that he and his colleagues 
think “might be exempt from current GMO regulations”. 
“In terms of science, our approach is just another improvement in the field 
of genome editing. However, in terms of regulations and public acceptance, our 
method could be path-breaking,” says Kim. 
DNA-free CRISPR 
Conventionally, researchers get CRISPR/Cas9 working in a plant cell by 
first shuttling in the gene that codes for the Cas9 enzyme. The gene is introduced 
on a plasmid — a circular packet of DNA — which is usually carried into a plant 
by the bacterial pest Agrobacterium tumefaciens. As a result, Agrobacterium DNA 
can end up in the plant’s genome. Even if the pest is not used, fragments of the 
Cas9 gene may themselves be incorporated into the plant's genome. 
86 
 
 
To get around this problem, Kim and his colleagues avoid gene-shuttling 
altogether. They report a recipe to assemble the Cas9 enzyme together with its 
guide RNA sequences (which the enzyme requires to find its target) outside the 
plant, and use solvents to get the resulting protein complex into the plant. The 
technique works efficiently to knock out selected genes in tobacco plants, rice, 
lettuce and thale cress, they say, reporting their results in Nature Biotechnology2. 
“I think this is a milestone work for plant science,’ says bioethicist Tetsuya 
Ishii at Hokkaido University in Sapporo, Japan, who has extensively studied the 
framework of regulation surrounding genetic engineering in plants. 
Kim wants to use the technique to edit the banana; the crop's most popular 
cultivar, the Cavendish variety, is struggling to combat a devastating soil fungus 
and may go extinct. Gene editing could, for example, be used to knock out the 
receptor that the fungus uses to invade cells, without any need, in Kim’s view, to 
classify the resulting banana as a GMO. “We will save the banana so that our 
children and grandchildren can still enjoy the fruit,” he says. 
Skirting regulations 
Other scientists have recently achieved similar results with different 
genome-editing techniques. Jeffrey Wolt, a specialist in risk analysis of plant 
biotechnology at Iowa State University in Ames, points out that some researchers 
have introduced gene-editing protein complexes called TALENs directly into 
plants, for example3; others have used nanoparticles to usher in different gene-
editing proteins4. To his mind, Kim’s paper is just one more tool in plant breeders’ 
arsenals — although many researchers say that CRISPR is cheaper and easier to 
use than other tools. 
Jens Boch, a plant geneticist at Martin Luther University of Halle-
Wittenberg in Germany who helped to develop TALEN, says that he hopes that 
workarounds that avoid Agrobacterium will not be necessary. When plants 
reproduce sexually, their genes are remixed, so they produce some offspring that 
do not have the offending bacterial DNA; breeding these Agrobacterium-free 
plants should appease regulators, he hopes. Agrobacterium “is just too easy to use, 
and this is going to be the method of choice”, he says. “I don't believe that plant 
breeders will use Kim’s method.” (Still, Kim points out that some plants, such as 
the banana, do not reproduce sexually, so would not lose an Agrobacterium gene if 
it were lodged in their genome.) 
It is unclear what stance regulatory authorities will take on CRISPR-edited 
plants. The European Commission is currently debating regulations to take into 
account the latest techniques, and it is conceivable that it will still classify plants as 
GMOs even if they lack foreign DNA.   
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In the United States, editing plants with Agrobacterium is currently a trigger 
for regulation by the Animal and Plant Health Inspection Service, yet plants edited 
in other ways have bypassed regulations. But rules may change there too: in July, 
the White House launched a multiyear initiative to review federal regulations on 
agricultural biotechnology. 
If regulations on CRISPR plants do turn out to be severe, Boch says, “the 
method proposed by Kim is a very good one to circumvent some of the possible 
criticisms”. 
Nature October 19, 2015 
http://www.nature.com/news/crispr-tweak-may-help-gene-edited-crops-
bypass-biosafety-regulation-1.18590 
 
■ Glossary of essential terms  
№ English term  Russian equivalent 
1 biosafety биобезопасность 
2 gene-editing генное редактирование 
3 sidestepping обходя 
4 disease-resistant устойчив к болезням 
5 researchers исследователи 
6 jurisdictions юрисдикция 
7 avoid избегать 
8 fungus грибок 
9 altogether в целом 
10 milestone веха 
11 surrounding окружающий 
12 engineering инжиниринг, проектирование  
13 authorities власти 
14 agricultural biotechnology сельскохозяйственная биотехнология 
15 similar подобное 
16 launched запущенный 
17 circumvent обходить 
18 plant breeders селекционеры 
19 current современный 
I. Fill in the missing words: 
1. A twist on a revolutionary ……may make it possible to modify plant 
genomes while sidestepping national biosafety regulations. 
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2.  By disabling specific genes in wheat and rice, for example, researchers 
hope to make……. 
3. And some jurisdictions, such as the European Union, could decide to 
classify such plants as…..— making their acceptance by regulatory bodies 
contentious 
4. The gene is introduced on a plasmid —…..— which is usually carried into 
a plant by the bacterial pest…... 
5. It is unclear what stance regulatory authorities will take…... 
6. Conventionally, researchers ……in a plant cell by first shuttling in the 
gene that codes for the Cas9 enzyme. 
 
II. Find English equivalents to the following word combinations: 
№ English term Russian equivalent 
1 Genetically modified organisms  
2 Introducing foreign DNA  
3 Without any need  
4 The technique works efficiently  
5 To take into account the latest techniques  
6 Agricultural biotechnology  
7 They produce some offspring  
8 The offending bacterial DNA  
9 Stance regulatory authorities  
 
III. Find Russian equivalents to the following word combinations: 
1 Чужеродная ДНК  
2 Национальные правила безопасности  
3 Редактирования генома  
4 Техника работает эффективно  
5 Популярный сорт урожая  
6 Белковые комплексы  
7 Другие использовали наночастицы  
8 Обходные пути  
9 Использовать растворители  
10 Изменить геномы растения  
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IV. Use monolingual English dictionary and write down what could        
the words given below mean: 
Plant, stance, agricultural, strains, fungus. 
V. Find synonyms among the pool of words: 
Pool of words  Synonyms 
1)work/2)method/3)be employed/ 4)technique  
1)hope/2)plant/3)expectation4)/grower  
1)account/2)report/3)conceivable/4)thinkable  
1)specialist/2)provide food/3)feed/4)expert  
1)introduce/2)obligatory3)present/4)necessary  
 
VI. Fill in the missing words: 
Term(Noun) Adjective 
Prevention  
Bacteria  
Technique  
Risk  
Diversity  
 
VIII. Match the sentence halves. Make complete sentences: 
1 A twist on a revolutionary gene-
editing technique may make  
A called Cas9, guided by two RNA 
strands, to precisely cut segments of 
DNA in a genome. 
2 the process can introduce bits of 
foreign DNA  
B to edit the banana 
3 Kim and his team tweaked the 
technique so  
C regulation by the Animal and Plant 
Health Inspection Service, yet plants 
edited in other ways have bypassed 
regulations 
4 Even if the pest is not used, 
fragments of the Cas9 gene may 
themselves be incorporated  
D it possible to modify plant genomes 
while sidestepping national biosafety 
regulations 
5 Kim wants to use the technique  E into the plant's genome. 
6 In the United States, editing plants F that it can delete specific plant genes 
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with Agrobacterium is currently a 
trigger for  
without introducing foreign DNA 
7 Plant scientists have been quick to 
experiment with the popular 
CRISPR/Cas9 technique, which 
uses an enzyme  
G into plant genomes 
 
IX. Fill in the missing words: 
Term(verb) Noun 
Classify   
Control  
Discuss  
Appear  
Change  
Determinate  
Use  
 
X. Make sentences with the given words: 
GMOs, Agrobacterium tumefaciens, gene-editing, fungus, scientists, 
enzyme. 
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ADDITIONAL TEXTS  
Text 1. What Sparked the Cambrian Explosion? 
An evolutionary burst 540 million years ago filled the seas with an astonishing 
diversity of animals. The trigger behind that revolution is finally coming into focus 
               
Given the importance of oxygen for animals, researchers suspected that a 
sudden increase in the gas to near-modern levels in the ocean could have spurred 
the Cambrian explosion. To test that idea, they have studied ancient ocean 
sediments laid down during the Ediacaran and Cambrian periods, which together 
ran from about 635 million to 485 million years ago. 
A series of dark, craggy pinnacles rises 80 meters above the grassy plains of 
Namibia. The peaks call to mind something ancient — the burial mounds of past 
civilizations or the tips of vast pyramids buried by the ages. 
The stone formations are indeed monuments of a faded empire, but not from 
anything hewn by human hands. They are pinnacle reefs, built by cyanobacteria on 
the shallow sea floor 543 million years ago, during a time known as the Ediacaran 
period. The ancient world occupied by these reefs was truly alien. The oceans held 
so little oxygen that modern fish would quickly founder and die there. A gooey 
mat of microbes covered the sea floor at the time, and on that blanket lived a 
variety of enigmatic animals whose bodies resembled thin, quilted pillows. Most 
were stationary, but a few meandered blindly over the slime, grazing on the 
microbes. Animal life at this point was simple, and there were no predators. But an 
evolutionary storm would soon upend this quiet world. 
Within several million years, this simple ecosystem would disappear, and 
give way to a world ruled by highly mobile animals that sported modern 
anatomical features. The Cambrian explosion, as it is called, produced arthropods 
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with legs and compound eyes, worms with feathery gills and swift predators that 
could crush prey in tooth-rimmed jaws. Biologists have argued for decades over 
what ignited this evolutionary burst. Some think that a steep rise in oxygen sparked 
the change, whereas others say that it sprang from the development of some key 
evolutionary innovation, such as vision. The precise cause has remained elusive, in 
part because so little is known about the physical and chemical environment at that 
time. 
But over the past several years, discoveries have begun to yield some 
tantalizing clues about the end of the Ediacaran. Evidence gathered from 
the Namibian reefs and other sites suggests that earlier theories were overly 
simplistic — that the Cambrian explosion actually emerged out of a complex 
interplay between small environmental changes that triggered major evolutionary 
developments. 
Some scientists now think that a small, perhaps temporary, increase in 
oxygen suddenly crossed an ecological threshold, enabling the emergence of 
predators. The rise of carnivory would have set off an evolutionary arms race that 
led to the burst of complex body types and behaviours that fill the oceans today. 
“This is the most significant event in Earth evolution,” says Guy Narbonne, a 
palaeobiologist at Queen's University in Kingston, Canada. “The advent of 
pervasive carnivory, made possible by oxygenation, is likely to have been a major 
trigger.” 
ENERGY TO BURN 
In the modern world, it's easy to forget that complex animals are relative 
newcomers to Earth. Since life first emerged more than 3 billion years ago, single-
celled organisms have dominated the planet for most of its history. Thriving in 
environments that lacked oxygen, they relied on compounds such as carbon 
dioxide, sulfur-containing molecules or iron minerals that act as oxidizing agents 
to break down food. Much of Earth's microbial biosphere still survives on these 
anaerobic pathways. 
Animals, however, depend on oxygen — a much richer way to make a 
living. The process of metabolizing food in the presence of oxygen releases much 
more energy than most anaerobic pathways. Animals rely on this potent, controlled 
combustion to drive such energy-hungry innovations as muscles, nervous systems 
and the tools of defence and carnivory — mineralized shells, exoskeletons and 
teeth. 
Given the importance of oxygen for animals, researchers suspected that a 
sudden increase in the gas to near-modern levels in the ocean could have spurred 
the Cambrian explosion. To test that idea, they have studied ancient ocean 
sediments laid down during the Ediacaran and Cambrian periods, which together 
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ran from about 635 million to 485 million years ago. 
In Namibia, China and other spots around the world, researchers have 
collected rocks that were once ancient seabeds, and analysed the amounts of iron, 
molybdenum and other metals in them. The metals' solubility depends strongly on 
the amount of oxygen present, so the amount and type of those metals in ancient 
sedimentary rocks reflect how much oxygen was in the water long ago, when the 
sediments formed. 
These proxies seemed to indicate that oxygen concentrations in the oceans 
rose in several steps, approaching today's sea-surface concentrations at the start of 
the Cambrian, around 541 million years ago — just before more-modern animals 
suddenly appeared and diversified. This supported the idea of oxygen as a key 
trigger for the evolutionary explosion. 
But last year, a major study of ancient sea-floor sediments challenged that 
view. Erik Sperling, a palaeontologist at Stanford University in California, 
compiled a database of 4,700 iron measurements taken from rocks around the 
world, spanning the Ediacaran and Cambrian periods. He and his colleagues did 
not find a statistically significant increase in the proportion of oxic to anoxic water 
at the boundary between the Ediacaran and the Cambrian. 
“Any oxygenation event must have been far, far smaller than what people 
normally considered,” concludes Sperling. Most people assume “that the 
oxygenation event essentially raised oxygen to essentially modern-day levels. And 
that probably wasn't the case”, he says. 
The latest results come at a time when scientists are already reconsidering 
what was happening to ocean oxygen levels during this crucial period. Donald 
Canfield, a geobiologist at the University of Southern Denmark in Odense, doubts 
that oxygen was a limiting factor for early animals. In a study published last 
month, he and his colleagues suggest that oxygen levels were already high enough 
to support simple animals, such as sponges, hundreds of millions of years before 
they actually appeared. Cambrian animals would have needed more oxygen than 
early sponges, concedes Canfield. “But you don't need an increase in oxygen 
across the Ediacaran/Cambrian boundary,” he says; oxygen could already have 
been abundant enough “for a long, long time before”. 
“The role of oxygen in the origins of animals has been heavily debated,” 
says Timothy Lyons, a geobiologist at the University of California, Riverside. “In 
fact, it's never been more debated than it is now.” Lyons sees a role for oxygen in 
evolutionary changes, but his own work with molybdenum and other trace metals 
suggests that the increases in oxygen just before the Cambrian were mostly 
temporary peaks that lasted a few million years and gradually stepped upward 
(see 'When life sped up'). 
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MODERN MIRRORS 
Sperling has looked for insights into Ediacaran oceans by studying oxygen-
depleted regions in modern seas around the globe. He suggests that biologists have 
conventionally taken the wrong approach to thinking about how oxygen shaped 
animal evolution. By pooling and analysing previously published data with some 
of his own, he found that tiny worms survive in areas of the sea floor where 
oxygen levels are incredibly low — less than 0.5% of average global sea-surface 
concentrations. Food webs in these oxygen-poor environments are simple, and the 
animals feed directly on microbes. In places where sea-floor oxygen levels are a bit 
higher — about 0.5–3% of concentrations at the sea surface — animals are more 
abundant but their food webs remain limited: the animals still feed on microbes 
rather than on each other. But around somewhere between 3% and 10% oxygen 
levels, predators emerge and start to consume other animals. 
The implications of this finding for evolution are profound, Sperling 
says.The modest oxygen rise that he thinks may have occurred just before the 
Cambrian would have been enough to trigger a big change. “If oxygen levels were 
3% and they rose past that 10% threshold, that would have had a huge influence on 
early animal evolution,” he says. “There's just so much in animal ecology, lifestyle 
and body size that seems to change so dramatically through those levels.” 
The gradual emergence of predators, driven by a small rise in oxygen, would 
have meant trouble for Ediacaran animals that lacked obvious defences. “You're 
looking at soft-bodied, mostly immobile forms that probably lived their lives by 
absorbing nutrients through their skin,” says Narbonne. 
Studies of those ancient Namibian reefs suggest that animals were indeed 
starting to fall prey to predators by the end of the Ediacaran. When palaeobiologist 
Rachel Wood from the University of Edinburgh, UK, examined the rock 
formations, she found spots where a primitive animal called Cloudina had taken 
over parts of the microbial reef. Rather than spreading out over the ocean floor, 
these cone-shaped creatures lived in crowded colonies, which hid their vulnerable 
body parts from predators — an ecological dynamic that occurs in modern reefs. 
Cloudina were among the earliest animals known to have grown hard, 
mineralized exoskeletons. But they were not alone. Two other types of animal in 
those reefs also had mineralized parts, which suggests that multiple, unrelated 
groups evolved skeletal shells around the same time. “Skeletons are quite costly to 
produce,” says Wood. “It's very difficult to come up with a reason other than 
defence for why an animal should bother to create a skeleton for itself.” Wood 
thinks that the skeletons provided protection against newly evolved predators. 
Some Cloudina fossils from that period even have holes in their sides, which 
scientists interpret as the marks of attackers that bore into the creatures' shells. 
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Palaeontologists have found other hints that animals had begun to eat each 
other by the late Ediacaran. In Namibia, Australia and Newfoundland in Canada, 
some sea-floor sediments have preserved an unusual type of tunnel made by an 
unknown, wormlike creature. Called Treptichnus burrows, these warrens branch 
again and again, as if a predator just below the microbial mat had systematically 
probed for prey animals on top. The Treptichnus burrows resemble those of 
modern priapulid, or 'penis', worms — voracious predators that hunt in a 
remarkably similar way on modern sea floors. 
The rise of predation at this time put large, sedentary Ediacaran animals at a 
big disadvantage. “Sitting around doing nothing becomes a liability,” says 
Narbonne. 
THE WORLD IN 3D 
The moment of transition from the Ediacaran to the Cambrian world is 
recorded in a series of stone outcrops rounded by ancient glaciers on the south 
edge of Newfoundland. Below that boundary are impressions left by quilted 
Ediacaran animals, the last such fossils recorded on Earth. And just 1.2 meters 
above them, the grey siltstone holds trails of scratch marks, thought to have been 
made by animals with exoskeletons, walking on jointed legs — the earliest 
evidence of arthropods in Earth's history. 
No one knows how much time passed in that intervening rock — maybe as 
little as a few centuries or millennia, says Narbonne. But during that short span, the 
soft-bodied, stationary Ediacaran fauna suddenly disappeared, driven to extinction 
by predators, he suggests. 
Narbonne has closely studied the few fauna that survived this transition, and 
his findings suggest that some of them had acquired new, more complex types of 
behaviour. The best clues come from traces left by peaceful, wormlike animals that 
grazed on the microbial mat. Early trails from about 555 million years ago 
meander and criss-cross haphazardly, indicating a poorly developed nervous 
system that was unable to sense or react to other grazers nearby — let alone 
predators. But at the end of the Ediacaran and into the early Cambrian, the trails 
become more sophisticated: creatures carved tighter turns and ploughed closely 
spaced, parallel lines through the sediments. In some cases, a curvy feeding trail 
abruptly transitions into a straight line, which Narbonne interprets as potential 
evidence of the grazer evading a predator. 
This change in grazing style may have contributed to the fragmentation of 
the microbial mat, which began early in the Cambrian. And the transformation of 
the sea floor, says Narbonne, “may have been the most profound change in the 
history of life on Earth”, . The mat had previously covered the seabed like a 
coating of plastic wrap, leaving the underlying sediments largely anoxic and off 
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limits to animals. Because animals could not burrow deeply in the Ediacaran, he 
says, “the mat meant that life was two-dimensional”. When grazing capabilities 
improved, animals penetrated the mat and made the sediments habitable for the 
first time, which opened up a 3D world. 
Tracks from the early Cambrian show that animals started to burrow several 
centimeters into the sediments beneath the mat, which provided access to 
previously untapped nutrients — as well as a refuge from predators. It's also 
possible that animals went in the opposite direction. Sperling says that the need to 
avoid predators (and pursue prey) may have driven animals into the water column 
above the seabed, where enhanced oxygen levels enabled them to expend energy 
through swimming. 
The emerging evidence about oxygen thresholds and ecology could also 
shed light on another major evolutionary question: when did animals originate? 
The first undisputed fossils of animals appear only 580 million years ago, but 
genetic evidence indicates that basic animal groups originated as far back as 700 
million to 800 million years ago. According to Lyons, the solution may be that 
oxygen levels rose to perhaps 2% or 3% of modern levels around 800 million years 
ago. These concentrations could have sustained small, simple animals, just as they 
do today in the ocean's oxygen-poor zones. But animals with large bodies could 
not have evolved until oxygen levels climbed higher in the Ediacaran. 
Understanding how oxygen influenced the appearance of complex animals 
will require scientists to tease more-subtle clues out of the rocks. “We've been 
challenging people working on fossils to tie their fossils more closely to our 
oxygen proxies,” says Lyons. It will mean deciphering what oxygen levels were in 
different ancient environments, and connecting those values with the kinds of traits 
exhibited by the animal fossils found in the same locations. 
This past autumn, Woods visited Siberia with that goal in mind. She 
collected fossils of Cloudina and another skeletonized animal, Suvorovella, from 
the waning days of the Ediacaran. Those sites gave her the chance to gather fossils 
from many different depths in the ancient ocean, from the more oxygen-rich 
surface waters to deeper zones. Wood plans to look for patterns in where animals 
were growing tougher skeletons, whether they were under attack by predators and 
whether any of this had a clear link with oxygen levels, she says. “Only then can 
you pick out the story.” 
Scientific American June 29, 2015 
            http://www.scientificamerican.com/article/a-battle-of-the-sexes-is-waged-in-
the-genes-of-humans-bulls-and-more/ 
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Text 2. Biotech Interest in Mini Organs Booms 
Biologists are building banks of ‘organoids’, and learning a lot about human 
development on the way 
  
It was an otherwise normal day in November when Madeline Lancaster 
realized that she had accidentally grown a brain. For weeks, she had been trying to 
get human embryonic stem cells to form neural rosettes, clusters of cells that can 
become many different types of neuron. But for some reason her cells refused to 
stick to the bottom of the culture plate. Instead they floated, forming strange, 
milky-looking spheres. 
“I didn’t really know what they were,” says Lancaster, who was then a 
postdoc at the Institute of Molecular Biotechnology in Vienna. That day in 2011, 
however, she spotted an odd dot of pigment in one of her spheres. Looking under 
the microscope, she realized that it was the dark cells of a developing retina, an 
outgrowth of the developing brain. And when she sliced one of the balls open, she 
could pick out a variety of neurons. Lancaster realized that the cells had assembled 
themselves into something unmistakably like an embryonic brain, and she went 
straight to her adviser, stem-cell biologist Jürgen Knoblich, with the news. “I’ve 
got something amazing,” she told him. “You’ve got to see it.” 
Lancaster and her colleagues were not the first to grow a brain in a dish. In 
2008, researchers in Japan reported that they had prompted embryonic stem cells 
from mice and humans to form layered balls reminiscent of a cerebral cortex. Since 
then, efforts to grow stem cells into rudimentary organs have taken off. Using 
carefully timed chemical cues, researchers around the world have produced three-
dimensional structures that resemble tissue from the eye, gut, liver, kidney, 
pancreas, prostate, lung, stomach and breast. These bits of tissue, called organoids 
because they mimic some of the structure and function of real organs, are 
furthering knowledge of human development, serving as disease models and drug-
screening platforms, and might eventually be used to rescue damaged organs 
(see ‘The organoid bank’). “It’s probably the most significant development in the 
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stem-cell field in the last five or six years,” says Austin Smith, director of the 
Wellcome Trust/MRC Stem Cell Institute at the University of Cambridge, UK.  
The current crop of organoids isn’t perfect. Some lack key cell types; others 
imitate only the earliest stages of organ development or vary from batch to batch. 
So researchers are toiling to refine their organoids—to make them more complex, 
more mature and more reproducible. Still, biologists have been amazed at how 
little encouragement cells need to self-assemble into elaborate structures. “It 
doesn’t require any super-sophisticated bioengineering,” says Knoblich. “We just 
let the cells do what they want to do, and they make a brain.” 
 
Growing a gut 
This shouldn’t come as a major surprise, says molecular biologist Melissa 
Little at the University of Queensland, Australia. “The embryo itself is incredibly 
able to self-organize; it doesn’t need a template or a map.” That has been known 
since the early 1900s, when embryologists showed that sponges that had been 
broken up into single cells could reassemble themselves. But such work fell out of 
fashion, and modern biologists have focused their attention on purifying cells and 
growing them in culture—often in flat layers that do little to mimic normal human 
tissue. 
Studying these cells to understand how an organ functions is like studying a 
pile of bricks to understand the function of a house, says Mina Bissell, a cancer 
researcher at the Lawrence Berkeley National Laboratory in California. “We 
should just begin to make the house,” she says. Bissell’s work on cultures of breast 
cells helped to propagate the idea that cells behave differently in 3D cultures than 
in conventional flat ones. By the mid-2000s, the idea was catching on. The burst of 
enthusiasm was fuelled by Yoshiki Sasai, a stem-cell biologist at the RIKEN 
Center for Developmental Biology in Kobe, Japan, who turned heads when he 
grew a cerebral cortex, followed by a rudimentary optic cup and pituitary gland.  
Just a year after Sasai announced his layered cortex, Hans Clevers, a stem-
cell researcher at the Hubrecht Institute in Utrecht, the Netherlands, reported the 
creation of a mini-gut. The breakthrough stemmed from a discovery in 2007, when 
Clevers and his colleagues had identified intestinal stem cells in mice. In the body, 
these cells seemed to have an unlimited capacity to divide and replenish the 
intestinal lining, and one of Clevers’ postdocs, Toshiro Sato, was tasked with 
culturing them in the lab.  
Rather than growing the cells flat, the pair decided to embed them in 
matrigel, a soft jelly that resembles the extracellular matrix, the mesh of molecules 
that surrounds cells. “We were just trying things,” Clevers says. “We hoped that 
we would make maybe a sphere or a blob of cells.” Several months later, when 
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Clevers put his eye to Sato’s microscope, he saw more than blobs. The cells had 
divided, differentiated into multiple types, and formed hollow spheres that were 
dotted with knobby protrusions. Inside, the team found structures that resembled 
the intestine’s nutrient-absorbing villi as well as the deep valleys between them 
called crypts. “The structures, to our total astonishment, looked like real guts,” 
Clevers says. “They were beautiful.” 
The mini-guts, reported in 2009, may prove to be a powerful tool in 
personalized medicine. Clevers and his team are using them to study the 
effectiveness of drugs in people with cystic fibrosis, who have genetic defects that 
affect ion channels and disrupt the movement of water in and out of the cells lining 
the lungs and intestine. The researchers take rectal biopsies from people with the 
disease, use the cells to create personalized gut organoids and then apply a 
potential drug. If the treatment opens the ion channels, then water can flow inwards 
and the gut organoids swell up. “It’s a black-and-white assay,” Clevers says, one 
that could prove quicker and cheaper than trying drugs in people to see whether 
they work. 
He has already used the system to assess whether a drug called Kalydeco 
(ivacaftor), and 5 other cystic-fibrosis drugs, will work in about 100 patients; at 
least 2 of them are now taking Kalydeco as a result. 
Organoids may also help physicians to choose the best therapies for people 
with cancer. Earlier this year, Clevers revealed that he had grown a bank of 
organoids from cells extracted from colorectal tumours, and David Tuveson, a 
cancer researcher at Cold Spring Harbor Laboratory in New York, worked with 
Clevers to generate pancreas organoids using biopsies taken from people with 
pancreatic cancer. In both cases, the organoids could be used to find drugs that 
work best on particular tumours. “What patients are looking for is a logical 
approach to their cancer,” Tuveson says. “I’m very excited about what we’re 
learning.” 
 
The small-scale stomach 
That excitement is shared by developmental biologist James Wells, who last 
year reported that he and his team had created an organoid that resembled part of a 
human stomach. 
Wells started with a different raw material to Clevers, whose organoids arise 
from adult stem cells that can generate only a limited number of cell types. Wells, 
who is at the Cincinnati Children’s Hospital Medical Center in Ohio, and his 
colleagues craft organoids from embryonic stem cells, which have the ability to 
become almost any type of cell. As a result, they have been able to create mini-
organs that are more complex. 
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A decade ago, Wells and his colleagues began trying to coax human 
embryonic stem cells to form intestinal cells. When the team manipulated two key 
signalling pathways, the layer of cells produced tiny round buds. Wells noticed that 
these ‘spheroids’ mimicked sections of the primitive gut tube, which forms four 
weeks after conception. This was thrilling, because he realized that he now had a 
starting point from which to develop a variety of organoids. “Every organ from 
your mouth down to your anus—oesophagus, lungs, trachea, stomach, pancreas, 
liver, intestine, bladder—all of them come from this very primitive tube,” he says. 
Wells and his colleagues mined the literature and their own experience to 
determine what chemical cues might send these gut tubes down the developmental 
path toward a specific organ. Using this strategy, in 2011 the team developed its 
first human organoid, an intestine about the size of a sesame seed. But growing a 
stomach was a bigger challenge. In humans, the organ has two key areas: the 
fundus at the top, which churns out acid, and the antrum towards the base, which 
produces many key digestive hormones—and the signalling pathways that lead to 
one versus the other were unknown. What is more, “the human stomach is different 
from the stomachs of most animals that we use in the lab”, so there is no good 
animal model, says Kyle McCracken, a former graduate student of Wells and now 
a medical student at the center. 
The researchers went for a trial-and-error approach: they made some 
educated guesses and painstakingly tested different combinations of growth 
factors. Eventually, the effort paid off. In a 2014 paper, Wells and his team 
revealed that they had created organoids that resembled the antrum. Using these as 
a model system, the team says that it has figured out the chemical trigger that 
prompts the development of a fundus. Now the researchers are working to answer 
other basic questions about stomach development and physiology, such as which 
factors regulate acid secretion, and they are trying to generate other mini-organs 
from their primitive gut tubes. 
This newfound ability to examine human development excites Daniel St 
Johnston, a developmental geneticist at the University of Cambridge’s Gurdon 
Institute. “You can actually watch how the cells organize themselves to make 
complicated structures,” he says—something that is impossible in a human 
embryo. But most organoids are still single tissues, which limits what 
developmental biologists can learn, he says. “There are certain questions you can’t 
really address because they depend upon the physiology of the whole organism.” 
 
The baby kidney 
Melissa Little has spent more than a decade marvelling at the complexity of 
the kidney. “It has, in an adult, probably 25–30 different cell types, each doing 
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different jobs,” she says. Tubular structures called nephrons filter fluid from the 
blood and produce urine. The surrounding space, called the interstitium, holds an 
intricate network of blood vessels and the plumbing that carries urine away. 
In 2010, Little and her colleagues started trying to turn embryonic stem cells 
into a progenitor cell that gives rise to nephrons. For three years, they tried various 
combinations and timings of growth factors. “It really took a lot of mucking 
around to make progress,” she says. But finally, in 2013, the team landed on just 
the right mixture. Little had been aiming to produce just the progenitor cells. But 
when she looked in the dish she saw two cell types spontaneously patterning 
themselves as they would in an embryo. “There was a moment of, ‘Oh wow. Isn’t 
that amazing’,” she says. 
This organoid resembles an embryonic kidney rather than an adult one: it 
has a mix of nephron progenitors and the cells that give rise to urine-collecting 
ducts. “If you want to get them to mature further, that’s where the challenge really 
lies,” Little says. So her team has been working to grow a more-sophisticated 
version—with blood vessels and interstitium. The hope then is to transplant the 
mini-organs into mice to see if they will mature and produce urine. “I’m pretty 
excited about what we can build,” Little says. 
Because the kidney plays a key part in drug metabolism and excretion, Little 
thinks that her mini-kidneys could be useful for testing drug candidates for toxicity 
before they reach clinical trials. And researchers say that other human organoids, 
such as heart and liver, could similarly be used to screen drug candidates for toxic 
effects—offering a better read-out on the response of an organ than is possible with 
standard tissue culture or animal testing. 
But Michael Shen, a stem-cell researcher at Columbia University in New 
York who has created a prostate organoid, is sceptical that these model systems 
could completely replace lab animals. Animals can show how a therapy affects the 
immune system, for example, something that organoid systems cannot currently 
do. “You want to be able to validate your experimental findings in an in 
vivo system,” he says. “I view that as a rigorous test.” 
 
Little livers 
Takanori Takebe was inspired to grow a liver after a chilling spell in New 
York. While working in the organ-transplantation division at Columbia University 
in 2010, Takebe saw people die from liver failure owing to a lack of organs. “That 
was a sad situation,” he says. When he looked into tissue engineering, he thought 
that the usual methods—seeding cells onto an artificial scaffold—seemed destined 
to fail. Part of the problem, he says, is that adult liver cells are very difficult to 
grow. “We cannot maintain it in culture for even a couple of hours.” 
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Takebe, who took up a research position at Yokohama City University in 
Japan, decided to work on induced pluripotent stem (iPS) cells, adult cells that 
have been reprogrammed to behave like embryonic stem cells. He coaxed human 
iPS cells into forming liver-cell precursors, or hepatoblasts. In the embryo, 
hepatoblasts rely on a complex symphony of signals from other nearby cells to 
mature, and Takebe suspected that these support cells would also be necessary to 
develop a liver in a dish. He and his colleagues mixed hepatoblasts with such 
cells—called mesenchymal and endothelial cells—and it worked. The team 
managed to create ‘liver buds’, structures no bigger than a lentil that resemble the 
liver of a six-week-old human embryo. The researchers went on to find that, unlike 
mature liver cells, such structures can survive in culture for as long as two months. 
A liver bud is still a far cry from an entire liver—a hefty, multi-lobed organ 
composed of tens of billions of hepatocytes. But Takebe hopes that if he can infuse 
many thousands of buds into a failing organ, he might be able to rescue enough of 
its function to make a transplant unnecessary. The process seems to work in mice. 
When Takebe and his group transplanted a dozen of the buds into mouse 
abdomens, they saw dramatic effects. Within two days, the buds had connected up 
with the mouse’s blood supply, and the cells went on to develop into mature liver 
cells that were able to make liver-specific proteins and to metabolize drugs. To 
mimic liver failure, the team wiped out the animals’ natural liver function with a 
toxic drug. After a month, most of the control mice had died, but most of those that 
received liver bud transplants had survived. 
Takebe and his team hope to start human trials in four years. “We will target 
the children that critically need a liver transplant,” he says. He and his colleagues 
are currently working to make the liver buds smaller and produce them in huge 
quantities that they can infuse through the large portal vein that feeds the liver. 
Takebe thinks that the timeline is “doable”. But Smith says that the process seems 
rushed, and that the basic biology of these organs needs to be well understood 
before they are used in the clinic. “It’s like running before you can walk,” he says. 
Biologists know that their mini-organs are still a crude mimic of their life-
sized counterparts. But that gives them something to aim for, says Anthony Atala, 
director of the Wake Forest Institute for Regenerative Medicine in Winston-Salem, 
North Carolina. “The long-term goal is that you will be able to replicate more and 
more of the functionality of a human organ.” Already, the field has brought 
together developmental biologists, stem-cell biologists and clinical scientists. Now 
the aim is to build more-elaborate organs—ones that are larger and that integrate 
more cell types. 
And Wells says that even today’s rudimentary organoids are facilitating 
discoveries that would have been difficult to make in an animal model, in which 
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the molecular signals are hard to manipulate. “In a Petri dish it’s easy,” he says. 
“We have chemicals and proteins that we can just dump onto these cells.” 
Scientific American July 29, 2015 
http://www.scientificamerican.com/article/biotech-interest-in-mini-organs-
booms/ 
 
 
Text 3. Synthetic Biology's First Malaria Drug 
Meets Market Resistance 
Commercial use of genetically engineered yeast to make medicine has modest 
impact 
By Mark Peplow, Nature magazine on February 25, 2016 
 
 
 
When Paris-based pharmaceutical giant Sanofi started to sell malaria drugs 
made with the help of genetically engineered yeast in 2014, the move was hailed as 
a triumph for synthetic biology. The yeast was fermented in a vat to produce a 
chemical that Sanofi converted into artemisinin, which is used to make leading 
malaria treatments called artemisinin-based combination therapies (ACTs). Many 
hoped that the process would offer a cheap and plentiful supply of drugs to tackle a 
disease that claims almost half a million lives worldwide every year. 
Yet Sanofi produced no ‘semi-synthetic’ artemisinin (SSA) at all in 
2015, Nature has learned. And the company is now selling the manufacturing site 
in Garessio, Italy, where it made its SSA. 
That such celebrated drugmaking technology—developed with the help of 
US$64 million from the Bill & Melinda Gates Foundation—stands idle illustrates 
the complicated web of economic forces that affects the market for malaria drugs. 
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“This is a perfect example of how a new manufacturing process becomes 
extremely hard to scale up when there is a complex ecosystem of players,” says 
Prashant Yadav, a health-policy researcher at the William Davidson Institute at the 
University of Michigan, Ann Arbor, who studies the ACT market. 
Before the advent of SSA, the only source of artemisinin was the sweet 
wormwood plant (Artemisia annua), the discovery of which won Chinese scientist 
Youyou Tu a share of the 2015 Nobel Prize in Physiology or Medicine. But 
the agricultural supply has been erratic. Shortages ofA. annua send prices soaring, 
which attracts more farmers to plant it; their produce then swamps the market, 
depressing prices and triggering fresh shortages (see ‘A stable artemisinin 
market?’). 
 
S U P P L E M E N T  O R  S A V I O U R ?  
The synthetic-biology route promised to end this rollercoaster by providing a 
stable and reliable source of artemisinin. Sanofi developed the capacity to produce 
almost 60 tonnes of the chemical per year—about one-third of global need—and 
the company hoped to supply other ACT manufacturers with the raw materials. 
“In reality, that has not happened,” says Yadav. Sanofi has so far used its 
SSA to make more than 39 million treatments of its own version of ACT—
representing about 10% of global ACT demand—but has not sold the chemical to 
other drugmakers. 
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That is partly because of a glut in agricultural artemisinin. For the past two 
years, the naturally derived chemical has sold for less than $250 per kilogram—
below Sanofi’s ‘no profit–no loss’ margin of around $350–400 per kilogram. “If 
that price is already very low and there’s a bumper crop, there’s no reason to fire 
up a fermenter,” says Jay Keasling of the University of California, Berkeley, who 
led the team that first developed the yeast strain. 
But ACT manufacturers such as China’s Guilin Pharma and India’s Cipla 
are also reluctant to buy their drug ingredients from Sanofi, says Yadav, because 
the company is a direct competitor in the ACT market. 
And Sanofi has not found it worthwhile to increase production of its own 
ACT because demand has plateaued. This is in part the result of growing efforts to 
diagnose malaria before doling out medicine: malaria treatments are often taken by 
people with fevers who do not actually have malaria, so more-accurate diagnoses 
help to reduce the number of treatments needed. Whether demand will rise again 
will depend on how international efforts to tackle malaria develop in the future, 
and how much funding will be available to purchase ACTs. 
By July, Sanofi will complete the sale of its Garessio manufacturing plant to 
Bulgarian company Huvepharma, a contract manufacturer responsible for 
fermenting the engineered yeast in vats to make artemisinic acid—the precursor to 
artemisinin—for Sanofi. 
Nicola de Risi, a manager for Huvepharma in Rome who will head the 
firm’s Italian division, hopes that by gaining control of the entire SSA production 
process (from yeast to final product), the company will be able to lower costs and 
make sales to other ACT manufacturers. But Huvepharma will switch to using 
plant-derived artemisinin if it cannot make SSA cost-competitive, de Risi says. 
PATH, a global-health organization based in Seattle, Washington, which 
coordinated the development of SSA, says that it still considers the project a 
success. “Since SSA entered the market, we have observed better price stability, 
and there has been adequate supply of artemisinin,” it said in a statement. 
“There is merit to the argument that SSA has contributed somewhat to 
stabilizing prices,” says Yadav. But the main causes of price stability, he adds, are 
the recent steady demand for ACTs and long-term purchasing contracts with ACT 
manufacturers, set up by the Global Fund to Fight AIDS, Tuberculosis and 
Malaria. 
PATH and Keasling say that SSA was always intended to be a supplemental 
source to fill gaps in agricultural production, or to cope with spikes in demand. But 
Claire Marris, a sociologist of science at City University London who previously 
worked at the Centre for Synthetic Biology and Innovation at Imperial College 
London, says that in her experience, SSA is often portrayed by those working in 
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the field as simply a low-cost, high-volume substitute for agricultural artemisinin. 
“It was constantly talked about,” she says. Now, Marris worries that unrealistic 
expectations for SSA’s achievements could damage public trust in synthetic 
biology. 
When the Gates Foundation awarded the first of its grants for the SSA 
project in 2004, it explicitly aimed to lower the cost of each ACT treatment from 
$2.40 to “well under a dollar”. But the median price of Sanofi’s ACT had already 
dipped to $0.92 per adult treatment by 2012, well before the introduction of SSA, 
and it has changed little since then. 
De Risi says that SSA production will restart later this year so that Sanofi 
can produce its own ACT treatment. “I think it’s good for synthetic artemisinin,” 
says Yadav, who points out that other ACT producers may be more willing to buy 
artemisinin from Huvepharma because it is not an ACT producer itself—and 
therefore not a direct competitor. 
Meanwhile, Guilin Pharma and Cipla are making plans to develop their own 
SSA, and Keasling hopes that more research and development work could make 
the synthetic process cheaper in the long term. “I’d like to see SSA take over as the 
dominant form, and some day I think it will,” says Keasling. “But we have to be 
patient.” 
Scientific American February 25, 2016 
http://www.scientificamerican.com/article/synthetic-biology-s-first-malaria-
drug-meets-market-resistance/ 
 
 
Text 4. CRISPR/Cas9 and Targeted Genome 
Editing: A New Era in Molecular Biology 
The development of efficient and reliable ways to make precise, targeted 
changes to the genome of living cells is a long-standing goal for biomedical 
researchers. Recently, a new tool based on a bacterial CRISPR-associated protein-
9 nuclease (Cas9) from Streptococcus pyogenes has generated considerable 
excitement. This follows several attempts over the years to manipulate gene 
function, including homologous recombination and RNA interference (RNAi). 
RNAi, in particular, became a laboratory staple enabling inexpensive and high-
throughput interrogation of gene function, but it is hampered by providing only 
temporary inhibition of gene function and unpredictable off-target effects. Other 
recent approaches to targeted genome modification – zinc-finger nucleases [ZFNs,] 
and transcription-activator like effector nucleases [TALENs ]– enable researchers 
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to generate permanent mutations by introducing doublestranded breaks to activate 
repair pathways. These approaches are costly and time-consuming to engineer, 
limiting their widespread use, particularly for large scale, high-throughput studies. 
The Biology of Cas9 
The functions of CRISPR (Clustered Regularly Interspaced Short 
Palindromic Repeats) and CRISPR-associated (Cas) genes are essential in adaptive 
immunity in select bacteria and archaea, enabling the organisms to respond to and 
eliminate invading genetic material. These repeats were initially discovered in the 
1980s in E. coli , but their function wasn’t confirmed until 2007 by Barrangou and 
colleagues, who demonstrated that S. thermophiluscan acquire resistance against a 
bacteriophage by integrating a genome fragment of an infectious virus into its 
CRISPR locus . 
Three types of CRISPR mechanisms have been identified, of which type II is 
the most studied. In this case, invading DNA from viruses or plasmids is cut into 
small fragments and incorporated into a CRISPR locus amidst a series of short 
repeats (around 20 bps). The loci are transcribed, and transcripts are then processed 
to generate small RNAs (crRNA – CRISPR RNA), which are used to guide 
effector endonucleases that target invading DNA based on sequence 
complementarity 
(Figure1)  
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One Cas protein, Cas9 (also known as Csn1), has been shown, through 
knockdown and rescue experiments to be a key player in certain CRISPR 
mechanisms (specifically type II CRISPR systems). The type II CRISPR 
mechanism is unique compared to other CRISPR systems, as only one Cas protein 
(Cas9) is required for gene silencing . In type II systems, Cas9 participates in the 
processing of crRNAs , and is responsible for the destruction of the target DNA . 
Cas9’s function in both of these steps relies on the presence of two nuclease 
domains, a RuvC-like nuclease domain located at the amino terminus and a HNH-
like nuclease domain that resides in the mid-region of the protein . 
To achieve site-specific DNA recognition and cleavage, Cas9 must be 
complexed with both a crRNA and a separate trans-activating crRNA (tracrRNA or 
trRNA), that is partially complementary to the crRNA . The tracrRNA is required 
for crRNA maturation from a primary transcript encoding multiple pre-crRNAs. 
This occurs in the presence of RNase III and Cas9 . 
During the destruction of target DNA, the HNH and RuvC-like nuclease 
domains cut both DNA strands, generating double-stranded breaks (DSBs) at sites 
defined by a 20-nucleotide target sequence within an associated crRNA transcript 
(11, 14). The HNH domain cleaves the complementary strand, while the RuvC 
domain cleaves the noncomplementary strand. 
The double-stranded endonuclease activity of Cas9 also requires that a short 
conserved sequence, (2–5 nts) known as protospacer-associated motif (PAM), 
follows immediately 3´- of the crRNA complementary sequence. In fact, even fully 
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complementary sequences are ignored by Cas9-RNA in the absence of a PAM 
sequence . 
Cas9 and CRISPR as a New Tool in Molecular Biology 
The simplicity of the type II CRISPR nuclease, with only three required 
components (Cas9 along with the crRNA and trRNA) makes this system amenable 
to adaptation for genome editing. This potential was realized in 2012 by the 
Doudna and Charpentier labs. Based on the type II CRISPR system described 
previously, the authors developed a simplified two-component system by 
combining trRNA and crRNA into a single synthetic single guide RNA (sgRNA). 
sgRNAprogrammed Cas9 was shown to be as effective as Cas9 programmed with 
separate trRNA and crRNA in guiding targeted gene alterations (Figure 2A). 
To date, three different variants of the Cas9 nuclease have been adopted in 
genome-editing protocols. The first is wild-type Cas9, which can site-specifically 
cleave double-stranded DNA, resulting in the activation of the doublestrand break 
(DSB) repair machinery. DSBs can be repaired by the cellular Non-Homologous 
End Joining (NHEJ) pathway , resulting in insertions and/or deletions (indels) 
which disrupt the targeted locus. Alternatively, if a donor template with homology 
to the targeted locus is supplied, the DSB may be repaired by the homology-
directed repair (HDR) pathway allowing for precise replacement mutations to be 
made (Figure 2A) . 
Cong and colleagues took the Cas9 system a step further towards increased 
precision by developing a mutant form, known as Cas9D10A, with only nickase 
activity. This means it cleaves only one DNA strand, and does not activate NHEJ. 
Instead, when provided with a homologous repair template, DNA repairs are 
conducted via the high-fidelity HDR pathway only, resulting in reduced indel 
mutations . Cas9D10A is even more appealing in terms of target specificity when 
loci are targeted by paired Cas9 complexes designed to generate adjacent DNA 
nicks (see further details about “paired nickases” in Figure 2B). 
The third variant is a nuclease-deficient Cas9 (dCas9, Figure 2C) . Mutations 
H840A in the HNH domain and D10A in the RuvC domain inactivate cleavage 
activity, but do not prevent DNA binding . Therefore, this variant can be used to 
sequence-specifically target any region of the genome without cleavage. Instead, 
by fusing with various effector domains, dCas9 can be used either as a gene 
silencing or activation tool .Furthermore, it can be used as a visualization tool. For 
instance, Chen and colleagues used dCas9 fused to Enhanced Green Fluorescent 
Protein (EGFP) to visualize repetitive DNA sequences with a single sgRNA or 
nonrepetitive loci using multiple sgRNAs. 
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Figure 2. CRISPR/Cas9 System Applications 
 
 
A. Wild-type Cas9 nuclease site specifically cleaves double-stranded DNA 
activating double-strand break repair machinery. In the absence of a homologous 
repair template non-homologous end joining can result in indels disrupting the 
target sequence. Alternatively, precise mutations and knock-ins can be made by 
providing a homologous repair template and exploiting the homology directed 
repair pathway. 
B. Mutated Cas9 makes a site specific single-strand nick. Two sgRNA can be 
used to introduce a staggered double-stranded break which can then undergo 
homology directed repair. 
C. Nuclease-deficient Cas9 can be fused with various effector domains 
allowing specific localization. For example, transcriptional activators, repressors, 
and fluorescent proteins. 
Targeting Efficiency and Off-target Mutations 
Targeting efficiency, or the percentage of desired mutation achieved, is one 
of the most important parameters by which to assess a genome-editing tool. The 
targeting efficiency of Cas9 compares favorably with more established methods, 
such as TALENs or ZFNs . For example, in human cells, custom-designed ZFNs 
and TALENs could only achieve efficiencies ranging from 1% to 50% . In 
contrast, the Cas9 system has been reported to have efficiencies up to >70% in 
zebrfish and plants,and ranging from 2–5% in induced pluripotent stem cells . In 
addition, Zhou and colleagues were able to improve genome targeting up to 78% in 
one-cell mouse embryos, and achieved effective germline transmission through the 
use of dual sgRNAs to simultaneously target an individual gene . 
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A widely used method to identify mutations is the T7 Endonuclease I 
mutation detection assay (36, 37) (Figure 3). This assay detects heteroduplex DNA 
that results from the annealing of a DNA strand, including desired mutations, with 
a wildtype DNA strand (37). 
 
 
Genomic DNA is amplified with primers bracketing the modified locus. PCR 
products are then denatured and re-annealed yielding 3 possible structures. 
Duplexes containing a mismatch are digested by T7 Endonuclease I. The DNA is 
then electrophoretically separated and fragment analysis is used to calculate 
targeting efficiency. 
Another important parameter is the incidence of off-target mutations. Such 
mutations are likely to appear in sites that have differences of only a few 
nucleotides compared to the original sequence, as long as they are adjacent to a 
PAM sequence. This occurs as Cas9 can tolerate up to 5 base mismatches within 
the protospacer region  or a single base difference in the PAM sequence . Off-
target mutations are generally more difficult to detect, requiring whole-genome 
sequencing to rule them out completely. 
Recent improvements to the CRISPR system for reducing off-target 
mutations have been made through the use of truncated gRNA (truncated within 
the crRNA-derived sequence) or by adding two extra guanine (G) nucleotides to 
the 5´ end. Another way researchers have attempted to minimize off-target effects 
is with the use of “paired nickases”. This strategy uses D10A Cas9 and two 
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sgRNAs complementary to the adjacent area on opposite strands of the target site 
(Figure 2B). While this induces DSBs in the target DNA, it is expected to create 
only single nicks in off-target locations and, therefore, result in minimal off-target 
mutations. 
By leveraging computation to reduce off-target mutations, several groups 
have developed webbased tools to facilitate the identification of potential CRISPR 
target sites and assess their potential for off-target cleavage. Examples include the 
CRISPR Design Tool and the ZiFiT Targeter, Version 4.2 . 
Applications as a Genome-editing and Genome Targeting Tool 
Following its initial demonstration in 2012, the CRISPR/Cas9 system has 
been widely adopted. This has already been successfully used to target important 
genes in many cell lines and organisms, including human, bacteria, zebrafish, C. 
elegans, plants, Xenopus tropicalis, yeast, Drosophila, monkeys, rabbits, pigs, rats 
and mice. Several groups have now taken advantage of this method to introduce 
single point mutations (deletions or insertions) in a particular target gene, via a 
single gRNA. Using a pair of gRNA-directed Cas9 nucleases instead, it is also 
possible to induce large deletions or genomic rearrangements, such as inversions or 
translocations. A recent exciting development is the use of the dCas9 version of the 
CRISPR/Cas9 system to target protein domains for transcriptional regulation, 
epigenetic modification , and microscopic visualization of specific genome loci. 
The CRISPR/Cas9 system requires only the redesign of the crRNA to 
change target specificity. This contrasts with other genome editing tools, including 
zinc finger and TALENs, where redesign of the protein-DNA interface is required. 
Furthermore, CRISPR/Cas9 enables rapid genome-wide interrogation of gene 
function by generating large gRNA libraries  for genomic screening. 
The future of CRISPR/Cas9 
The rapid progress in developing Cas9 into a set of tools for cell and 
molecular biology research has been remarkable, likely due to the simplicity, high 
efficiency and versatility of the system. Of the designer nuclease systems currently 
available for precision genome engineering, the CRISPR/Cas system is by far the 
most user friendly. It is now also clear that Cas9’s potential reaches beyond DNA 
cleavage, and its usefulness for genome locus-specific recruitment of proteins will 
likely only be limited by our imagination. 
          NEB expressions Issue I, 2014 
https://www.neb.com/tools-and-resources/feature-articles/crispr-cas9-and-
targeted-genome-editing-a-new-era-in-molecular-biology 
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Text 5. Scientists Discover Children’s Cells Living in 
Mothers’ Brains 
The connection between mother and child is ever deeper than thought 
 
 
The link between a mother and child is profound, and new research suggests 
a physical connection even deeper than anyone thought. The profound 
psychological and physical bonds shared by the mother and her child begin during 
gestation when the mother is everything for the developing fetus, supplying 
warmth and sustenance, while her heartbeat provides a soothing constant rhythm. 
The physical connection between mother and fetus is provided by the 
placenta, an organ, built of cells from both the mother and fetus, which serves as a 
conduit for the exchange of nutrients, gasses, and wastes. Cells may migrate 
through the placenta between the mother and the fetus, taking up residence in 
many organs of the body including the lung, thyroid, muscle, liver, heart, kidney 
and skin. These may have a broad range of impacts, from tissue repair and cancer 
prevention to sparking immune disorders. 
It is remarkable that it is so common for cells from one individual to 
integrate into the tissues of another distinct person. We are accustomed to thinking 
of ourselves as singular autonomous individuals, and these foreign cells seem to 
belie that notion, and suggest that most people carry remnants of other individuals. 
As remarkable as this may be, stunning results from a new study show that cells 
from other individuals are also found in the brain. In this study, male cells were 
found in the brains of women and had been living there, in some cases, for several 
decades. What impact they may have had is now only a guess, but this study 
revealed that these cells were less common in the brains of women who had 
Alzheimer’s disease, suggesting they may be related to the health of the brain. 
We all consider our bodies to be our own unique being, so the notion that we 
may harbor cells from other people in our bodies seems strange. Even stranger is 
the thought that, although we certainly consider our actions and decisions as 
originating in the activity of our own individual brains, cells from other individuals 
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are living and functioning in that complex structure. However, the mixing of cells 
from genetically distinct individuals is not at all uncommon. This condition is 
called chimerism after the fire-breathing Chimera from Greek mythology, a 
creature that was part serpent part lion and part goat. Naturally occurring chimeras 
are far less ominous though, and include such creatures as the slime mold and 
corals. 
 Microchimerism is the persistent presence of a few genetically distinct cells 
in an organism. This was first noticed in humans many years ago when cells 
containing the male “Y” chromosome were found circulating in the blood of 
women after pregnancy. Since these cells are genetically male, they could not have 
been the women’s own, but most likely came from their babies during gestation. 
In this new study, scientists observed that microchimeric cells are not only 
found circulating in the blood, they are also embedded in the brain. They examined 
the brains of deceased women for the presence of cells containing the male “Y” 
chromosome. They found such cells in more than 60 percent of the brains and in 
multiple brain regions. Since Alzheimer’s disease is more common in women who 
have hadmultiple pregnancies, they suspected that the number of fetal cells would 
be greater in women with AD compared to those who had no evidence for 
neurological disease. The results were precisely the opposite: there were fewer 
fetal-derived cells in women with Alzheimer’s. The reasons are unclear. 
Microchimerism most commonly results from the exchange of cells across 
the placenta during pregnancy, however there is also evidence that cells may be 
transferred from mother to infant through nursing. In addition to exchange between 
mother and fetus, there may be exchange of cells between twins in utero, and there 
is also the possibility that cells from an older sibling residing in the mother may 
find their way back across the placenta to a younger sibling during the latter’s 
gestation. Women may have microchimeric cells both from their mother as well as 
from their own pregnancies, and there is evenevidence for competition between 
cells from grandmother and infant within the mother. 
What it is that fetal microchimeric cells do in the mother’s body is unclear, 
although there are some intriguing possibilities. For example, fetal microchimeric 
cells are similar to stem cells in that they are able to become a variety of different 
tissues and may aid in tissue repair. One research group investigating this 
possibility followed the activity of fetal microchimeric cells in a mother rat after 
the maternal heart was injured: they discovered that the fetal cells migrated to the 
maternal heart and differentiated into heart cells helping to repair the damage. In 
animal studies, microchimeric cells were found inmaternal brains where they 
became nerve cells, suggesting they might be functionally integrated in the brain. It 
is possible that the same may be true of such cells in the human brain. 
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These microchimeric cells may also influence the immune system. A fetal 
microchimeric cell from a pregnancy is recognized by the mother’s immune 
system partly as belonging to the mother, since the fetus is genetically half 
identical to the mother, but partly foreign, due to the father’s genetic contribution. 
This may “prime” the immune system to be alert for cells that are similar to the 
self, but with some genetic differences. Cancer cells which arise due to genetic 
mutations are just such cells, and there are studies which suggest that 
microchimeric cells may stimulate the immune system to stem the growth of 
tumors. Many more microchimeric cells are found in the blood of healthy women 
compared to those with breast cancer, for example, suggesting that microchimeric 
cells can somehow prevent tumor formation. In other circumstances, the immune 
system turns against the self, causing significant damage. Microchimerism is more 
common in patients suffering from Multiple Sclerosis than in their healthy siblings, 
suggesting chimeric cells may have a detrimental role in this disease, perhaps by 
setting off an autoimmune attack. 
This is a burgeoning new field of inquiry with tremendous potential for 
novel findings as well as for practical applications. But it is also a reminder of our 
interconnectedness. 
Scientific American December 4, 2012 
http://www.scientificamerican.com/article/scientists-discover-childrens-
cells-living-in-mothers-brain/ 
 
 
Text 6. We Need More Proof That Prenatal Gene 
Screens Are Beneficial 
Blood tests are safer for pregnant women but do not tell the whole truth 
 
Expecting a baby often provokes mixed emotions—wonder and amazement 
but also concern. Will the child be healthy? Happy? Find his or her spot in the 
world? Several prenatal blood tests are now available that attempt to ease some of 
116 
 
the anxiety—at least about health. By analyzing trace amounts of fetal DNA in a 
pregnant woman's bloodstream, these tests (which go by such names as Harmony, 
MaterniT21 PLUS and verifi) can identify various genetic anomalies up to six 
months before birth. Whether or not parents to be take advantage of these 
laboratory measures is, of course, up to them. But results from screening tests can 
be misleading, and industry and federal regulators are not doing enough to ensure 
that people get all the information they need. 
At present, the tests detect major abnormalities—such as three copies of the 
21st, 18th or 13th chromosome, which lead, respectively, to Down, Edwards and 
Patau syndrome. These measures are a definite safety improvement over earlier 
procedures to check the genes of the unborn. Previously such chromosomal 
abnormalities could be detected prenatally only by invasive tests, such as 
amniocentesis, which carry a small risk of triggering a miscarriage. 
The new screens were originally offered to women older than 35 years, who 
are at a higher risk of delivering babies with Down syndrome or other genetic 
maladies. But now companies are marketing such tests to women with low-risk 
pregnancies as well. Last November a market research firm reported that the tests 
accounted for $563.4 million worth of sales in 2014—a figure that is expected to 
quadruple by 2022. 
Federal regulations have not caught up with the advancing technology, 
however. Under current rules, such gene screens are considered lab tests, which, 
unlike new drugs, do not have to show they offer clinically meaningful benefits. 
Instead manufacturers only need to demonstrate that their tests generate results 
within certain statistically acceptable limits of error. 
This standard made more sense in the days when blood tests looked 
primarily for individual compounds, such as sugar molecules or hormones. Gene 
tests are different: they take a lot more interpretation and analysis to determine if a 
suspicious result indicates a true genetic aberration or merely a benign variation. 
For one thing, the amount of fetal DNA found in the maternal bloodstream is 
minute and must be copied many times to generate enough material to test. The 
amplification process, among other things, may lead to double counting mistakes 
that give the false impression of an extra 21st chromosome, for example, where 
none exists. A second source of uncertainty stems from the fact that the new 
genetic tests are actually screening tests, which, by definition, cast a broad net that 
includes many more false-positive results than more specialized diagnostic 
procedures that are typically more accurate. 
Ignoring this distinction can lead to serious problems. If a screening test on 
1,000 people correctly identified 19 out of 20 true cases of a genetic problem, it 
would have what statisticians call a sensitivity rate of 95 percent. That sounds 
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pretty good, but that same test might also yield 10 false positives—10 other people 
in the group for whom the test incorrectly suggested a problem. The sensitivity rate 
would still be 95 percent because the test caught most of the true positives. But just 
over 65 percent of all the positive results—19 out of 29—were actually correct. 
It is this last ratio—what statisticians called the positive predictive value—
that tells you how much faith you should really have in a particular test result. And 
yet most gene-screening companies do not provide the positive predictive values 
for their tests. Instead they tout their tests' sensitivity rate, which can mislead 
patients and even their physicians. Problems with prediction are why anyone who 
receives a positive result from a screening test should follow it up with a more 
precise diagnostic exam. 
The U.S. Food and Drug Administration also needs to follow up on these 
tests. It should accelerate efforts to change the rules so that the makers of gene 
screens give more clinically relevant information, such as predictive values. The 
companies that offer noninvasive prenatal screening should do more to educate all 
of us about a test's potential drawbacks. And expectant parents should think 
carefully about whether they want to undergo these screenings in the first place, 
particularly because new blood tests that supposedly provide a glimpse into the 
entire fetal genome—including possible predispositions to heart disease, cancer or 
diabetes—are just around the corner. 
Scientific American February 1, 2016 
http://www.scientificamerican.com/article/we-need-more-proof-that-
prenatal-gene-screens-are-beneficial/ 
 
Text 7. Monkeys Are Genetically Modified to Show 
Autism Symptoms 
But it is unclear how well the results match the condition in humans 
 
 
The laboratory monkeys run obsessively in circles, largely ignore their peers 
and grunt anxiously when stared at. Engineered to have a gene that is related to 
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autism spectrum disorder in people, the monkeys are the most realistic animal 
model of the condition yet, say their creators. Researchers hope that the animals 
will open up new ways to test treatments and investigate the biology of autism. But 
the jury is still out on how well the monkeys’ condition matches that of people 
with autism. 
Autism has a vast array of symptoms and types, but researchers think that at 
least 100 genes play a part. The scientists who led the latest work, which is 
published on 25 January in Nature, turned to the autism-related gene MECP2: both 
people who have extra copies of the gene (MECP2-duplication syndrome) and 
people who have certain mutations in this gene (Rett’s syndrome) share many of 
the symptoms of autism. Previously researchers have engineered monkeys to have 
autism-related genes, but this is the first published demonstration of a link between 
those genes and the animals’ behavior. 
Back in 2010, the team, led by researchers at the Chinese Academy of 
Sciences’ Institute of Neuroscience in Shanghai attached human MECP2 genes to a 
harmless virus, which they injected into the eggs of crab-eating macaque monkeys 
(Macaca fascicularis) before fertilizing them. The developing embryos were then 
implanted into female monkeys. The result was eight genetically manipulated 
newborns, who had between one and seven extra copies of MECP2. Examinations 
of other, stillborn monkeys revealed that the extra copies were being expressed in 
the brain. “That was the first exciting moment,” says Zilong Qiu, a molecular 
biologist at the Institute of Neuroscience and a co-author on the paper. 
The next breakthrough came about a year later when the monkeys showed 
behaviors that hinted at autism: running around in tight circles in a strange manner. 
“If another monkey is in its way, it will either jump over the monkey, or go around 
it, but then it would return to its original circular path,” says co-author Sun Qiang, 
a reproductive biologist at the institute. 
The team launched a battery of behavioral tests, which showed that all of the 
monkeys had at least one autism-like symptom, such as repetitive or asocial 
behavior, and that the symptoms were more severe in males, as seen in people with 
the MECP2 duplications. But this still wasn’t enough to be sure that the monkeys 
were a sound model of autism — and a paper that the team submitted for 
publication in 2013 was rejected. Among other things, reviewers wanted to know 
whether the unusual behavior was just the result of fiddling around with the 
genome. “We needed to show where the gene makes a difference,” says Qiu. 
That opportunity came with the next generation of macaques, which the 
team created with unprecedented speed. When the monkeys were 27 months old 
and not yet sexually mature, Sun’s team took testes from the males, matured the 
tissue artificially by grafting it under the skin on the backs of castrated mice, and 
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used the resulting sperm to fertilize eggs from non-engineered macaques. The 
offspring showed asocial behavior at about 11 months. That both gene and 
symptoms seemed to be passed on to a second generation was finally enough to 
convince reviewers, says Qiu.  
The macaque model is “superior” to existing mouse models of autism 
because “it actually shows more clearly some of the autism-like behaviors”, says 
Alysson Muotri, who researches stem cells, autism and Rett’s syndrome at the 
University of California, San Diego. But he adds that the symptoms in both mice 
and monkeys still seem less severe than “what we actually observe in human 
patients”. “It remains to be seen if the model can actually generate novel insights 
into the human condition,” he says. 
Huda Zoghbi, a pioneer of MECP2 studies in mice at Baylor College of 
Medicine in Houston, Texas, is even more cautious. The monkeys do not mimic 
some of the human MECP2-duplication symptoms, such as seizures and severe 
cognitive problems, she notes. This could be because the expression of the gene in 
the monkey model is triggered by a different mechanism from that in humans — a 
limitation that the authors recognize — and she advises caution in using the model 
to make assumptions about human autism. 
Qiu, meanwhile, is excited by the prospect of using the model to identify 
exactly where in the brain the MECP2 overexpression causes trouble. His team is 
already using brain-imaging technology on the monkeys to pinpoint such areas. 
Next, the researchers plan to use the CRISPR gene-editing technique to knock out 
the extra MECP2 copies in cells in those regions and then check whether the 
autisim-like symptoms stop.  
It is unlikely that such a technique would be approved for use in people any 
time soon. But the regions identified in the monkey study could be targeted with 
other, existing treatments — such as deep brain stimulation, which has had success 
for Parkinson’s disease and depression. Because the structure of the mouse brain is 
so different from that of human brains, Qiu says that the monkey imaging will 
allow more parallels to be drawn with humans than mice studies could. 
Working with a mental-health hospital, the team is also trying to identify the 
autism-linked genes that are most common in the Chinese population. 
If non-human primates prove to be a useful model for psychiatric disorders, 
China and other countries that are investing heavily in research on monkeys, such 
as Japan, could gain an edge in brain research. Muotri says that such studies 
probably wouldn’t be done in the United States, for example, where research on 
non-human primates is more expensive and controversial than it is in Japan or 
China. “China and Japan have a clear advantage over the US on this area,” he says. 
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Scientific American January 25, 2016 
http://www.scientificamerican.com/article/monkeys-are-genetically-
modified-to-show-autism-symptoms/ 
 
 
Text 8. Why Studying Fertility in Sea Urchins 
Makes Sense [Excerpt] 
 
Google “sea urchin fertilization” and you’ll find dozens of animations and videos 
of lone sea urchin sperm finding its way home to an egg  
Admittedly, spontaneous sex on the subway is a bit of a stretch (and 
probably nauseating for anyone who rides the G train on a regular basis). But the 
idea that sex depends upon a crowd is no exaggeration—especially for the less-
than-agile lot. 
Take sea urchins. A few leaky males can cause an entire nearby cluster of 
sea urchins to unleash clouds of sperm, which they pump out through holes in the 
tops of their heads. As is so often the case, males tend to let loose their loads first, 
followed by the females. It’s a familiar pattern, occurring in sea cucumbers and 
abalone, among others. With sea cucumbers—squishy, sausage-shaped cousins of 
sea stars and sea urchins—researchers think the slight delay between male and 
female spawning times might help increase fertilization rates. The sperm released 
by males forms a dense cloud just off the bottom through which the females’ 
buoyant eggs must float on their way to the surface. 
In general, bottom-dwelling, or benthic, invertebrates such as sea 
cucumbers, sea stars, and sea urchins don’t tend to travel very far, certainly not 
when compared with migrating bluefin, but even compared with horseshoe crabs. 
(Deep-sea species may be an exception, as they have to scavenge across fair 
distances for sparse food supplies.) But around coastal and shallow seas, many 
invertebrates stick close to home—tubed feet can only take you so far. When it’s 
time to have sex, these species huddle up with their neighbors as individuals 
broadcast millions (sometimes billions) of sperm and eggs into the currents. 
In an ironic twist, this strategy for boosting fertilization success can also 
pose a significant threat: even in the enormous expanse of sea, there can be such a 
thing as too much sperm. For most eggs in the animal kingdom, polyspermy—
multiple sperm penetrating an egg—is fatal (those choosey female Beroë 
ctenophores are a rare exception). To understand what’s going on, we’ve got to 
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dive down to the microscopic front line where sperm meets egg. The battle of the 
sexes rages on even at this unicellular level, and, believe it or not, sea urchins are 
the go-to animal for studying this kind of stuff. An extremely diverse group, sea 
urchins can be the size of a small brown bur or enormous, such as the softball-
sized, long-spined black sea urchins, which wield four- to twelve-inch needlelike 
spines. They look more like a medieval weapon than the underwater lawn mowers 
they truly are. Impressive to behold, disastrous to touch, sea urchins can be found 
from the shallows to thousands of feet deep, from the warmest tropical seas to the 
undersea plains of the Arctic Ocean. 
Google “sea urchin fertilization” and you’ll find dozens of animations and 
videos of lone sea urchin sperm finding its way home to an egg. Why the plethora 
of sea urchin sex tapes? Because studying fertilization in sea urchins makes sense. 
They are easy to keep in aquaria, spawn on command (a quick injection of 
potassium chloride, aka sea urchin ejaculation juice, is all it takes), their gametes 
are easy to collect once in the water, and because fertilization takes place outside 
the body, it’s much easier to observe and manipulate than, say, inside an elephant. 
And, not insignificantly, PETA has yet to march on behalf of captive sea urchins. 
So, anyone out there who has ever received fertility treatments, any of the 
hundreds of thousands of couples who have successfully tried IVF, and especially 
any of the estimated five million or more people who now exist because of such 
assisted reproductive technology—thank sea urchins. All of those innovations 
stand on the shoulders of a basic understanding of what actually happens when 
sperm and egg collide. And we know that from studying sea urchins. 
 
Scientific American February 13, 2016 
http://www.scientificamerican.com/article/why-studying-fertility-in-sea-
urchins-makes-sense-excerpt/ 
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Text 9. Antibiotics in Animal Feed May Endanger 
Kids, Doctors Warn 
The widespread practice of giving antibiotics to healthy livestock to promote 
growth and prevent disease is making the drugs ineffective, the American Academy 
of Pediatrics says 
 
(Reuters Health) - Overuse of antibiotics in animal feed is making it harder 
for doctors to treat life-threatening infections in young children, a report from U.S. 
pediatricians warns. 
The report from the American Academy of Pediatrics (AAP) says the 
widespread practice of giving antibiotics to healthy livestock to promote growth 
and prevent disease among animals is making the drugs ineffective when they are 
needed to treat infections in people. 
“The antibiotics that are fed to the animals lead to the development of 
antibiotic resistant bacteria in the animal,” study co-author Dr. Theoklis Zaoutis of 
the University of Pennsylvania and the Children’s Hospital of Philadelphia said by 
email. “These bacteria can then be spread to other animals, the environment and to 
humans.” 
More than two million Americans become ill with antibiotic-resistant 
infections each year, and 23,000 die as a result, Zaoutis and co-author Dr. Jerome 
Paulson report in the journal Pediatrics. Paulson formerly chaired the executive 
committee of the AAP’s Council on Environmental Health, 
They estimate that national costs to the U.S. healthcare system attributable to 
antibiotic resistant infections run from $21 billion to $34 billion annually. 
Infants and children are affected by antibiotic-resistant bacteria in the food 
supply, direct contact with animals and exposure in the environment, the 
researchers report. 
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For most infections, incidence was highest among children under age five, 
according to data the researchers cited from Center for Disease Control and 
Prevention's Foodborne Diseases Active Surveillance Network. 
While people can’t get antibiotics without a prescription, animals can, the 
researchers point out. 
Pediatricians and parents can help combat antibiotic resistance by avoiding 
use of antibiotics to treat colds or other viral illnesses. 
Parents and other consumers may also help discourage the use of antibiotics 
in livestock feed by choosing to buy only organic products or foods labeled as 
“raised without antibiotics,” said Urvashi Rangan, executive director of the 
Consumer Reports Food Safety and Sustainability Center. 
“Consuming foods from animals produced without the routine use of 
antibiotics is one important step in reducing personal risk; so is cooking our foods 
thoroughly,” Rangan, who wasn’t involved in the report, said by email. 
But the long-term solution to antibiotic resistance may require changes in the 
way we produce animals for food, including stopping the use of antibiotics and 
other drugs in healthy animals and also implementing better drug-free hygiene and 
management practices to curb disease risk on farms, Rangan added. 
Even purchasing organic doesn’t guarantee that there will not be resistant 
bacteria present, noted Timothy Landers, an antibiotics researcher at Ohio State 
University in Columbus. 
“From a farmer’s perspective, the use of antibiotics helps ensure that food is 
safe, nutritious and affordable,” Landers, who wasn’t involved in the study, said by 
email. “What we have lacked is a coordinated, integrated approach to antibiotic 
resistance including experts on human health, food production animal health and 
the environment.” 
Scientific American November 16, 2015 
http://www.scientificamerican.com/article/antibiotics-in-animal-feed-may-
endanger-kids-doctors-warn/ 
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Text 10. Gene-Modified Tomatoes Churn Out 
Healthy Nutrients 
Plants, engineered to make extra substances that protect human cells, show GMO 
crops may improve health 
 
 
A variety of tomato that has been genetically engineered to produce large 
quantities of potentially health-boosting compounds—including flavanols and 
anthocyanins—has been developed by researchers in the UK. 
A single tomato of the new variety contains the same amount 
of resveratrol as 50 bottles of red wine, or the same amount of genistein (a 
compound found in soy beans that is thought to have health benefits) as 2.5kg of 
tofu. As tomato plants grow quickly and produce a lot of fruit, farming this new 
variety could be a way to produce these nutrients in industrial quantities much 
more cheaply than synthesising them chemically, or extracting small amounts from 
other plant sources. 
The variety was made by introducing a gene from the model 
plant Arabidopsis thaliana—called AtMYB12—into the tomato genome.  The 
gene codes for a transcription factor that binds to the promoter regions of genes 
encoding various metabolic enzymes. ‘In Arabidopsis [the] MYB12 [transcription 
factor] regulates the production of flavonols … which are important in UV 
protection and signalling,’ says Cathie Martin, who led the study at the John Innes 
Centre in Norwich, UK. 
When AtMYB12 is introduced into tomato plants, it switches on metabolic 
pathways that shift the plant’s energy and carbon pathways towards the production 
of flavonols and phenylpropanoids as the fruit develops. This causes these 
desirable metabolites to build up in the fruit. ‘As much as 10% of the carbon in the 
fruit can be flavonols,’ says Martin. ‘This high level accumulation is a special 
feature of AtMYB12 because it targets both primary and secondary metabolism 
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and increases the supply of aromatic amino acid precursors as well as ATP and 
reducing power.’ 
By introducing additional plant genes—such as the enzymes necessary for 
the production of resveratrol in grapes—the plants can be engineered to produce 
specific compounds that are thought to have certain nutritional or health benefits. 
‘The tomato is a wonderful production system. If metabolic engineering is targeted 
to the end of fruit development, the fruit can serve as a bag in which to accumulate 
natural products, without impacting yield,’ says Martin. 
Broadening the debate 
As well as being a good way to produce large quantities of the target 
nutrients, Martin says the tomatoes could potentially be sold for consumption 
down the line. ‘If the different compounds we have engineered in tomato can be 
shown to protect against chronic diseases in preclinical studies, we could consider 
applying for regulatory approval for commercial sales. This we are doing with high 
anthocyanin tomato juice which has well-proven protective effects.’ 
Martin adds that the AtMYB12 gene could also be engineered into other 
fruits, and potentially certain vegetables where the products could be accumulated 
in a storage organ such as a tuber. 
‘This research gives us a better understanding of how healthy nutrients are 
genetically controlled in tomato, and maybe other fruits,’ comments Huw Jones, a 
senior research scientist at agricultural science institute Rothamsted Research. ‘It is 
a great example of how biotechnology could provide health benefits directly to 
consumers.’ He adds that the work ‘will further broaden the debate on GMOs in 
the EU’. 
Martin agrees that boosting plants’ ability to produce compounds that are 
seen as healthy may help improve the public perception of genetically engineered 
food. ‘I think when consumers see a product which offers a benefit to them, and 
which could not be derived by natural breeding methods, they will understand 
much better the potential that biotech crops have to benefit society.’ 
Scientific American November 2, 2015 
http://www.scientificamerican.com/article/gene-modified-tomatoes-churn-out-
healthy-nutrients/ 
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Web – Resources and Support 
Web links to some useful and helpful resources 
1. http://www.scientificamerican.com/article/snakebite-antivenom-
development-is-stuck-in-the-19th-century-what-s-next/ 
2. http://www.scientificamerican.com/article/improving-humans-with-
customized-genes-sparks-debate-among-scientists1/ 
3. http://www.scientificamerican.com/article/where-to-draw-the-line-on-gene-
editing-technology/ 
4. http://www.scientificamerican.com/article/childhood-cancer-risk-hides-in-
families/  
5. http://www.scientificamerican.com/article/general-anesthesia-causes-no-
cognitive-deficit-in-infants/ 
6. http://www.scientificamerican.com/article/bee-symbiosis-reveals-life-s-
deepest-partnerships-q-a/ 
7. http://www.scientificamerican.com/article/disguised-nanoparticles-slip-past-
body-s-immune-defense/ 
8. http://www.scientificamerican.com/article/where-could-the-first-crispr-baby-
be-born/? 
9. http://www.scientificamerican.com/article/the-woman-who-stared-at-wasps/ 
10. http://www.scientificamerican.com/article/dinosaurs-evolved-in-a-
startlingly-short-time/ 
11. http://blogs.scientificamerican.com/guest-blog/beyond-resveratrol-the-anti-
aging-nad-fad/ 
12. http://www.nature.com/news/crispr-tweak-may-help-gene-edited-crops-
bypass-biosafety-regulation-1.18590 
13. http://www.scientificamerican.com/article/a-battle-of-the-sexes-is-waged-in-
the-genes-of-humans-bulls-and-more/ 
14. http://www.scientificamerican.com/article/biotech-interest-in-mini-organs-
booms/ 
15. http://www.scientificamerican.com/article/synthetic-biology-s-first-malaria-
drug-meets-market-resistance/ 
16. https://www.neb.com/tools-and-resources/feature-articles/crispr-cas9-and-
targeted-genome-editing-a-new-era-in-molecular-biology 
17. http://www.scientificamerican.com/article/scientists-discover-childrens-
cells-living-in-mothers-brain/ 
18. http://www.scientificamerican.com/article/we-need-more-proof-that-
prenatal-gene-screens-are-beneficial/ 
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19. http://www.scientificamerican.com/article/monkeys-are-genetically-
modified-to-show-autism-symptoms/ 
20. http://www.scientificamerican.com/article/why-studying-fertility-in-sea-
urchins-makes-sense-excerpt/ 
21. http://www.scientificamerican.com/article/antibiotics-in-animal-feed-may-
endanger-kids-doctors-warn/ 
22. http://www.scientificamerican.com/article/gene-modified-tomatoes-churn-
out-healthy-nutrients/ 
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